1
Office of Directorate General of Foreign Trade New Delhi -0
------------------------------------------------------------------------------
Para 4.7 Decision
Minutes of the Norms Committee – 3 Meeting No. 3/82-ALC4/2019 dated 05.07.2019 (actually held on 05.07.2019 and 12.07.2019) for considering the cases/issues under Duty Exemption Scheme (Chapter-4) of Foreign Trade Policy, 2015-20 pertaining to Chemical and Allied products falling under Chapter 29 and 30, held under the Chairmanship of Shri Satyan Sharda, Addl. DGFT in Room No.11, Udyog Bhawan, New Delhi.
Following members were present:-
(i) Shri Nirmal Kumar, Dy. Director General of Foreign Trade (ii) Shri Ajay Kumar, Assistant Director (iii) Consultant, Technical Expert Pharmaceuticals (iv) Consultant, Technical Expert Chemicals
The committee went through the minutes of earlier meeting No. 2/82-ALC4/2019 dated 21.06.2019 (actually held on 21.06.2019 and 28.06.2019) and approved the same.
MEETING NUMBER : 3/82-ALC4/2019 MEETING DATE : 05.07..2019 (Actually held on 05.07.2019 and 12.07.2019)
ONLINE CASES
| 1 |
Case No.:104/23/82-<br>ALC4/2013 |
Party Name:PCL OIL &<br>SOLVENTS LTD., |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Approved |
|
HQ File<br>:01/82/050/01151/AM14/ |
RLA File<br>:05/24/040/00201/AM14/ |
Lic.No/Date:0510372321<br>29.11.2013 |
|
|
**Decision:**The Committee considered case as per agenda and deliberated on the matter in the presence<br>of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as<br>per details below or as applied by firm whichever is lower:<br>Export product<br>Qty.<br>Sl.<br>No.<br>Import items<br>Qty.<br>PVC Plasticizer( DOP )<br>1 kg<br>1<br>Phthalic Anhydride<br>0.400 kg<br>2<br>2-Ethylhexanol (Octanol)<br>0.700 kg<br>RA concerned maytake further necessaryaction asper above decision of NC. |
|
|
|
2
| Case No.:1063/15/82- |
|
Party Name:MALLADI |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
DRUGS & |
|
ALC4/2019 |
|
Approved |
|
|
PHARMACEUTICALS |
|
05.07.2019 |
|
|
|
|
LIMITED |
|
|
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0410160592 |
|
|
| :01/82/050/02520/AM19/ |
|
:04/24/040/00046/AM16/ |
|
27.05.2015 |
|
|
|
|
**Decision:**The Committee considered case as |
**Decision:**The Committee considered case as |
**Decision:**The Committee considered case as |
per agenda and deliberated on the matter in the presence |
per agenda and deliberated on the matter in the presence |
per agenda and deliberated on the matter in the presence |
per agenda and deliberated on the matter in the presence |
|
|
of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP |
|
|
|
|
|
as |
|
|
per details below or as applied by firm whichever is lower: |
|
|
|
|
|
|
| 2 |
|
|
Export product |
Qty. |
Sl. |
Import items |
Qty. |
|
|
|
|
|
|
No. |
|
|
|
|
|
|
Phenylepherine Bitartrate |
1 kg |
1 |
3-Hydroxy Acetophenone |
1.92 kg |
|
|
|
|
|
|
2 |
Methanol |
3.42 kg |
|
|
|
|
|
|
3 |
L(+)Tartaric Acid |
2.00 kg |
|
|
|
|
|
|
4 |
Methyl Isobutyl Ketone |
Not shown in |
|
|
|
|
|
|
|
|
CE certificate |
|
|
|
|
|
|
5 |
Acetic Anhydride |
1.60 kg |
|
|
|
|
|
|
6 |
Iso Propyl Alcohol |
5.17 kg |
|
|
|
|
|
|
7 |
Caustic soda Flakes |
0.46 kg |
|
|
|
RA concerned maytake further necessaryaction asper above decision of NC. |
|
|
|
|
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
| Case No.:137/14/82- |
|
Party Name:HPL ADDITIVES |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2015 |
|
LIMITED(FORMERLY |
|
ALC4/2019 |
|
Approved |
|
|
KNOWN HIGH POLYMER |
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0510395972 |
|
|
| :01/82/050/01273/AM16/ |
|
:05/23/040/00275/AM16/ |
|
19.10.2015 |
|
|
Decision: The Committee considered the cases as per agenda and in the light of earlier decision taken 3 in meeting no. 5/82-ALC4/2015 dated 25.06.2015, it was decided to ratify norms under Para 4.7 of HBP v1 as per details given below or as applied by the firm, whichever is less:
|
Export product |
Qty. |
Import items |
Qty. |
|
Azodicarbonamide |
1 kg |
Hydrazine Hydrate (100%) |
0.548 kg |
|
|
|
Technical Grade Urea |
1.316 kg |
| RA maytake appropriate action asper the decision of Norms Committee. |
|
|
|
|
3
| Case No.:324/15/82- |
|
Party Name:RA CHEM |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
PHARMA LIMITED |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0910065457 |
|
|
| :01/82/050/01781/AM19/ |
|
:09/24/040/00291/AM18/ |
|
14.09.2017 |
|
|
|
Case No.:324/15/82- |
Case No.:324/15/82- |
Party Name:RA CHEM |
Party Name:RA CHEM |
Party Name:RA CHEM |
Party Name:RA CHEM |
Party Name:RA CHEM |
Party Name:RA CHEM |
Party Name:RA CHEM |
Meet No/Date:3/82- |
Status: |
|
<br>ALC4/2018 |
|
<br>PHARMA LIMITED |
|
|
|
|
|
|
<br>ALC4/2019<br>05.07.2019 |
<br>Approved |
|
HQ File<br>:01/82/050/01781/AM19/ |
|
RLA File<br>:09/24/040/00291/AM18/ |
|
|
|
|
|
|
Lic.No/Date:0910065457<br>14.09.2017 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| 4 |
**Decision:**The Committ |
|
e considered case as per agenda |
|
|
|
|
|
|
and deliberated on the matt |
er in the presence |
|
<br>of the technical experts and it was decided to ratify the ad-hoc input output norms under par<br>per details below or as applied by firm whichever is lower:<br>Export product<br>Qty.<br>Sl.<br>No.<br>Import items<br>2-(2,3-Dichlorophenyl)<br>Methylene<br>Hydrazine Carboximdamidine<br>1 kg<br>1<br>2,3-Dichloro Benzoyl Chloride<br>2<br>Amino Guanidine Bicarbonate<br>3<br>Cuprous Cyanide<br>4<br>Hexane |
|
|
|
|
|
|
|
|
|
<br>a 4.7 of HBP as<br>Qty.<br> <br>1.60 kg<br> <br>1.06 kg<br>0.69 kg<br>2.02 kg |
|
|
|
|
|
Qty. |
|
Sl.<br>No. |
|
Import items |
|
Qty. |
|
|
|
|
|
1 kg |
|
1 |
|
2,3-Dichloro Benzoyl Chloride |
|
<br>1.60 kg |
|
|
|
|
|
|
|
2 |
|
Amino Guanidine Bicarbonate |
|
<br>1.06 kg |
|
|
|
|
|
|
|
3 |
|
Cuprous Cyanide |
|
0.69 kg |
|
|
|
|
|
|
|
4 |
|
Hexane |
|
2.02 kg |
|
|
|
|
|
|
|
|
|
|
|
|
|
RA concerned maytake further |
|
necessary |
|
action asper above decision of NC. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 5 |
Case No.:44/12/82-<br>ALC4/2018 |
|
Party Name:KRISHNA<br>ANTIOXIDANTS PVT. LTD. |
|
|
|
|
|
|
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Approved |
|
|
|
|
|
|
|
|
|
|
|
|
|
HQ File |
|
RLA File |
|
|
|
|
|
|
Lic.No/Date:0310821359 |
|
|
<br>:01/82/050/00671/AM19/ |
|
:03/94/040/00145/AM19/ |
|
|
|
|
|
|
31.05.2018 |
|
|
**Decision:**The Committee considered the cases as per agenda and in the light of earlier decision taken<br>in meeting no. 1/82-ALC4/2019 dated 03.06.2019, it was decided to ratify norms under Para 4.7 of HBP v1<br>as per details given below or as applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl.<br>No.<br>Import items<br>Qty.<br>TRI ISODECYL PHOSPHITE<br>1 kg<br>1<br>YELLOW PHOSPHORUS<br>0.065 kg<br>2<br>PHENOL<br>0.090 kg<br>3<br>ISODECYL ALCOHOL<br>0.973 kg |
|
|
|
|
|
|
|
|
|
|
|
|
Export product |
|
Qty. |
|
Sl.<br>No. |
|
Import items |
|
|
Qty. |
|
|
TRI ISODECYL PHOSPHITE |
|
1 kg |
|
1 |
|
YELLOW PHOSPHORUS |
|
|
0.065 kg |
|
|
|
|
|
|
2 |
|
PHENOL |
|
|
0.090 kg |
|
|
|
|
|
|
3 |
|
ISODECYL ALCOHOL |
|
|
0.973 kg |
|
RA |
maytake appropriate action asper the decision of Norms Committee. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 6 |
Case No.:462/15/82-<br>ALC4/2018 |
|
Party Name:SMILAX |
|
|
|
|
|
|
Meet No/Date:3/82- |
Status: |
|
|
|
<br>LABORATORIES LIMITED |
|
|
|
|
|
|
ALC4/2019<br>05.07.2019 |
Deferred |
|
HQ File<br>:01/82/050/01919/AM19/ |
|
RLA File<br>:09/24/040/00223/AM19/ |
|
|
|
|
|
|
Lic.No/Date:0910066557<br>10.08.2018 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
|
|
|
|
|
Case No.:462/15/82- |
|
Party Name:SMILAX |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
LABORATORIES LIMITED |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
| 6 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0910066557 |
|
Defer |
|
|
:01/82/050/01919/AM19/ |
|
:09/24/040/00223/AM19/ |
|
10.08.2018 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
4
|
|
Case No.:464/15/82- |
|
Party Name:MYLAN |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
LABORATORIES LIMITED |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
| 7 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0910066565 |
|
Defer |
|
|
:01/82/050/01921/AM19/ |
|
:09/24/040/00175/AM19/ |
|
13.08.2018 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
Case No.:537/15/82- |
|
Party Name:MEDWISE |
|
Meet No/Date:3/82- |
|
Status: |
|
ALC4/2018 |
|
OVERSEAS PRIVATE |
|
ALC4/2019 |
|
Deferred |
|
|
|
LIMITED |
|
05.07.2019 |
|
|
|
HQ File |
|
RLA File |
|
Lic.No/Date:0810143251 |
|
Defer |
|
:01/82/050/01994/AM19/ |
|
:08/24/040/00141/AM19/ |
|
13.08.2018 |
|
Date:05.07.2019 |
8 Decision: The Committee considered the case as per agenda in the presence of technical experts and it was decided to call for following information:
(i) Export quantity in Nos. of tablets. (ii) DML.
|
|
Case No.:470/15/82- |
|
Party Name:JODAS EXPOIM |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
PVT.LTD |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
| 9 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0510407550 |
|
Defer |
|
|
:01/82/050/01927/AM19/ |
|
:05/23/040/00232/AM19/ |
|
20.08.2018 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
|
Case No.:471/15/82- |
|
Party Name:JODAS EXPOIM |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
PVT.LTD |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
| 10 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0510407551 |
|
Defer |
|
|
:01/82/050/01928/AM19/ |
|
:05/23/040/00231/AM19/ |
|
20.08.2018 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
| Case No.:472/15/82- |
|
Party Name:WINTAC |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
LIMITED, |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0710113733 |
|
Defer |
| :01/82/050/01929/AM19/ |
|
:07/24/040/00131/AM19/ |
|
20.08.2018 |
|
Date:05.07.2019 |
11 Decision: RLA, Bangalore was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. However, the application is still awaited from RLA, Bangalore. Hence, it was decided to issue a Reminder to RLA, Bangalore for furnishing a copy of application expeditiously.
Further, the Committee considered the case as per agenda and it was decided to call for a copy of DML from the firm.
5
| 12 |
Case No.:474/15/82-<br>ALC4/2018 |
Party Name:MEDREICH<br>LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/01931/AM19/ |
RLA File<br>:07/24/040/00129/AM19/ |
Lic.No/Date:0710113746<br>23.08.2018 |
Defer<br>Date:05.07.2019 |
|
<br>**Decision:**The Committee considered the case as per agenda in the presence of technical experts and it<br>was decided to call for following information:<br>(i)<br>Copy of DML.<br>(ii)<br>Master Batch Formula. |
|
|
|
| 13 |
Case No.:475/15/82-<br>ALC4/2018 |
Party Name:WINTAC<br>LIMITED,<br>RLA File<br>:07/24/040/00098/AM19/ |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred<br> <br>Defer<br>Date:05.07.2019 |
|
<br>HQ File<br>:01/82/050/01932/AM19/ |
|
Lic.No/Date:0710113754<br>24.08.2018 |
|
|
Decision:<br>RLA, Bangalore was requested vide e-mail dated 05.04.2019 to furnish the hard copy of<br>4.07 application of subject Advance Authorization. Application awaited from RLA, Bangalore. However,<br>the application is still awaited. Hence, it was decided to issue a Reminder to RLA, Bangalore for furnishing<br>a copyof application expeditiously. |
|
|
|
| 14 |
<br>Case No.:35/15/82-<br>ALC4/2018 |
Party Name:AUROBINDO<br>PHARMA LIMITED<br>RLA File<br>:09/24/040/00249/AM19/ |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred<br> <br>Defer<br>Date:05.07.2019 |
|
<br>HQ File<br>:01/82/050/01492/AM19/ |
|
Lic.No/Date:0910066604<br>29.08.2018 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 15 |
<br>Case No.:492/15/82-<br>ALC4/2018 |
Party Name:ORTIN<br>LABORATORIES LTD |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/01949/AM19/ |
RLA File<br>:09/24/040/00245/AM19/ |
Lic.No/Date:0910066600<br>29.08.2018 |
Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 16 |
<br>Case No.:502/15/82-<br>ALC4/2018 |
Party Name:SUVEN LIFE<br>SCIENCES LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/01959/AM19/ |
RLA File<br>:09/24/040/00260/AM19/ |
Lic.No/Date:0910066621<br>03.09.2018 |
Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
6
| Case No.:504/15/82- |
|
Party Name:GLOBAL |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
CALCIUM PRIVATE |
|
ALC4/2019 |
|
Approved |
|
|
LIMITED, |
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0710113808 |
|
|
| :01/82/050/01961/AM19/ |
|
:07/24/040/00116/AM19/ |
|
03.09.2018 |
|
|
17
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
| Export product |
Qty. |
Sl.<br>No. |
Import items |
Qty. |
| MAGNESIUM ASCORBATE |
1 kg |
1 |
ASCORBIC ACID |
1.1 kg |
| CALCIUM ASCORBATE (BP/USP) |
1 kg |
1 |
ASCORBIC ACID |
0.964 kg |
| ZINC ASCORBATE |
<br>1 kg |
1 |
ASCORBIC ACID |
<br>0.989 kg |
| SODIUM ASCORBATE (BP/EP/USP) |
1 kg |
1 |
ASCORBIC ACID |
1.03 kg |
RA concerned may take further necessary action as per above decision of NC.
|
|
Case No.:44/15/82- |
|
Party Name:DISCOVERY |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
LABORATORIES PRIVATE |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
LIMITED |
|
05.07.2019 |
|
|
| 18 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0910066631 |
|
Defer |
|
|
:01/82/050/01501/AM19/ |
|
:09/24/040/00283/AM19/ |
|
06.09.2018 |
|
Date:05.07.2019 |
|
|
**Decision:**The Committee |
|
considered the case as per agenda and it was decided to call for complete |
|
|
|
|
|
|
technical details asper Appendix 4E alongwith chemistry,Molecular weight and % ofyield. |
|
|
|
|
|
|
|
|
Case No.:40/15/82- |
|
Party Name:INCHEM |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
LABORATORIES PRIVATE |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
LIMITED |
|
05.07.2019 |
|
|
| 19 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0910066657 |
|
Defer |
|
|
:01/82/050/01497/AM19/ |
|
:09/24/040/00230/AM19/ |
|
11.09.2018 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
|
Case No.:41/15/82- |
|
Party Name:INCHEM |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
LABORATORIES PRIVATE |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
LIMITED |
|
05.07.2019 |
|
|
| 20 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0910066658 |
|
Defer |
|
|
:01/82/050/01498/AM19/ |
|
:09/24/040/00261/AM19/ |
|
11.09.2018 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
7
| Case No.:667/15/82- |
|
Party Name:GLOBAL |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
CALCIUM PRIVATE |
|
ALC4/2019 |
|
Approved |
|
|
LIMITED |
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0710113844 |
|
|
| :01/82/050/02124/AM19/ |
|
:07/24/040/00147/AM19/ |
|
12.09.2018 |
|
|
|
|
**Decision:**The Committee |
**Decision:**The Committee |
considered the cases as per agenda and in the light of earlier decision |
considered the cases as per agenda and in the light of earlier decision |
considered the cases as per agenda and in the light of earlier decision |
considered the cases as per agenda and in the light of earlier decision |
considered the cases as per agenda and in the light of earlier decision |
|
|
taken in meeting no. 1/82-ALC4/2019 dated |
|
|
03.06.2019, it was decided to ratify norms under Para 4.7 of |
|
|
|
|
|
HBP v1 as per details given below or as applied by the firm, whichever is less: |
|
|
|
|
|
|
|
|
|
Export product |
Qty. |
Sl. No. |
Import items |
Qty. |
|
|
|
|
MAGNESIUM CITRATE(USP/ |
1 kg |
1 |
CITRIC ACID - ANY GRADE |
1.001 kg |
|
| 21 |
|
|
NONAHYDRATE Eur.Ph/<br>ANHYDROUS Eur.Ph/ |
|
2 |
MAGNESIUM CARBONATE -<br>ANY GRADE |
0.730 kg |
|
|
|
|
DODECAHYDRATE Eur.Ph) |
|
|
|
|
|
|
|
|
CALCIUM CITRATE(USP) |
1 kg |
1 |
CITRIC ACID - ANY GRADE |
0.816 kg |
|
|
|
|
|
|
2 |
CALCIUM CARBONATE |
0.708 kg |
|
|
|
|
ZINC CITRATE(USP) |
1 kg |
1 |
CITRIC ACID - ANY GRADE |
0.880 kg |
|
|
|
|
POTASSIUM CITRATE(BP/ |
1 kg |
1 |
CITRIC ACID - ANY GRADE |
0.859 kg |
|
|
|
|
Eur.Ph/ USP) |
|
|
|
|
|
|
|
RA maytake appropriate action asper the decision of Norms Committee. |
|
|
|
|
|
|
Decision: The Committee considered the cases as per agenda and in the light of earlier decision taken in meeting no. 1/82-ALC4/2019 dated 03.06.2019, it was decided to ratify norms under Para 4.7 of HBP v1 as per details given below or as applied by the firm, whichever is less:
|
|
Case No.:519/15/82- |
|
Party Name:SUVEN LIFE |
|
Meet No/Date:3/82- |
|
Status: Deferred |
|
|
ALC4/2018 |
|
SCIENCES LIMITED |
|
ALC4/2019 |
|
|
|
|
|
|
|
|
05.07.2019 |
|
|
| 22 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0910066679 |
|
Defer |
|
|
:01/82/050/01976/AM19/ |
|
:09/24/040/00288/AM19/ |
|
18.09.2018 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
| Case No.:538/15/82- |
|
Party Name:NAVIN |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
FLUORINE |
|
ALC4/2019 |
|
Approved |
|
|
INTERNATIONAL |
|
05.07.2019 |
|
|
|
|
LIMITED |
|
|
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310823846 |
|
|
| :01/82/050/01995/AM19/ |
|
:03/95/040/00112/AM19/ |
|
19.09.2018 |
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the 23 presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
| Export product |
Qty. |
Sl.<br>No. |
Import items |
Qty. |
| META AMINO BENZO TRI<br>FLUORIDE (MABTF) |
1 kg |
1 |
BENZOTRIFLUORIDE<br>(BTF) |
1.07 kg |
8
| Case No.:558/15/82- |
|
Party |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
Name:METROPOLITAN |
|
ALC4/2019 |
|
Approved |
|
|
EXIMCHEM PRIVATE LTD. |
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310823899 |
|
|
| :01/82/050/02015/AM19/ |
|
:03/95/040/00613/AM19/ |
|
21.09.2018 |
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of 24 HBP as per details below or as applied by firm whichever is lower:
| Export product |
Qty. |
Sl.<br>No. |
Import items |
Qty. |
| CPPM (3-(2-CHLORO<br>PROPIONYLAMINO)-PROPIONIC<br>ACID METHYL ESTER |
1 kg |
1 |
BETA ALANINE |
0.707 kg |
|
|
2 |
2-CHLORO PROPIONYL<br>CHLORIDE |
1.11 kg |
| 25 |
Case No.:525/15/82-<br>ALC4/2018 |
Party Name:SHILPA<br>MEDICARE LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/01982/AM19/ |
RLA File<br>:07/24/040/00164/AM19/ |
Lic.No/Date:0710113890<br>25.09.2018 |
Defer<br>Date:05.07.2019 |
|
**Decision:**RLA, Bangalore was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. However, the application is still awaited from RLA,<br>Bangalore. Hence, it was decided to issue a Reminder to RLA, Bangalore for furnishing a hard copy of 4.07<br>application expeditiously. |
|
|
|
Decision: RLA, Bangalore was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. However, the application is still awaited from RLA, Bangalore. Hence, it was decided to issue a Reminder to RLA, Bangalore for furnishing a hard copy of 4.07 application expeditiously.
9
| Case No.:531/15/82- |
|
Party Name:CADILA |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
HEALTHCARE LTD |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0810143555 |
|
|
| :01/82/050/01988/AM19/ |
|
:08/24/040/00212/AM19/ |
|
25.09.2018 |
|
|
|
Case No.:531/15/82-<br>ALC4/2018 |
Party Name:CADILA<br>HEALTHCARE LTD |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019<br>Lic.No/Date:0810143555<br>25.09.2018 |
Status:<br>Approved |
|
HQ File<br>:01/82/050/01988/AM19/ |
RLA File<br>:08/24/040/00212/AM19/ |
|
|
| 26 |
<br>**Decision:**The Committee considered case as per agenda and deliberated on the matter in the presence of<br>the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per<br>details below or as applied by firm whichever is lower:<br>Export product<br>Qty.<br>Sl.<br>No.<br>Import items<br>Qty.<br>DIHYDROERGOTAMINE<br>MESYLATE<br>INJECTION<br>USP<br>1MG/ML<br>(1ML<br>VIAL)<br>(ACTIVE<br>INGREDIENT<br>:<br>DIHYDROERGOTAMINE<br>MESYLATE USP - NET WT.<br>166.66<br>GMS)<br>&<br>(PACKING<br>MATERIAL IN FINISHED FORM<br>- NET NOS. 62500)<br>166664<br>Number<br>1<br>DIHYDROERGOTAMINE<br>MESYLATE USP<br>183.33<br>gram<br>2<br>2 ML USP TYPE I AMBER<br>TREATED<br>GLASS<br>VIAL<br>(AS PER GENERAL NOTE<br>FOR<br>CHEMICAL<br>AND<br>ALLIED PRODUCTS POINT<br>NO.<br>5,<br>WASTAGE<br>ALLOWED @ 5%)<br>Relevant<br>as per<br>packing<br>policy<br>3<br>13<br>MM<br>FLUROTEC<br>RUBBER<br>STOPPER<br>(AS PER GENERAL NOTE<br>FOR<br>CHEMICAL<br>AND<br>ALLIED PRODUCTS POINT<br>NO.<br>5,<br>WASTAGE<br>ALLOWED @ 1%)<br>Relevant<br>as per<br>packing<br>policy<br>RA concerned maytake further necessaryaction asper above decision of NC. |
|
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
| 27 |
Case No.:534/15/82-<br>ALC4/2018 |
Party Name:YASH<br>RASAYAN & CHEMICALS |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred<br> <br>Defer<br>Date:05.07.2019 |
|
<br>HQ File<br>:01/82/050/01991/AM19/ |
RLA File<br>:34/24/040/00184/AM19/ |
Lic.No/Date:3410044523<br>26.09.2018 |
|
|
**Decision:**RLA, Vadodara was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. However, the application is still awaited from RLA,<br>Vadodara. Hence, it was decided to issue a Reminder to RLA, Vadodara for furnishing a hard copy of 4.07<br>application expeditiously. |
|
|
|
Decision: RLA, Vadodara was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. However, the application is still awaited from RLA, Vadodara. Hence, it was decided to issue a Reminder to RLA, Vadodara for furnishing a hard copy of 4.07 application expeditiously.
| 28 |
Case No.:536/15/82-<br>ALC4/2018 |
Party Name:YASH<br>RASAYAN & CHEMICALS |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred<br> <br>Defer<br>Date:05.07.2019 |
|
<br>HQ File<br>:01/82/050/01993/AM19/ |
RLA File<br>:34/24/040/00185/AM19/ |
Lic.No/Date:3410044524<br>26.09.2018 |
|
|
**Decision:**RLA, Vadodara was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. However, the application is still awaited from RLA,<br>Vadodara. Hence, it was decided to issue a Reminder to RLA, Vadodara for furnishing a hard copy of 4.07<br>application expeditiously. |
|
|
|
Decision: RLA, Vadodara was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. However, the application is still awaited from RLA, Vadodara. Hence, it was decided to issue a Reminder to RLA, Vadodara for furnishing a hard copy of 4.07 application expeditiously.
10
| Case No.:560/15/82- |
|
Party Name:MATRIX FINE |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
SCIENCES PVT.LTD., |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310824019 |
|
|
| :01/82/050/02017/AM19/ |
|
:03/95/040/00488/AM19/ |
|
26.09.2018 |
|
|
|
Case No.:560/15/82-<br>ALC4/2018 |
Party Name:MATRIX FINE<br>SCIENCES PVT.LTD., |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019<br>Lic.No/Date:0310824019<br>26.09.2018 |
Status:<br>Approved |
|
HQ File<br>:01/82/050/02017/AM19/ |
RLA File<br>:03/95/040/00488/AM19/ |
|
|
| 29 |
<br>**Decision:**The Committee considered the cases as per agenda and in the light of earlier decision taken in<br>meeting no. 14/82-ALC4/2018 dated 14.02.2019, it was decided to ratify norms under Para 4.7 of HBP v1 as<br>per details given below or as applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl.<br>No.<br>Import items<br>Qty.<br>D Alpha Tocopherol having Net Content<br>of Fatty Acid Distillate / Deoderised<br>Distillate 727000.00 KGS<br>Methenol 99 PERCENT 222400.00 KGS<br>S Heptane 71200.00 KGS Acetone<br>29000.00 KGS<br>1 kg<br>1<br>Fatty Acid Distillate /<br>Deoderised Distillate<br>33.50 kg<br>2<br>Methenol99%<br>10.25 kg<br>3<br>S-Heptane<br>3.28 kg<br>4<br>Acetone<br>1.34 kg<br>Note:<br>1. RA will verify the documents for the export of following bye-products, at the time of<br>redemption, against the present licence viz:<br>(i)<br>Fatty Acid Distillate / Residue – 3.63 kg per kg export of D Alpha Tocopherol.<br>(ii)<br>Phytosteral – 1.09 kg per kg export of D Alpha Tecopherol.<br>2. In future, the firm shall take the export obligation for the by-products alongwith the main<br>export product – D Alpha Tocopherol.<br>RA may take appropriate action as per the decision of Norms Committee. |
|
|
|
Decision: The Committee considered the cases as per agenda and in the light of earlier decision taken in meeting no. 14/82-ALC4/2018 dated 14.02.2019, it was decided to ratify norms under Para 4.7 of HBP v1 as per details given below or as applied by the firm, whichever is less:
|
Case No.:612/15/82- |
|
Party Name:MANGALAM |
|
Meet No/Date:3/82- |
|
Status: |
|
ALC4/2018 |
|
ORGANICS LIMITED |
|
ALC4/2019 |
|
Deferred |
|
|
|
(FORMERLY DUJODWALA |
|
05.07.2019 |
|
|
|
HQ File |
|
RLA File |
|
Lic.No/Date:0310824148 |
|
Defer |
|
:01/82/050/02069/AM19/ |
|
:03/95/040/00560/AM19/ |
|
03.10.2018 |
|
Date:05.07.2019 |
30 Decision: The Committee considered the case as per agenda in the presence of technical experts and it was decided to call for following information from the firm:
(i) Complete technical details as per Appendix 4E (ii) Catalogue of import item No. 2.
11
| Case No.:543/15/82- |
|
Party Name:VIVIMED LABS |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
LIMITED |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0910066709 |
|
|
| :01/82/050/02000/AM19/ |
|
:09/24/040/00316/AM19/ |
|
04.10.2018 |
|
|
|
|
ALC4/2018<br>LIMITED<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02000/AM19/<br>RLA File<br>:09/24/040/00316/AM19/<br>Lic.No/Date:0910066709<br>04.10.2018 |
ALC4/2018<br>LIMITED<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02000/AM19/<br>RLA File<br>:09/24/040/00316/AM19/<br>Lic.No/Date:0910066709<br>04.10.2018 |
ALC4/2018<br>LIMITED<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02000/AM19/<br>RLA File<br>:09/24/040/00316/AM19/<br>Lic.No/Date:0910066709<br>04.10.2018 |
ALC4/2018<br>LIMITED<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02000/AM19/<br>RLA File<br>:09/24/040/00316/AM19/<br>Lic.No/Date:0910066709<br>04.10.2018 |
ALC4/2018<br>LIMITED<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02000/AM19/<br>RLA File<br>:09/24/040/00316/AM19/<br>Lic.No/Date:0910066709<br>04.10.2018 |
ALC4/2018<br>LIMITED<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02000/AM19/<br>RLA File<br>:09/24/040/00316/AM19/<br>Lic.No/Date:0910066709<br>04.10.2018 |
ALC4/2018<br>LIMITED<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02000/AM19/<br>RLA File<br>:09/24/040/00316/AM19/<br>Lic.No/Date:0910066709<br>04.10.2018 |
|
|
**Decision:**The Committee considered the cases as per agenda and in the light of earlier decision |
|
|
|
|
|
|
|
|
taken in meeting no. 6/82-ALC4/2014 dated 29.08.2014, it was decided to ratify norms under Para 4.7 of |
|
|
|
|
|
|
|
|
HBP v1 as per details given below or as applied by the firm, whichever is less: |
|
|
|
|
|
|
|
|
|
Export product |
Qty. |
Sl. |
Import items |
Qty. |
|
| 31 |
|
|
|
|
No. |
|
|
|
|
|
|
ROFLOX TABLETS 250 mg (10 |
1 |
1 |
Levofloxacin Hemihydrate |
261.35 mg |
|
|
|
|
PACKS) |
Number |
|
USP |
/ 250 mg |
|
|
|
|
|
|
|
|
tablet |
|
|
|
|
ROFLOX TABLETS 500 mg (10 |
1 |
1 |
Levofloxacin Hemihydrate |
522.70 mg |
|
|
|
|
PACKS) |
Number |
|
USP |
/ 500 mg |
|
|
|
|
|
|
|
|
tablet |
|
|
|
|
ROFLOX TABLETS 500 mg (5 |
1 |
1 |
Levofloxacin Hemihydrate |
522.70 mg |
|
|
|
|
PACKS) |
Number |
|
USP |
/ 500 mg |
|
|
|
|
|
|
|
|
tablet |
|
|
|
RA maytake appropriate action asper the |
|
decision of Norms Committee. |
|
|
|
|
Decision: The Committee considered the cases as per agenda and in the light of earlier decision taken in meeting no. 6/82-ALC4/2014 dated 29.08.2014, it was decided to ratify norms under Para 4.7 of HBP v1 as per details given below or as applied by the firm, whichever is less:
|
|
Case No.:562/15/82- |
|
Party Name:ORTIN |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
LABORATORIES LTD |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
| 32 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0910066712 |
|
Defer |
|
|
:01/82/050/02019/AM19/ |
|
:09/24/040/00302/AM19/ |
|
04.10.2018 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
|
Case No.:563/15/82- |
|
Party Name:S M S |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
PHARMACEUTICALS LTD |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
| 33 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0910066714 |
|
Defer |
|
|
:01/82/050/02020/AM19/ |
|
:09/24/040/00318/AM19/ |
|
04.10.2018 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
| 34 |
<br>Case No.:565/15/82-<br>ALC4/2018 |
Party Name:S M S<br>PHARMACEUTICALS LTD |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019<br>Lic.No/Date:0910066716<br>04.10.2018 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02022/AM19/ |
RLA File<br>:09/24/040/00319/AM19/ |
|
Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
12
| 35 |
Case No.:567/15/82-<br>ALC4/2018 |
Party Name:VERVE HUMAN<br>CARE LABORATORIES |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred<br>Defer<br>Date:05.07.2019 |
|
<br>HQ File<br>:01/82/050/02024/AM19/ |
RLA File<br>:61/24/040/00009/AM19/ |
Lic.No/Date:6110001546<br>04.10.2018 |
|
|
**Decision:**The Committee considered the case as per agenda in the presence of technical experts and it<br>was decided to call for following information from the firm:<br>(i)<br>Copyof DML alongwith approved composition of each export item. |
|
|
|
| Case No.:568/15/82- |
|
Party Name:PAB ORGANICS |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
PVT.LTD, |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:3410044551 |
|
|
| :01/82/050/02025/AM19/ |
|
:34/24/040/00124/AM19/ |
|
05.10.2018 |
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of 36 HBP as per details below or as applied by firm whichever is lower:
| Export product |
Qty. |
Sl. |
Import items |
Qty. |
|
|
No. |
|
|
| +/-, -3- (CARBAMOYL METHYL) - |
1 kg |
1 |
2-CYANOACETAMIDE |
1.40 kg |
| 5- METHYLHEXANOIC ACID |
|
2 |
ISOVALERALDEHYDE |
0.72 kg |
|
|
|
(ISOVALERAL) |
|
|
|
Case No.:569/15/82- |
|
Party Name:JODAS EXPOIM |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
PVT.LTD |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
| 37 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0510408024 |
|
Defer |
|
|
:01/82/050/02026/AM19/ |
|
:05/23/040/00297/AM19/ |
|
08.10.2018 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
|
Case No.:570/15/82- |
|
Party Name:JODAS EXPOIM |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
PVT.LTD |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
| 38 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0510408025 |
|
Defer |
|
|
:01/82/050/02027/AM19/ |
|
:05/23/040/00295/AM19/ |
|
08.10.2018 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
|
Case No.:572/15/82- |
|
Party Name:A.R. LIFE |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
SCIENCES PVT LTD |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
| 39 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0910066726 |
|
Defer |
|
|
:01/82/050/02029/AM19/ |
|
:09/24/040/00309/AM19/ |
|
08.10.2018 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
13
40
|
Case No.:578/15/82- |
|
Party Name:SURVIVAL |
|
Meet No/Date:3/82- |
|
Status: |
|
ALC4/2018 |
|
TECHNOLOGIES PVT.LTD. |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
05.07.2019 |
|
|
|
HQ File |
|
RLA File |
|
Lic.No/Date:0310824348 |
|
Defer |
|
:01/82/050/02035/AM19/ |
|
:03/95/040/00679/AM19/ |
|
10.10.2018 |
|
Date:05.07.2019 |
Decision: The Committee considered the case as per agenda in the presence of technical experts and it was decided to call for following information from the firm:
(i) Justification for use of 2 ml of Sodium Borohydride in reaction. (ii) Justification for low recovery of solvent.
| Case No.:587/15/82- |
|
Party Name:CAMUS |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
BIOTECH PRIVATE |
|
ALC4/2019 |
|
Approved |
|
|
LIMITED |
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0910066735 |
|
|
| :01/82/050/02044/AM19/ |
|
:09/24/040/00299/AM19/ |
|
10.10.2018 |
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower: 41
| Export product |
Qty. |
Sl. |
Import items |
Qty. |
|
|
No. |
|
|
| D2 AMINO BUTANOL |
1 kg |
1 |
DL-2-AMINO-1-BUTANOL |
2.2642 kg |
|
|
2 |
MONOSODIUM |
0.90 kg |
|
|
|
GLUTAMATE |
|
|
|
3 |
TOLUENE |
0.60 kg |
| Case No.:101/15/82- |
|
Party Name:O C |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
SPECIALITIES PVT.LTD. |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310824363 |
|
|
| :01/82/050/01558/AM19/ |
|
:03/95/040/00699/AM19/ |
|
11.10.2018 |
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of 42 HBP as per details below or as applied by firm whichever is lower:
| Export product |
Qty. |
Sl. |
Import items |
Qty. |
|
|
No. |
|
|
| METHYL-2- |
1 kg |
1 |
PROPIONIC ACID |
0.911 kg |
| CHLOROPROPIONATE |
|
|
|
|
14
| 43 |
Case No.:582/15/82-<br>ALC4/2018 |
Party Name:MACSON<br>PRODUCTS |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred<br> <br>Defer<br>Date:05.07.2019 |
|
<br>HQ File<br>:01/82/050/02039/AM19/ |
RLA File<br>:52/24/040/00039/AM19/ |
Lic.No/Date:5210042796<br>11.10.2018 |
|
|
**Decision:**RLA, Surat was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. However, the application is still awaited from RLA, Surat.<br>Hence,it was decided to issue a Reminder to RLA,Surat for furnishinga copyof application expeditiously. |
|
|
|
| 44 |
Case No.:590/15/82-<br>ALC4/2018 |
Party Name:VERVE HUMAN<br>CARE LABORATORIES |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02047/AM19/ |
RLA File<br>:61/24/040/00011/AM19/ |
Lic.No/Date:6110001553<br>11.10.2018 |
Defer<br>Date:05.07.2019 |
|
**Decision:**RLA, Dehradun was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. However, the application is still awaited from RLA,<br>Dehradun. Hence, it was decided to issue a Reminder to RLA, Dehradun for furnishing a copy of<br>application expeditiously. |
|
|
|
Decision: RLA, Dehradun was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. However, the application is still awaited from RLA, Dehradun. Hence, it was decided to issue a Reminder to RLA, Dehradun for furnishing a copy of application expeditiously.
| 45 |
Case No.:801/15/82-<br>ALC4/2018 |
Party Name:DEEPAK<br>PHENOLICS LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02258/AM19/ |
RLA File<br>:34/24/040/00230/AM19/ |
Lic.No/Date:3410044580<br>11.10.2018 |
Defer<br>Date:05.07.2019 |
|
**Decision:**RLA, Vadodara was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. However, the application is still awaited from RLA,<br>Vadodara. Hence, it was decided to issue a Reminder to RLA, Vadodara for furnishing a copy of<br>application expeditiously. |
|
|
|
Decision: RLA, Vadodara was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. However, the application is still awaited from RLA, Vadodara. Hence, it was decided to issue a Reminder to RLA, Vadodara for furnishing a copy of application expeditiously.
| Case No.:588/15/82- |
|
Party Name:S V LABS PVT |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
LTD |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0910066750 |
|
|
| :01/82/050/02045/AM19/ |
|
:09/24/040/00330/AM19/ |
|
15.10.2018 |
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the 46 presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
|
Export product |
Qty. |
Sl. |
Import items |
Qty. |
|
|
|
No. |
|
|
|
FCE (SA) |
1 kg |
1 |
5-Flouro Cytosine |
0.44 kg |
| RA concerned maytake further necessaryaction asper above decision of NC. |
|
|
|
|
|
15
| Case No.:589/15/82- |
|
Party Name:S V LABS PVT |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
LTD |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0910066751 |
|
|
| :01/82/050/02046/AM19/ |
|
:09/24/040/00339/AM19/ |
|
15.10.2018 |
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of 47 HBP as per details below or as applied by firm whichever is lower:
| Export product |
Qty. |
Sl.<br>No. |
Import items |
Qty. |
| FCE (SA) |
1 kg |
1 |
5-Flouro Cytosine |
0.44 kg |
|
|
2 |
2,5-DIHYDROXY-1,4<br>DITHANE (DIOL) |
0.28 kg |
| 48 |
<br>Case No.:592/15/82-<br>ALC4/2018 |
Party Name:SRIAM LABS<br>PRIVATE LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred<br>Defer<br>Date:05.07.2019 |
|
<br>HQ File<br>:01/82/050/02049/AM19/ |
RLA File<br>:09/24/040/00338/AM19/ |
Lic.No/Date:0910066753<br>16.10.2018 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
| Case No.:157/15/82- |
|
Party Name:VAKS PHARMA |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
PVT.LTD., |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310824491 |
|
Defer |
| :01/82/050/01614/AM19/ |
|
:03/95/040/00732/AM19/ |
|
17.10.2018 |
|
Date:05.07.2019 |
49 Decision: The Committee considered the case as per agenda in the presence of technical experts and it was decided to call for following information from the firm:
(i) Whether the Soft Gelatin Capsules to be exported are empty or filled. (ii) In case of Filled Capsules, complete details of each type of capsules such as weight of empty capsules, weight of finished goods, their approved composition, wastage claimed etc. is to be furnished.
16
| Case No.:173/15/82- |
|
Party Name:VITAL |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
LABORATORIES PRIVATE |
|
ALC4/2019 |
|
Approved |
|
|
LIMITED |
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310824503 |
|
|
| :01/82/050/01630/AM19/ |
|
:03/95/040/00415/AM19/ |
|
17.10.2018 |
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
50
| Export product |
Qty. |
Sl.<br>No. |
Import items |
Qty. |
| LUMEFANTRINE PH.I. |
1 kg |
1 |
9H FLUORENE |
0.90 kg |
|
|
2 |
PARA CHLORO<br>BENZALDEHYDE |
0.3476 kg |
|
|
3 |
METHANOL |
2.19 kg |
|
|
4 |
METHYLENE DICHLORIDE |
1.38 kg |
| 51 |
<br>Case No.:174/15/82-<br>ALC4/2018 |
Party Name:VITAL<br>LABORATORIES PRIVATE<br>LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred<br> <br>Defer<br>Date:05.07.2019 |
|
<br>HQ File<br>:01/82/050/01631/AM19/ |
RLA File<br>:03/95/040/00527/AM19/ |
Lic.No/Date:0310824501<br>17.10.2018 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 52 |
<br>Case No.:178/15/82-<br>ALC4/2018 |
Party Name:VITAL<br>LABORATORIES PRIVATE<br>LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/01635/AM19/ |
RLA File<br>:03/95/040/00548/AM19/ |
Lic.No/Date:0310824502<br>17.10.2018 |
Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
17
| Case No.:175/15/82- |
|
Party Name:VITAL |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
LABORATORIES PRIVATE |
|
ALC4/2019 |
|
Approved |
|
|
LIMITED |
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310824604 |
|
|
| :01/82/050/01632/AM19/ |
|
:03/95/040/00547/AM19/ |
|
23.10.2018 |
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower: 53
| Export product |
Qty. |
Sl. |
Import items |
Qty. |
|
|
No. |
|
|
| YOHIMBINE HYDROCHLORIDE |
1 kg |
1 |
YOHIMBINE BARK |
100.0 kg |
| BP/EP/USP |
|
|
(CONTAINING YOHIMBINE |
|
|
|
|
CONTENT MAXIMUM 1 - |
|
|
|
|
1.2%) |
|
|
|
Case No.:169/15/82- |
|
Party Name:WOCKHARDT |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
LIMITED |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
| 54 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0310824651 |
|
Defer |
|
|
:01/82/050/01626/AM19/ |
|
:03/95/040/00755/AM19/ |
|
24.10.2018 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
| Case No.:595/15/82- |
|
Party Name:SHODHANA |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
LABORATORIES LTD |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0910066758 |
|
|
| :01/82/050/02052/AM19/ |
|
:09/24/040/00343/AM19/ |
|
24.10.2018 |
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower: 55
| Export product |
Qty. |
Sl. |
Import items |
Qty. |
|
|
No. |
|
|
| 4-Hydroxy Carbazole |
1 kg |
1 |
Resorcinol |
2.31 kg |
|
|
|
Raw Material |
|
|
|
2 |
Phenyl Hydrazine HCL |
2.50 kg |
|
|
|
RawMaterial |
|
18
| Case No.:596/15/82- |
|
Party Name:AUROBINDO |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
PHARMA LIMITED |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0910066761 |
|
|
| :01/82/050/02053/AM19/ |
|
:09/24/040/00346/AM19/ |
|
25.10.2018 |
|
|
|
Case No.:596/15/82- |
Case No.:596/15/82- |
Party Name:AUROBINDO |
Party Name:AUROBINDO |
Party Name:AUROBINDO |
Party Name:AUROBINDO |
Meet No/Date:3/82- |
Status: |
Status: |
Status: |
|
<br>ALC4/2018 |
|
<br>PHARMA LIMITED<br>RLA File<br>:09/24/040/00346/AM19/ |
|
|
|
<br>ALC4/2019<br>05.07.2019 |
<br>Approved |
|
|
|
HQ File |
|
|
|
|
|
Lic.No/Date:0910066761 |
|
|
|
|
<br>:01/82/050/02053/AM19/ |
|
|
|
|
|
<br>25.10.2018 |
|
|
|
|
**Decision:**The Co |
|
mmittee considered case as per |
|
|
|
agenda and deliberated on |
the matter in the |
|
|
|
<br>presence of the technical experts and it wa<br>HBP as per details below or as applied by<br>Export product<br>Qty.<br>SultamicillinTosylate<br>1 kg |
|
|
|
<br>s decided to ratify the ad-hoc input output norms<br>firm whichever is lower: |
|
|
<br>under para 4.7 of<br>Qty.<br>0.6049 kg |
|
|
|
|
Export product |
|
Qty. |
Sl. No. |
Import items |
|
|
Qty. |
|
|
|
SultamicillinTosylate |
|
1 kg |
1 |
Iodomethyl Sulbactam |
|
|
0.6049 kg |
|
|
|
|
|
|
2 |
6-Amino Penicillanic Acid (6-APA) |
|
|
0.418 kg |
|
|
|
|
|
|
3 |
Methyl Acetoacetate (MAA) |
|
|
0.366 kg |
|
| 56 |
|
|
|
|
4 |
D(-) Alph<br>Base) |
a Phenyl Glycine Base (PG |
|
0.3301 kg |
|
|
|
|
|
|
5 |
Potassium |
Carbonate (Anhydrous) |
|
0.1873 kg |
|
|
|
|
|
|
6 |
Activated<br>Enoanticr |
Carbon (Carbon<br>omos) |
|
00487 k |
|
|
|
|
|
|
|
|
|
|
. g |
|
|
|
|
|
|
7 |
Penicillin |
G Amidase (Particle size |
|
1.00 gram |
|
|
|
|
|
|
|
<br>250 - 500 micron, Creamish to Brown<br>regularly shaped beads)<br>or (Immobilized Acylase Enzyme)<br>Xinase |
|
|
|
|
|
|
|
|
|
8 |
Dimethylformamide (D M F) |
|
|
2.522 kg |
|
|
|
|
|
|
9 |
Isopropyl Alcohol (IPA) |
|
|
0.390 kg |
|
|
|
|
|
|
10 |
Methanol (Methyl Alcohol) |
|
|
0.620 kg |
|
|
|
|
|
|
11 |
Toluene |
|
|
0.258kg |
|
|
RA concerned maytake further necessary |
|
|
|
action asper above decision of NC. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 57 |
Case No.:597/15/82- |
|
Party Name:AUROBINDO<br>PHARMA LIMITED |
|
|
|
Meet No/Date:3/82- |
Status:<br>Deferred |
|
|
|
<br>ALC4/2018 |
|
|
|
|
|
ALC4/2019<br>05.07.2019 |
|
|
|
|
<br>HQ File<br>:01/82/050/02054/AM19/ |
|
RLA File<br>:09/24/040/00345/AM19/ |
|
|
|
Lic.No/Date:0910066762<br>25.10.2018 |
Defer<br>Date:05.07.2019 |
|
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
|
|
Case No.:597/15/82- |
|
Party Name:AUROBINDO |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
PHARMA LIMITED |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
| 57 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0910066762 |
|
Defer |
|
|
:01/82/050/02054/AM19/ |
|
:09/24/040/00345/AM19/ |
|
25.10.2018 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
| Case No.:599/15/82- |
|
Party Name:LITMUS |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
ORGANICS P. LTD. |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310824684 |
|
Defer |
| :01/82/050/02056/AM19/ |
|
:03/95/040/00747/AM19/ |
|
25.10.2018 |
|
Date:05.07.2019 |
58 Decision: The Committee considered the case as per agenda in the presence of technical experts and it was decided to call for following information from the firm:
(i) Stepwise yield of reaction. (ii) Calculation Sheet to arrive at the quantity of raw material asked on the basis of chemistry, molecular weight and % of yield.
19
| Case No.:107/15/82- |
|
Party Name:POSY |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
PHARMACHEM PVT. LTD. |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0810143768 |
|
|
| :01/82/050/01564/AM19/ |
|
:08/24/040/00229/AM19/ |
|
26.10.2018 |
|
|
Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 15/82-ALC4/2018 , dated 22.03.2019, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as 59 per details below or as applied by firm whichever is lower:
| Exportproduct<br>SODIUM CITRATE BP/USP |
Qty. |
Sl. No. |
Import items |
Qty. |
|
1 kg |
1 |
CITRIC ACID<br>MONOHYDRATE |
0.421 kg |
|
|
2. |
CAUSTIC SODA FLAKES /<br>PEARLS |
0.736 kg |
| Case No.:163/15/82- |
|
Party Name:NAPROD LIFE |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
SCIENCES PVT. LTD. |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310824723 |
|
|
| :01/82/050/01620/AM19/ |
|
:03/95/040/00766/AM19/ |
|
26.10.2018 |
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per 60 details below or as applied by firm whichever is lower:
| Export product |
Qty. |
Sl.<br>No. |
Import items |
Qty. |
| L-Asparaginase<br>for<br>Injection<br>10000IU<br>(<br>net<br>contain<br>of<br>L-<br>Asparaginase 0.652Kgs ) |
7500<br>vials |
1 |
L-Asparaginase |
0.700 kg |
20
| Case No.:600/15/82- |
|
Party Name:CADILA |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
HEALTHCARE LTD |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0810143760 |
|
|
| :01/82/050/02057/AM19/ |
|
:08/24/040/00233/AM19/ |
|
26.10.2018 |
|
|
|
Case No.:600/15/82-<br>ALC4/2018 |
Party Name:CADILA<br>HEALTHCARE LTD<br>RLA File<br>:08/24/040/00233/AM19/ |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Approved |
|
HQ File<br>:01/82/050/02057/AM19/ |
|
Lic.No/Date:0810143760<br>26.10.2018 |
|
| 61 |
<br>**Decision:**The Committee considered case as per agenda and deliberated on the matter in the<br>presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of<br>HBP as per details below or as applied by firm whichever is lower:<br>Export product<br>Qty.<br>Sl.<br>No.<br>Import items<br>Qty. / 1.2<br>gm tablet<br>MESALAMINE DELAYED<br>RELEASE TABLETS 1.2<br>GRAM<br>(ACTIVE INGREDIENT :<br>MESALAMINE USP - NEW<br>WT. 112723.06 KGS)<br>1 Number<br>1<br>MESALAMINE USP<br>1.224 gm<br>2<br>MAGNESIUM STEARATE<br>PH.E/NF/JP<br>0.013 gm<br>3<br>SODIUM STARCH<br>GLYCOLATE NF/JP<br>0.012 gm<br>4<br>HYPEROMELLOSE 15 CPS<br>USP<br>0.030 gm<br>5<br>TRIETHYL CITRATE NF<br>0.015 gm<br>6<br>TALC PH.E/USP/JP<br>0.011 gm<br>7<br>ISOPROPYL ALCOHOL USP<br>0.50 gm<br>8<br>MICROCRYSTALLINE<br>CELLULOSE NF/PH.E<br>(AVICEL PH200)<br>0.0140 gm<br>9<br>METHACRYLIC ACID AND<br>METHYL METHACRYLATE<br>COPOLYMER NF<br>0.0345 gm<br>10<br>METHACRYLIC ACID<br>COPOLYMER NF<br>(EUDRAGIT L 100)<br>0.0185 gm<br>RA concerned maytake further necessaryaction asper above decision of NC. |
|
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
| 62 |
<br>Case No.:602/15/82-<br>ALC4/2018 |
Party Name:GLAND<br>PHARMA LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02059/AM19/ |
RLA File<br>:09/24/040/00229/AM19/ |
Lic.No/Date:0910066775<br>26.10.2018 |
Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 63 |
<br>Case No.:603/15/82-<br>ALC4/2018 |
Party Name:THERAPIVA<br>PRIVATE LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02060/AM19/ |
RLA File<br>:09/24/040/00359/AM19/ |
Lic.No/Date:0910066778<br>26.10.2018 |
Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
21
| 64 |
<br>Case No.:604/15/82-<br>ALC4/2018 |
Party Name:ORTIN<br>LABORATORIES LTD |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02061/AM19/ |
RLA File<br>:09/24/040/00347/AM19/ |
Lic.No/Date:0910066780<br>26.10.2018 |
Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 65 |
<br>Case No.:605/15/82-<br>ALC4/2018 |
Party Name:SUVEN LIFE<br>SCIENCES LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02062/AM19/ |
RLA File<br>:09/24/040/00354/AM19/ |
Lic.No/Date:0910066781<br>26.10.2018 |
Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 66 |
Case No.:608/15/82-<br>ALC4/2018 |
Party Name:MACSON<br>PRODUCTS |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred<br> <br>Defer<br>Date:05.07.2019 |
|
<br>HQ File<br>:01/82/050/02065/AM19/ |
RLA File<br>:52/24/040/00058/AM19/ |
Lic.No/Date:5210042821<br>26.10.2018 |
|
|
**Decision:**RLA, Surat was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. However, the application is still awaited from RLA,<br>Bangalore. Hence, it was decided to issue a Reminder to RLA, Surat for furnishing a copy of application<br>expeditiously. |
|
|
|
Case No.:162/15/82- Party Name:VITAL Meet No/Date:3/82- Status: ALC4/2018 LABORATORIES PRIVATE ALC4/2019 Approved LIMITED 05.07.2019 HQ File RLA File Lic.No/Date:0310824779 :01/82/050/01619/AM19/ :03/95/040/00751/AM19/ 29.10.2018
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower: 67
| Export product |
Qty. |
Sl.<br>No. |
Import items |
Qty. |
| LUMEFANTRINE PH.I. |
1 kg |
1 |
9H FLUORENE |
0.90 kg |
|
|
2 |
PARA CHLORO BENZALDEHYDE |
0.3476 kg |
|
|
3 |
METHANOL |
2.19 kg |
|
|
4 |
METHYLENE DICHLORIDE |
1.38 kg |
22
|
Case No.:164/15/82- |
|
Party Name:VN CREATIVE |
|
Meet No/Date:3/82- |
|
Status: |
|
ALC4/2018 |
|
CHEMICALS PRIVATE |
|
ALC4/2019 |
|
Deferred |
|
|
|
LIMITED |
|
05.07.2019 |
|
|
|
HQ File |
|
RLA File |
|
Lic.No/Date:0310824780 |
|
Defer |
|
:01/82/050/01621/AM19/ |
|
:03/95/040/00692/AM19/ |
|
29.10.2018 |
|
Date:05.07.2019 |
68 Decision: The Committee considered the case as per agenda in the presence of technical experts and it was decided to call for following information from the firm:
(i) Complete technical details as per Appendix 4E with chemistry, molecular weight and % of yield.
| Case No.:607/15/82- |
|
Party Name:CADILA |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
HEALTHCARE LTD |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0810143774 |
|
|
| :01/82/050/02064/AM19/ |
|
:08/24/040/00188/AM19/ |
|
29.10.2018 |
|
|
|
Case No.:607/15/82-<br>ALC4/2018 |
Party Name:CADILA<br>HEALTHCARE LTD<br>RLA File<br>:08/24/040/00188/AM19/ |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Approved |
|
HQ File<br>:01/82/050/02064/AM19/ |
|
Lic.No/Date:0810143774<br>29.10.2018 |
|
| 69 |
<br>**Decision:**The Committee considered case as per agenda and deliberated on the matter in the<br>presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of<br>HBP as per details below or as applied by firm whichever is lower:<br>Export product<br>Qty.<br>Sl.<br>No.<br>Import items<br>Qty.<br>VALSARTAN TABLETS 40 MG<br>(ACTIVE INGREDIENT :<br>VALSARTAN PH EUR - NET WT.<br>35.977 KGS)<br>1 Number<br>1<br>VALSARTAN PH EUR<br>40.8 mg/<br>40 mg<br>tablet<br>VALSARTAN TABLETS 80 MG<br>(ACTIVE INGREDIENT :<br>VALSARTAN PH EUR - NET WT.<br>203.941 KGS)<br>1 Number<br>1<br>VALSARTAN PH EUR<br>81.60 mg/<br>80 mg<br>tablet<br>VALSARTAN TABLETS 160 MG<br>(ACTIVE INGREDIENT :<br>VALSARTAN PH EUR - NET WT.<br>407.884 KGS)<br>1 Number<br>1<br>VALSARTAN PH EUR<br>163.20<br>mg/ 160<br>mg tablet<br>VALSARTAN &<br>HYDROCHLOROTHIAZIDE<br>TABLETS 80/12.5 MG<br>(ACTIVE INGREDIENT :<br>VALSARTAN PH EUR - NET WT.<br>134.955)<br>1 Number<br>1<br>VALSARTAN PH EUR<br>81.60 mg/<br>80 mg<br>tablet<br>VALSARTAN &<br>HYDROCHLOROTHIAZIDE<br>TABLETS 160/12.5 MG<br>(ACTIVE INGREDIENT :<br>VALSARTAN PH EUR - NET WT.<br>479.888)<br>1 Number<br>1<br>VALSARTAN PH EUR<br>163.20<br>mg/ 160<br>mg tablet<br>VALSARTAN &<br>HYDROCHLOROTHIAZIDE<br>TABLETS 160/25 MG<br>(ACTIVE INGREDIENT :<br>VALSARTAN PH EUR - NET WT.<br>269.899KGS)<br>1 Number<br>1<br>VALSARTAN PH EUR<br>163.20<br>mg/ 160<br>mg tablet<br>RA concerned maytake further necessaryaction asper above decision of NC. |
|
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
23
| Case No.:76/15/82- |
|
Party Name:BLISS GVS |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
PHARMA LTD. |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310824793 |
|
|
| :01/82/050/01533/AM19/ |
|
:03/94/040/00687/AM19/ |
|
30.10.2018 |
|
|
|
|
Decision: |
Decision: |
The Committee considered case as per agenda and deliberated on the matter in the |
The Committee considered case as per agenda and deliberated on the matter in the |
The Committee considered case as per agenda and deliberated on the matter in the |
The Committee considered case as per agenda and deliberated on the matter in the |
The Committee considered case as per agenda and deliberated on the matter in the |
The Committee considered case as per agenda and deliberated on the matter in the |
The Committee considered case as per agenda and deliberated on the matter in the |
|
|
presence of the technical experts and it was |
|
|
decided to ratify the ad-hoc input output norms under para 4.7 of |
|
|
|
|
|
|
|
HBP as per details |
|
below or as applied by firm whichever is lower: |
|
|
|
|
|
|
| 70 |
|
|
Export product |
|
|
Qty. |
Sl.<br>No. |
Import items |
Qty. |
|
|
|
|
BG-CLIND |
Clindamycin<br>Vaginal |
|
784300.00 |
1 |
CLINDAMYCIN |
80 kg |
|
|
|
|
Suppositories |
100<br>Mg |
|
Number |
|
PHOSPHATE |
|
|
|
|
|
( Net Contain |
clindamycin phosphate |
|
|
|
|
|
|
|
|
|
78.43 Kgs.) |
|
|
|
|
|
|
|
|
|
|
VAGID-CL |
Clindamycin<br>and |
|
98000.00 |
1 |
CLINDAMYCIN |
10 kg |
|
|
|
|
Clotrimazole |
Vaginal Suppositories |
|
Number |
|
PHOSPHATE |
|
|
|
|
|
( Net Contain |
clindamycin phosphate |
|
|
|
|
|
|
|
|
|
9.8 Kgs.) |
|
|
|
|
|
|
|
|
|
RA concerned maytake further necessaryaction asper above decision of NC. |
|
|
|
|
|
|
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
|
|
Case No.:610/15/82- |
|
Party Name:JODAS EXPOIM |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
PVT.LTD |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
| 71 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0510408268 |
|
Defer |
|
|
:01/82/050/02067/AM19/ |
|
:05/23/040/00334/AM19/ |
|
30.10.2018 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
| Case No.:611/15/82- |
|
Party Name:OPTRIX |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
LABORATORIES PRIVATE |
|
ALC4/2019 |
|
Approved |
|
|
LIMITED |
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0910066796 |
|
|
| :01/82/050/02068/AM19/ |
|
:09/24/040/00331/AM19/ |
|
01.11.2018 |
|
|
|
|
Decision: |
Decision: |
The Committee considered the cases as per agenda and in the light of earlier decision |
The Committee considered the cases as per agenda and in the light of earlier decision |
The Committee considered the cases as per agenda and in the light of earlier decision |
The Committee considered the cases as per agenda and in the light of earlier decision |
The Committee considered the cases as per agenda and in the light of earlier decision |
|
|
taken in meeting no. 1/82-ALC4/2019 dated 03.06.2019, it was decided to ratify norms under Para 4.7 of |
|
|
|
|
|
|
|
|
HBP v1 as per details given below or as applied by the firm, whichever is less: |
|
|
|
|
|
|
|
|
|
Export |
Qty. |
Sl. |
Import items |
Qty. |
|
| 72 |
|
|
Product |
|
No. |
|
|
|
|
|
|
TEDIZOLID |
1 kg |
1 |
5-Bromo-2-(2-Methyl-2H-Tetrazol-5-Yl)-Pyridine |
0.746 kg |
|
|
|
|
PHOSPHATE |
|
2 |
(R)-3-(4-Bromo-3-fluorophenyl)-5- |
0.90 kg |
|
|
|
|
|
|
|
(hydroxymethyl)oxazolidin-2-one |
|
|
|
|
|
|
|
3 |
Dichlorobis(di-tert-butylphenylphosphine)palladium(II) |
0.025 kg |
|
|
|
|
|
|
4 |
Bis(pinacolato)diboron |
0.706 kg |
|
|
|
|
|
|
5 |
1,1- |
Not Shown |
|
|
|
|
|
|
|
Bis(diphenylphosphino)ferrocene]dichloropalladium(II) |
in the |
|
|
|
|
|
|
|
|
chemistry |
|
|
|
RA maytake appropriate action asper the decision of Norms Committee. |
|
|
|
|
|
|
Decision: The Committee considered the cases as per agenda and in the light of earlier decision taken in meeting no. 1/82-ALC4/2019 dated 03.06.2019, it was decided to ratify norms under Para 4.7 of HBP v1 as per details given below or as applied by the firm, whichever is less:
24
| Case No.:193/15/82- |
|
Party Name:RUMIT LIFE |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
CARE |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310824914 |
|
|
| :01/82/050/01650/AM19/ |
|
:03/95/040/00736/AM19/ |
|
05.11.2018 |
|
|
|
Case No.:193/15/82-<br>ALC4/2018 |
Case No.:193/15/82-<br>ALC4/2018 |
Party Name:RUMIT LIFE<br>CARE |
Party Name:RUMIT LIFE<br>CARE |
Party Name:RUMIT LIFE<br>CARE |
Party Name:RUMIT LIFE<br>CARE |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Approved |
Status:<br>Approved |
|
HQ File<br>:01/82/050/01650/AM19/ |
|
RLA File<br>:03/95/040/00736/AM19/ |
|
|
|
Lic.No/Date:0310824914<br>05.11.2018 |
|
|
| 73 |
<br>**Decision:**The Committee considered case as per agenda and deliberated on<br>presence of the technical experts and it was decided to ratify the ad-hoc input output norms<br>HBP as per details below or as applied by firm whichever is lower:<br>Export product<br>Qty.<br>Sl.<br>No.<br>Import items<br>BETAMETHASONE<br>DIPROPIONATE<br>1 kg<br>1<br>BETAMETHASONE 17<br>PROPIONATE<br>RA concerned maytake further necessaryaction asper above decision of NC. |
|
|
|
|
|
|
the matter in the<br>under para 4.7 of<br>Qty.<br>0.94 kg |
|
|
|
Export product |
|
Qty. |
Sl.<br>No. |
Import items |
|
|
Qty. |
|
|
BETAMETHASONE<br>DIPROPIONATE |
|
1 kg |
1 |
BETAMETHASONE 17<br>PROPIONATE |
|
|
0.94 kg |
|
|
|
|
|
|
|
|
|
|
| 74 |
<br>Case No.:198/15/82-<br>ALC4/2018 |
Party Name:RUMIT<br>LIFECARE |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred<br> <br>Defer<br>Date:05.07.2019 |
|
<br>HQ File<br>:01/82/050/01655/AM19/ |
RLA File<br>:03/95/040/00737/AM19/ |
Lic.No/Date:0310824932<br>06.11.2018 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
| Case No.:613/15/82- |
|
Party Name:MELOG |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
SPECIALITY CHEMICALS |
|
ALC4/2019 |
|
Approved |
|
|
PVT. LTD. |
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310824922 |
|
|
| :01/82/050/02070/AM19/ |
|
:03/95/040/00775/AM19/ |
|
06.11.2018 |
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the 75 presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
| Export product |
Qty. |
Sl. No. |
Import items |
Qty. |
| 4,4-BIPHENOL |
1 kg |
1 |
2,6-DI-TERT-BUTYLPHENOL |
1.129 kg |
|
|
2 |
METHANOL |
0.30kg |
| 76 |
<br>Case No.:614/15/82-<br>ALC4/2018 |
Party Name:SUVEN LIFE<br>SCIENCES LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02071/AM19/ |
RLA File<br>:09/24/040/00360/AM19/ |
Lic.No/Date:0910066814<br>08.11.2018 |
Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
25
| 77 |
<br>Case No.:111/15/82-<br>ALC4/2018 |
Party Name:PUNJAB<br>CHEMICALS AND CROP<br>PROTECTION LTD |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/01568/AM19/ |
RLA File<br>:03/95/040/00709/AM19/ |
Lic.No/Date:0310824946<br>12.11.2018 |
Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 78 |
<br>Case No.:616/15/82-<br>ALC4/2018 |
Party Name:VIVIMED LIFE<br>SCIENCES PRIVATE<br>LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02073/AM19/ |
RLA File<br>:09/24/040/00387/AM19/ |
Lic.No/Date:0910066821<br>12.11.2018 |
Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 79 |
<br>Case No.:87/15/82-<br>ALC4/2018 |
Party Name:DEEPAK<br>NITRITE LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/01544/AM19/ |
RLA File<br>:34/24/040/00267/AM19/ |
Lic.No/Date:3410044685<br>13.11.2018 |
Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| Case No.:115/15/82- |
|
Party Name:WOCKHARDT |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
LIMITED |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310824984 |
|
|
| :01/82/050/01572/AM19/ |
|
:03/95/040/00780/AM19/ |
|
13.11.2018 |
|
|
|
Case No.:115/15/82-<br>ALC4/2018 |
Party Name:WOCKHARDT<br>LIMITED<br>RLA File<br>:03/95/040/00780/AM19/ |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Approved |
|
HQ File<br>:01/82/050/01572/AM19/ |
|
Lic.No/Date:0310824984<br>13.11.2018 |
|
| 80 |
<br>**Decision:**The Committee considered case as per agenda and deliberated on the matter in the presence of<br>the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per<br>details below or as applied by firm whichever is lower:<br>Export product<br>Qty.<br>Sl.<br>No.<br>Import items<br>Qty.<br>FOSPHENYTOIN SODIUM INJECTION<br>USP 75 MG/ML 2ML VIAL (25 VIAL<br>PACK) EACH 2ML VIAL CONTAINS<br>FOSPHENYTOIN SODIUM USP 150 MG<br>(Total 139550 Vials and Total Net Content<br>of Fosphenytoin Sodium USP upto 22.502<br>KGS)<br>1 vial<br>1<br>FOSPHENYTOIN<br>SODIUM USP<br>165mg/2 ml<br>injection<br>FOSPHENYTOIN SODIUM INJECTION<br>USP 75 MG/ML 10ML VIAL (10 VIAL<br>PACK) EACH 10ML VIAL CONTAINS<br>FOSPHENYTOIN SODIUM USP 750 MG<br>(Total 28580 Vials and Total Net Content of<br>Fosphenytoin Sodium USP upto 22.506<br>KGS)<br>1 vial<br>1<br>FOSPHENYTOIN<br>SODIUM USP<br>825 mg/10 ml<br>injection<br>RA concerned maytake further necessaryaction asper above decision of NC. |
|
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
26
| 81 |
<br>Case No.:634/15/82-<br>ALC4/2018 |
Party Name:AUROBINDO<br>PHARMA LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02091/AM19/ |
RLA File<br>:09/24/040/00376/AM19/ |
Lic.No/Date:0910066832<br>13.11.2018 |
Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| Case No.:656/15/82- |
|
Party Name:HONOUR LAB |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
LIMITED |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0910066835 |
|
|
| :01/82/050/02113/AM19/ |
|
:09/24/040/00369/AM19/ |
|
13.11.2018 |
|
|
Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 15/82-ALC4/2018 , dated 22.03.2019, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower: 82
| Export Product |
Qty. |
Sl. |
Import items |
Qty. |
|
|
No. |
|
|
| (1R, 2S, 5R)-2-Isopropyl-5- |
1 kg |
1 |
N,N-Dimethyl Formamide(DMF) |
0.25 kg |
| methylcyclohexyl (2R, 5S)-5- |
|
2 |
Hexamethyl disilazane |
0.708 kg |
| (4-amino-2-oxopyrimidin- |
|
3 |
Cytosine |
0.434 kg |
| 1(2H)-yl)-1,3-oxathiolane-2-<br>carboxylate |
|
4 |
Triphosgene |
0.500 kg |
| Case No.:619/15/82- |
|
Party Name:SUVEN LIFE |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
SCIENCES LIMITED |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0910066842 |
|
|
| :01/82/050/02076/AM19/ |
|
:09/24/040/00372/AM19/ |
|
14.11.2018 |
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of 83 HBP as per details below or as applied by firm whichever is lower:
| Export product |
Qty. |
Sl. |
Import items |
Qty. |
|
|
No. |
|
|
| (2-CHLORO-5-IODO PHENYL)- |
1 kg |
1 |
ISO PROPYL ALCOHOL |
2.00 kg |
| (4-FLUORO PHENYL)- |
|
|
(IPA) |
|
| METHANONE |
|
2 |
FLUORO BENZENE |
2.498 kg |
27
| Case No.:621/15/82- |
|
Party Name:PORUS |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
LABORATORIES PRIVATE |
|
ALC4/2019 |
|
Approved |
|
|
LIMITED |
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0910066847 |
|
|
| :01/82/050/02078/AM19/ |
|
:09/24/040/00390/AM19/ |
|
14.11.2018 |
|
|
|
Case No.:621/15/82-<br>ALC4/2018 |
Party Name:PORUS<br>LABORATORIES PRIVATE<br>LIMITED<br>RLA File<br>:09/24/040/00390/AM19/ |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Approved |
|
HQ File<br>:01/82/050/02078/AM19/ |
|
Lic.No/Date:0910066847<br>14.11.2018 |
|
| 84 |
<br>**Decision:**The Committee considered the case as per agenda in the presence of Technical Experts and<br>in<br>the<br>light<br>of<br>earlier<br>decision<br>taken<br>by<br>NC<br>in<br>its<br>Meeting<br>No.<br>9/82-ALC4/2018<br>, dated 18.09.2018, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as<br>per details below or as applied by firm whichever is lower:<br>Export Product<br>Qty.<br>Sl.<br>No.<br>Import items<br>Qty.<br>BISIMIDE<br>1 kg<br>1<br>BISPHENOL A<br>0.75 kg<br>2<br>HEXAETHYLGUANIDINIUM<br>CHLORIDE(HegCL(Catalyst)<br>0.13 kg<br>3<br>N METHYL PHTHALIMIDE<br>3.2 kg<br>4<br>METHANOL<br>1.00 kg<br>5<br>TOLUENE<br>2.00 kg<br>RA concerned maytake further necessaryaction asper above decision of NC. |
|
|
|
Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 9/82-ALC4/2018 , dated 18.09.2018, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:
| 85 |
<br>Case No.:622/15/82-<br>ALC4/2018 |
Party Name:GLAND<br>PHARMA LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02079/AM19/ |
RLA File<br>:09/24/040/00373/AM19/ |
Lic.No/Date:0910066848<br>14.11.2018 |
Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 86 |
Case No.:623/15/82-<br>ALC4/2018 |
Party Name:VINS<br>BIOPRODUCTS LTD` |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred<br> <br>Defer<br>Date:05.07.2019 |
|
<br>HQ File<br>:01/82/050/02080/AM19/ |
RLA File<br>:09/24/040/00363/AM19/ |
Lic.No/Date:0910066851<br>14.11.2018 |
|
|
**Decision:**The Committee considered the case as per agenda in the presence of technical experts and it<br>was decided to forward a copyof application to DBT for obtainingits comments. |
|
|
|
28
| Case No.:624/15/82- |
|
Party Name:MERCK |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
LIMITED |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310825036 |
|
|
| :01/82/050/02081/AM19/ |
|
:03/95/040/00817/AM19/ |
|
14.11.2018 |
|
|
|
Case No.:624/15/82-<br>ALC4/2018 |
Case No.:624/15/82-<br>ALC4/2018 |
Case No.:624/15/82-<br>ALC4/2018 |
Case No.:624/15/82-<br>ALC4/2018 |
Party Name:MERCK<br>LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Approved |
|
HQ File<br>:01/82/050/02081/AM19/ |
|
|
|
RLA File<br>:03/95/040/00817/AM19/ |
Lic.No/Date:0310825036<br>14.11.2018 |
|
|
| 87 |
<br>**Decision:**The Committee considered the cases as per agenda and in the light<br>taken in meeting no. 1/82-ALC4/2019 dated 03.06.2019, it was decided to ratify norms<br>HBP v1 as per details given below or as applied by the firm, whichever is less:<br>Export<br>Product<br>Qty.<br>Sl.No.<br>Import items<br> <br>Thiamine<br>Disulfide<br>1 kg<br>1<br>Thiamine HCL<br><br>2<br>Sodium Hydroxide Pellets<br> <br>3<br>Potassium Hexacyanoferate III GR<br> <br>4<br>Hydrochloric Acid Fuming37%<br> <br>5<br>Hydrogen Peroxide Solution 35% extrapure<br> <br>6<br>Acetone<br> <br>RA maytake appropriate action asper the decision of Norms Committee. |
|
|
|
|
|
|
of earlier decision<br>under Para 4.7 of<br>Qty.<br>1.4199kg<br>0.4605 kg<br>0.0022 kg<br>0.3356 kg<br>0.2157 kg<br>0.6023litres |
|
|
Export<br>Product |
Qty. |
Sl.No. |
<br>Import items |
|
|
Qty. |
|
|
Thiamine<br>Disulfide |
1 kg |
1 |
Thiamine HCL |
|
|
1.4199kg |
|
|
|
|
2 |
Sodium Hydroxide Pellets |
|
|
0.4605 kg |
|
|
|
|
3 |
Potassium Hexacyanoferate III GR |
|
|
0.0022 kg |
|
|
|
|
4 |
Hydrochloric Acid Fuming37% |
|
|
0.3356 kg |
|
|
|
|
5 |
Hydrogen Peroxide Solution 35% extrapure |
|
|
0.2157 kg |
|
|
|
|
6 |
Acetone |
|
|
0.6023litres |
|
|
|
|
|
asper the decision of Norms Committee. |
|
|
|
Decision: The Committee considered the cases as per agenda and in the light of earlier decision taken in meeting no. 1/82-ALC4/2019 dated 03.06.2019, it was decided to ratify norms under Para 4.7 of HBP v1 as per details given below or as applied by the firm, whichever is less:
| Case No.:84/15/82- |
|
Party Name:DEEPAK |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
NITRITE LIMITED |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:3410044702 |
|
|
| :01/82/050/01541/AM19/ |
|
:34/24/040/00257/AM19/ |
|
15.11.2018 |
|
|
Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 15/82-ALC4/2018 , dated 22.03.2019, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as 88 per details below or as applied by firm whichever is lower:
| Export product |
Qty. |
Sl.<br>No. |
Import items |
Qty. |
| 2- ETHYL HEXYL<br>NITRATE |
1 kg |
1 |
2-ETHYL HEXANOL |
0.748 kg |
|
|
2 |
NITRIC ACID |
Not allowed |
|
|
3 |
SULPHURIC ACID |
Not allowed |
|
|
4 |
SODA ASH |
Not allowed |
29
| 89 |
<br>Case No.:627/15/82-<br>ALC4/2018 |
Party Name:AUROBINDO<br>PHARMA LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019<br> <br><br>Lic.No/Date:0910066853<br>15.11.2018<br> <br> |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02084/AM19/ |
RLA File<br>:09/24/040/00382/AM19/ |
|
Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 90 |
<br>Case No.:630/15/82-<br>ALC4/2018 |
Party Name:VIVIN DRUGS &<br>PHARMACEUTICALS<br>LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019<br> <br><br>Lic.No/Date:0910066856<br>15.11.2018<br> <br> |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02087/AM19/ |
RLA File<br>:09/24/040/00391/AM19/ |
|
Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 91 |
Case No.:631/15/82-<br>ALC4/2018 |
Party Name:VIVIN DRUGS &<br>PHARMACEUTICALS<br>LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02088/AM19/ |
RLA File<br>:09/24/040/00392/AM19/ |
Lic.No/Date:0910066857<br>15.11.2018 |
Defer<br>Date:05.07.2019 |
|
**Decision:**RLA, Hyderabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. However, the application is still awaited from RLA,<br>Hyderabad. Hence, it was decided to issue a Reminder to RLA, Hyderabad for furnishing a copy of<br>application expeditiously. |
|
|
|
Case No.:105/15/82- Party Name:SAGA Meet No/Date:3/82- Status: ALC4/2018 LABORATORIES ALC4/2019 Approved 05.07.2019 HQ File RLA File Lic.No/Date:0810143909 :01/82/050/01562/AM19/ :08/24/040/00261/AM19/ 16.11.2018
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
92
| Export product |
Qty. |
Sl.<br>No. |
Import items |
Qty. |
| DIFLAH 500 (DIOSMIN AND<br>HESPERIDIN TABLETS 500 mg<br>PACK OF 30 TABLETS) (NET<br>QTY 250.005 KGS) |
16667.000<br>Packs(Each<br>pack<br>contains 30<br>tablets) |
1 |
DIOSMIN+HESPERIDIN 9:<br>MICRONIZED<br>POLICY CIRCULAR 9 DTD<br>30.06.2003 |
1<br> <br>255.00 kg |
30
| Case No.:643/15/82- |
|
Party Name:DHANUKA |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
LABORATORIES LTD |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0510408442 |
|
|
| :01/82/050/02100/AM19/ |
|
:05/23/040/00347/AM19/ |
|
16.11.2018 |
|
|
|
|
|
|
|
|
|
|
|
|
| <br> <br> <br> |
Case No.:643/15/82-<br>ALC4/2018<br> <br> |
Party Name:DHANUKA |
|
|
|
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status: |
|
|
|
|
LABORATORIES LTD |
|
|
|
|
Approved |
|
|
|
HQ File<br>:01/82/050/02100/AM19/<br> <br> |
RLA File<br>:05/23/040/00347/AM19/ |
|
|
|
Lic.No/Date:0510408442<br>16.11.2018 |
|
|
|
| 93<br> <br> <br> <br> |
**Decision:**The Committee considered the case as per agenda in the presence of Technical Experts and<br>in<br>the<br>light<br>of<br>earlier<br>decision<br>taken<br>by<br>NC<br>in<br>its<br>Meeting<br>No.<br>10/82-ALC4/2018<br>, dated 16.10.2018, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as<br>per details below or as applied by firm whichever is lower:<br>Export product<br>Qty.<br>Sl.No.<br>Import items<br>Qty.<br>7-AVNA<br>/7AVCA<br>1 kg<br>1.<br>7-Phenylacetamideo -3-<br>2.672 kg |
|
|
|
|
|
|
|
|
|
Export product |
|
Qty. |
Sl.No. |
Import items |
|
|
Qty. |
|
|
7-AVNA<br>/7AVCA |
|
1 kg |
1. |
7-Phenylacetamideo -3- |
|
|
2.672 kg |
|
|
POWDER |
|
|
|
Chloromethyl Cephalosporanic Acid<br>Para Methoxybenzyl Ester (GCLE)<br> |
|
|
|
|
|
|
|
|
2. |
Metha |
nol |
|
8.00 kg |
|
|
|
|
|
3. |
n-Buty |
l Acetate |
|
5.06 kg |
|
|
|
|
|
4 |
Methy |
lene Chloride |
|
12.66 kg |
|
|
|
|
|
5 |
Tih |
l hhi |
|
126 k |
|
|
|
|
|
|
rpe |
ny pospne |
|
. g |
|
|
|
|
|
6 |
Pheno |
l |
|
0.933 kg |
|
|
RA concerned maytake further necessaryaction asper |
|
|
|
|
|
|
|
|
|
|
|
|
|
above d |
ecision of NC. |
|
|
|
Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 10/82-ALC4/2018 , dated 16.10.2018, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:
| Case No.:644/15/82- |
|
Party Name:DHANUKA |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
LABORATORIES LTD |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0510408436 |
|
|
| :01/82/050/02101/AM19/ |
|
:05/23/040/00345/AM19/ |
|
16.11.2018 |
|
|
|
|
Decision: |
Decision: |
Decision: |
The Committee considered the case as |
The Committee considered the case as |
The Committee considered the case as |
The Committee considered the case as |
The Committee considered the case as |
per agenda in the presence of Technical Experts and |
per agenda in the presence of Technical Experts and |
per agenda in the presence of Technical Experts and |
per agenda in the presence of Technical Experts and |
per agenda in the presence of Technical Experts and |
|
|
in |
|
the<br>light |
of<br>earlier |
decision |
|
taken<br>by |
|
NC<br>in<br>its<br>Meeting |
No. |
10/82-ALC4/2018 |
|
|
|
|
, dated 16.10.2018, it was decided to ratify the ad-hoc |
|
|
|
|
|
|
|
input output norms under para 4.7 of HBP Vol. I as |
|
|
|
|
|
|
per |
|
details below |
or as applied by firm whichever is lower: |
|
|
|
|
|
|
|
|
|
| 94 |
|
|
Export product |
|
|
|
Qty. |
|
Sl.No. |
Import items |
|
|
Qty. |
|
|
|
|
7-AVNA |
|
/7AVCA |
|
1 kg |
|
1. |
7-Phenylacetamideo |
|
-3- |
2.672 kg |
|
|
|
|
POWDER |
|
|
|
|
|
|
Chloromethyl Cephalosporanic Acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Para Methoxybenzyl Ester (GCLE) |
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
Methanol |
|
|
8.00 kg |
|
|
|
|
|
|
|
|
|
|
3. |
n-Butyl Acetate |
|
|
5.06 kg |
|
|
|
|
|
|
|
|
|
|
4 |
Methylene Chloride |
|
|
12.66 kg |
|
|
|
|
|
|
|
|
|
|
5 |
Triphenyl phosphine |
|
|
1.26 kg |
|
|
|
|
|
|
|
|
|
|
6 |
Phenol |
|
|
0.933 kg |
|
|
|
RA |
|
concerned maytake further necessaryaction asper above decision of NC. |
|
|
|
|
|
|
|
|
|
|
Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 10/82-ALC4/2018 , dated 16.10.2018, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:
31
| Case No.:645/15/82- |
|
Party Name:DHANUKA |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
LABORATORIES LTD |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0510408439 |
|
|
| :01/82/050/02102/AM19/ |
|
:05/23/040/00346/AM19/ |
|
16.11.2018 |
|
|
|
Case No.:645/15/82-<br>ALC4/2018<br>HQ File<br>:01/82/050/02102/AM19/ |
Party Name:DHANUKA<br>LABORATORIES LTD<br>RLA File<br>:05/23/040/00346/AM19/ |
Party Name:DHANUKA<br>LABORATORIES LTD<br>RLA File<br>:05/23/040/00346/AM19/ |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019<br>Lic.No/Date:0510408439<br>16.11.2018 |
Status:<br>Approved |
Status:<br>Approved |
| 95 |
<br>**Decision:**The Committee considered the case as per agenda in the presence of Technical Experts and<br>in<br>the<br>light<br>of<br>earlier<br>decision<br>taken<br>by<br>NC<br>in<br>its<br>Meeting<br>No.<br>10/82-ALC4/2018<br>, dated 16.10.2018, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as<br>per details below or as applied by firm whichever is lower:<br>Export product<br>Qty.<br>Sl.<br>No.<br>Import items<br>Qty.<br>7-AVNA<br>/7AVCA<br>POWDER<br>1 kg<br>1.<br>7-Phenylacetamideo -3-Chloromethyl<br>Cephalosporanic Acid Para<br>Methoxybenzyl Ester (GCLE)<br>2.672 kg<br>2.<br>Methanol<br>8.00 kg<br>3.<br>n-Butyl Acetate<br>5.06 kg<br>4<br>Methylene Chloride<br>12.66 kg<br>5<br>Triphenyl phosphine<br>1.26 kg<br>6<br>Phenol<br>0.933 kg<br>RA concerned maytake further necessaryaction asper above decision of NC. |
|
|
|
|
|
|
|
|
|
|
|
|
| 96 |
Case No.:2/15/82-ALC4/2018 |
Party Name:DEEPAK<br>NITRITE LIMITED<br>RLA File<br>:34/24/040/00254/AM19/ |
|
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred<br> <br>Defer<br>Date:05.07.2019 |
|
|
<br>HQ File<br>:01/82/050/01459/AM19/ |
|
|
Lic.No/Date:3410044710<br>20.11.2018 |
|
|
|
<br>**Decision:**The Committee considered the case as per agenda and it was decided to call for following<br>information from the firm:<br>(i)<br>Complete 4E with all technical details chemistry, molecular weight, stoichiometric reaction<br>and % ofyield at everystage. |
|
|
|
|
|
| 97 |
Case No.:85/15/82-<br>ALC4/2018 |
Party Name:DEEPAK<br>NITRITE LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/01542/AM19/ |
RLA File<br>:34/24/040/00255/AM19/ |
Lic.No/Date:3410044711<br>20.11.2018 |
Defer<br>Date:05.07.2019 |
|
<br>**Decision:**The Committee considered the case as per agenda and it was decided to call for following<br>information from the firm:<br>(i) Complete 4E with all technical details including chemistry, molecular weight, stoichiometric<br>reaction and % ofyield at everystage. |
|
|
|
32
| 98 |
<br>Case No.:86/15/82-<br>ALC4/2018<br> <br> <br>HQ File<br>:01/82/050/01543/AM19/<br> <br> |
Party Name:DEEPAK<br>NITRITE LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status: Deferred |
|
|
RLA File<br>:34/24/040/00256/AM19/ |
Lic.No/Date:3410044712<br>20.11.2018 |
Defer<br>Date:05.07.2019 |
|
<br>**Decision:**The Committee considered the case as per agenda and it was decided to call for following<br>information from the firm:<br>(i)<br>Complete 4E with all technical details including chemistry, molecular weight,<br>stoichiometric reaction and % ofyield at everystage. |
|
|
|
| Case No.:110/15/82- |
|
Party Name:PRACHI |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
PHARMACEUTICALS PVT |
|
ALC4/2019 |
|
Approved |
|
|
LTD |
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310825158 |
|
|
| :01/82/050/01567/AM19/ |
|
:03/95/040/00848/AM19/ |
|
20.11.2018 |
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of 99 HBP as per details below or as applied by firm whichever is lower:
| Export product |
Qty. |
Sl.<br>No. |
Import items |
Qty. |
| THIAMINE HYDRO CHLORIDE |
1 kg |
1 |
THIAMINE<br>MONONITRATE |
1.02 kg |
| Case No.:155/15/82- |
|
Party Name:UNIMAX |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
CHEMICALS PVT LTD. |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:031082515 |
|
|
| :01/82/050/01612/AM19/ |
|
:03/95/040/00839/AM19/ |
|
2 |
|
|
|
|
|
|
20.11.2018 |
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the 100 presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
| Export product |
Qty. |
Sl. No. |
Import items |
Qty. |
| Erythromycin Phosphate |
1 kg |
1 |
Erythromycin Thiocyanate<br>Tech. Spec.: Erythromycin<br>Thiocyanate |
0.84 kg<br>Activity |
33
|
|
Case No.:638/15/82- |
|
Party Name:AUROBINDO |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
PHARMA LIMITED |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
| 101 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0910066874 |
|
Defer |
|
|
:01/82/050/02095/AM19/ |
|
:09/24/040/00386/AM19/ |
|
20.11.2018 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
Case No.:639/15/82- |
|
Party Name:CADILA |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
HEALTHCARE LTD |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
|
| 102 |
HQ File |
|
RLA File |
|
Lic.No/Date:0810143923 |
|
Defer |
|
|
:01/82/050/02096/AM19/ |
|
:08/24/040/00187/AM19/ |
|
20.11.2018 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Case No.:640/15/82- |
|
Party Name:AETHER |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
INDUSTRIES LIMITED |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
|
| 103 |
HQ File |
|
RLA File |
|
Lic.No/Date:5210042834 |
|
Defer |
|
|
:01/82/050/02097/AM19/ |
|
:52/24/040/00064/AM19/ |
|
20.11.2018 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Case No.:641/15/82- |
|
Party Name:HONEST BIO- |
|
Meet No/Date:3/82- |
|
Status: Deferred |
|
|
ALC4/2018 |
|
VET PVT. LTD |
|
ALC4/2019 |
|
|
|
|
|
|
|
|
05.07.2019 |
|
|
| 104 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0810143924 |
|
Defer |
|
|
:01/82/050/02098/AM19/ |
|
:08/24/040/00268/AM19/ |
|
20.11.2018 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
34
| Case No.:648/15/82- |
|
Party Name:CADILA |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
HEALTHCARE LTD |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0810143957 |
|
|
| :01/82/050/02105/AM19/ |
|
:08/24/040/00203/AM19/ |
|
26.11.2018 |
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
Export Product
LEFLUNOMIDE TABLETS USP 10 MG
(ACTIVE INGREDIENT : LEFLUNOMIDE USP - NET WT. 20.869 KGS)
105 LEFLUNOMIDE TABLETS USP 20 MG
(ACTIVE INGREDIENT : LEFLUNOMIDE USP - NET WT. 119.993 KGS)
| S.NO.<br>1<br>2<br>3 |
Import Items<br>LEFLUNOMIDE USP<br>LACTOSE MONOHYDRATE NF/PH.E<br>(PHARMATOSE 200M)<br>CORN STARCH NF(MAIZE STARCH B) |
For export of 1 No.Tablet<br>(Quantity in mg / tablet)<br>10 mg / tablet<br>20 mg / tablet<br>10.2 mg<br>20.40 mg<br>92.75 mg<br>82.75 mg<br>30.00 mg<br>30.00 mg |
RA may take appropriate action as per the decision of Norms Committee.
| 106 |
<br>Case No.:649/15/82-<br>ALC4/2018 |
Party Name:GLOBE<br>TROTTERS PVT LTD |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02106/AM19/ |
RLA File<br>:03/94/040/00713/AM19/ |
Lic.No/Date:0310825212<br>26.11.2018 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
35
| Case No.:653/15/82- |
|
Party Name:LUPIN |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
LIMITED |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:031082524 |
|
|
| :01/82/050/02110/AM19/ |
|
:03/95/040/00814/AM19/ |
|
7 |
|
|
|
|
|
|
27.11.2018 |
|
|
|
|
ALC4/2018<br>LIMITED<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02110/AM19/<br>RLA File<br>:03/95/040/00814/AM19/<br>Lic.No/Date:031082524<br>7<br>27.11.2018 |
ALC4/2018<br>LIMITED<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02110/AM19/<br>RLA File<br>:03/95/040/00814/AM19/<br>Lic.No/Date:031082524<br>7<br>27.11.2018 |
ALC4/2018<br>LIMITED<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02110/AM19/<br>RLA File<br>:03/95/040/00814/AM19/<br>Lic.No/Date:031082524<br>7<br>27.11.2018 |
ALC4/2018<br>LIMITED<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02110/AM19/<br>RLA File<br>:03/95/040/00814/AM19/<br>Lic.No/Date:031082524<br>7<br>27.11.2018 |
ALC4/2018<br>LIMITED<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02110/AM19/<br>RLA File<br>:03/95/040/00814/AM19/<br>Lic.No/Date:031082524<br>7<br>27.11.2018 |
ALC4/2018<br>LIMITED<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02110/AM19/<br>RLA File<br>:03/95/040/00814/AM19/<br>Lic.No/Date:031082524<br>7<br>27.11.2018 |
ALC4/2018<br>LIMITED<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02110/AM19/<br>RLA File<br>:03/95/040/00814/AM19/<br>Lic.No/Date:031082524<br>7<br>27.11.2018 |
|
|
**Decision:**The Committee considered case as per agenda and deliberated on the matter in the |
|
|
|
|
|
|
|
|
presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 |
|
|
|
|
|
|
|
|
of HBP as per details below or as applied by firm whichever is lower: |
|
|
|
|
|
|
|
|
|
Export product |
Qty. |
Sl. |
Import items |
Qty. |
|
|
|
|
|
|
No. |
|
|
|
|
|
|
DOXYCYCLINE FOR ORAL |
1 Number |
1 |
DOXYCYCLINE |
319.32 mg / 60 |
|
|
|
|
SUSPENSION 25MG/5ML - |
|
|
MONOHYDRATE |
ML Bottle |
|
| 107 |
|
|
60ML<br>(NET WT45.00 KGS, WT OF |
|
|
(MICRONIZED) |
|
|
|
|
|
DRUG : 55.80 KGS) |
|
|
|
|
|
|
|
|
DOXYCYCLINE CAPS USP |
1 Number |
2 |
DOXYCYCLINE |
51.7 mg / 50 mg |
|
|
|
|
50MG |
|
|
MONOHYDRATE |
tablet |
|
|
|
|
(NET WT. 100.00 KGS , WT OF |
|
|
(MICRONIZED) |
|
|
|
|
|
DRUGS : 114.00 KGS) |
|
|
|
|
|
|
|
|
DOXYCYCLINE CAPS USP |
1 Number |
3 |
DOXYCYCLINE |
77.55 mg / 75 mg |
|
|
|
|
75MG |
|
|
MONOHYDRATE |
tablet |
|
|
|
|
(NET WT.105.00 KGS, WT OF |
|
|
(MICRONIZED) |
|
|
|
|
|
DRUGS : 119.70 KGS) |
|
|
|
|
|
|
|
|
DOXYCYCLINE CAPS USP |
1 Number |
4 |
DOXYCYCLINE |
103.4 mg / 100 |
|
|
|
|
100MG |
|
|
MONOHYDRATE |
mg tablet |
|
|
|
|
(NET WT. 1300.00 KGS, WT OF |
|
|
(MICRONIZED) |
|
|
|
|
|
DRUG : 1482.00 KGS) |
|
|
|
|
|
|
|
RA concerned maytake further necessaryaction asper above decision of NC. |
|
|
|
|
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
| Case No.:657/15/82- |
|
Party Name:BDR |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
PHARMACEUTICALS |
|
ALC4/2019 |
|
Approved |
|
|
INTERNATIONAL PVT. |
|
05.07.2019 |
|
|
|
|
LTD. |
|
|
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:031082525 |
|
|
| :01/82/050/02114/AM19/ |
|
:03/94/040/00739/AM19/ |
|
4 |
|
|
|
|
|
|
28.11.2018 |
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the 108 presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
| Export product |
Qty. |
Sl.<br> |
Import items |
Qty. |
|
|
No. |
|
|
| Colistimethate Sodium for<br>Injection BP 1 Million<br>InternationalUnits pervial 10ml |
1 Number |
1 |
Colistimethate Sodium for<br>Injection BP |
96.63 mg/<br>vial |
36
|
Case No.:658/15/82- |
Party Name:ATHENA DRUG |
<br>Meet No/Date:3/82- |
Status: |
| 109 |
<br>ALC4/2018 |
<br>DELIVERY SOLUTIONS<br>PRIVATE LIMITED<br>RLA File |
<br> <br>ALC4/2019<br>05.07.2019 |
<br>Deferred<br> <br>Defer |
|
HQ File |
|
Lic.No/Date:0310825255 |
|
|
<br> <br>:01/82/050/02115/AM19/ |
<br>:03/94/040/00744/AM19/ |
<br>28.11.2018 |
<br> <br>Date:05.07.2019 |
|
<br>**Decision:**The Committee co |
nsidered the case as per agenda |
and it was decided to call |
for following |
|
<br>information:<br>(i)<br>Export description does not tally with DML. |
|
|
|
|
|
|
|
|
|
|
Case No.:659/15/82- |
|
Party Name:AUROBINDO |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
PHARMA LIMITED |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
| 110 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0910066905 |
|
Defer |
|
|
:01/82/050/02116/AM19/ |
|
:09/24/040/00410/AM19/ |
|
28.11.2018 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
|
Case No.:664/15/82- |
|
Party |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
Name:SMILAX LABORATORIES |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
LIMITED |
|
05.07.2019 |
|
|
| 111 |
|
HQ File |
|
RLA File :09/24/040/00358/AM19/ |
|
Lic.No/Date:0910066 |
|
Defer |
|
|
:01/82/050/02121/AM1 |
|
|
|
915 |
|
Date:05.07.2019 |
|
|
9/ |
|
|
|
28.11.2018 |
|
|
|
|
**Decision:**Deferred for |
|
comments of TE. |
|
|
|
|
| Case No.:669/15/82- |
|
Party Name:VERVE |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
HUMAN CARE |
|
ALC4/2019 |
|
Deferred |
|
|
LABORATORIES |
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:6110001560 |
|
Defer |
| :01/82/050/02126/AM19/ |
|
:61/24/040/00012/AM19/ |
|
28.11.2018 |
|
Date:05.07.2019 |
112 Decision: The Committee considered the case as per agenda and it was decided to call for following information:
(i) Copy of Drug Manufacturing Licence showing approved composition for export item exclusively.
|
|
Case No.:670/15/82- |
|
Party Name:VERVE |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
HUMAN CARE |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
LABORATORIES |
|
05.07.2019 |
|
|
| 113 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:6110001561 |
|
Defer |
|
|
:01/82/050/02127/AM19/ |
|
:61/24/040/00013/AM19/ |
|
28.11.2018 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
37
| 114 |
<br>Case No.:671/15/82-<br>ALC4/2018 |
Party Name:VERVE<br>HUMAN CARE<br>LABORATORIES |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02128/AM19/ |
RLA File<br>:61/24/040/00014/AM19/ |
Lic.No/Date:6110001562<br>28.11.2018 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 115 |
<br>Case No.:672/15/82-<br>ALC4/2018 |
Party Name:VERVE<br>HUMAN CARE<br>LABORATORIES |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02129/AM19/ |
RLA File<br>:61/24/040/00015/AM19/ |
Lic.No/Date:6110001563<br>28.11.2018 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 116 |
<br>Case No.:673/15/82-<br>ALC4/2018 |
Party Name:VERVE<br>HUMAN CARE<br>LABORATORIES |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02130/AM19/ |
RLA File<br>:61/24/040/00018/AM19/ |
Lic.No/Date:6110001564<br>28.11.2018 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 117 |
<br>Case No.:674/15/82-<br>ALC4/2018 |
Party Name:VERVE<br>HUMAN CARE<br>LABORATORIES |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02131/AM19/ |
RLA File<br>:61/24/040/00017/AM19/ |
Lic.No/Date:6110001565<br>28.11.2018 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
|
| 118 |
<br>Case No.:675/15/82-<br>ALC4/2018 |
Party Name:VERVE<br>HUMAN CARE<br>LABORATORIES |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02132/AM19/ |
RLA File<br>:61/24/040/00016/AM19/ |
Lic.No/Date:6110001566<br>28.11.2018 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
|
| 119 |
<br>Case No.:210/15/82-<br>ALC4/2018 |
Party Name:VENUS<br>REMEDIES LTD., |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/01667/AM19/ |
RLA File<br>:22/24/040/00064/AM19/ |
Lic.No/Date:2210016020<br>29.11.2018 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
38
| 120 |
Case No.:668/15/82-<br>ALC4/2018 |
Party Name:CADILA<br>HEALTHCARE LTD |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred<br> <br>Defer<br>Date:05.07.2019 |
|
HQ File<br>:01/82/050/02125/AM19/ |
RLA File<br>:08/24/040/00264/AM19/ |
Lic.No/Date:0810143988<br>29.11.2018 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 121 |
Case No.:689/15/82-<br>ALC4/2018 |
Party Name:AUROBINDO<br>PHARMA LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred<br> <br>Defer<br>Date:05.07.2019 |
|
HQ File<br>:01/82/050/02146/AM19/ |
RLA File<br>:09/24/040/00421/AM19/ |
Lic.No/Date:0910066921<br>29.11.2018 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
| Case No.:838/15/82- |
|
Party Name:IND SWIFT |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
LABORATORIES LIMITED |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:221001601 |
|
|
| :01/82/050/02295/AM19/ |
|
:22/24/040/00065/AM19/ |
|
9 |
|
|
|
|
|
|
29.11.2018 |
|
|
|
Case No.:838/15/82-<br>ALC4/2018<br>HQ File<br>:01/82/050/02295/AM19/ |
Party Name:IND SWIFT<br>LABORATORIES LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Approved |
|
|
RLA File<br>:22/24/040/00065/AM19/ |
Lic.No/Date:221001601<br>9<br>29.11.2018 |
|
| 122 |
**Decision:**The Committee considered case as per agenda and deliberated on the matter in the<br>presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7<br>of HBP as per details below or as applied by firm whichever is lower:<br>Export product<br>Qty.<br>Sl.<br>No.<br>Import items<br>Qty.<br>Clopidogrel Hydrogen Sulphate<br>1 kg<br>1<br>DL-2-Chloro Phenyl Glycine<br>1.00 kg<br>2<br>Methanol<br>4.87 kg<br>3<br>Methylene Chloride<br>2.03 kg<br>4<br>L(+) Tartaric Acid<br>0.667 kg<br>5<br>Acetone<br>0.34 kg<br>6<br>Thiophene-2-Ethanol<br>0.60 kg<br>7<br>Toluene<br>1.11 kg<br>8<br>Isopropyl Alcohol<br>0.99 kg<br>9<br>Para Toluene Sulfonyl<br>Chloride<br>1.029 kg<br>RA concerned maytake further necessaryaction asper above decision of NC. |
|
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
39
| Case No.:144/15/82- |
|
Party Name:USV PRIVATE |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
LIMITED |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310825333 |
|
|
| :01/82/050/01601/AM19/ |
|
:03/95/040/00897/AM19/ |
|
30.11.2018 |
|
|
|
Case No.:144/15/82-<br>ALC4/2018 |
Party Name:USV PRIVATE<br>LIMITED |
Party Name:USV PRIVATE<br>LIMITED |
Party Name:USV PRIVATE<br>LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019<br>Lic.No/Date:0310825333<br>30.11.2018 |
Status:<br>Approved |
|
HQ File<br>:01/82/050/01601/AM19/ |
RLA File<br>:03/95/040/00897/AM19/ |
|
|
|
|
| 123 |
**Decision:**The Committee considered case as per agenda and deliberated on<br>presence of the technical experts and it was decided to ratify the ad-hoc input output nor<br>of HBP as per details below or as applied by firm whichever is lower: |
|
|
|
|
the matter in the<br>ms under para 4.7 |
|
Export product |
Qty. |
Sl. No. |
Import items |
|
Qty. |
|
<br>Propafenone Hydrochloride<br>Extended Release Capsules<br>USP 225 MG<br>(6,999 Bottles x 60 Per<br>Bottles = 4,19,940<br>Capsules) ( Net Content<br>Weight=94.487 Kgs) |
6999.000<br>Bottles(Each<br>bottle<br>contains 60<br>tablets) |
1 |
Propafenone Hydrochloride |
|
268.04 kg |
|
Propafenone Hydrochloride<br>Extended Release Capsules<br>USP 425 MG<br>(6,600 Bottles x 60 Per<br>Bottles = 3,96,000<br>Capsules) ( Net Content<br>Weight=168.300 Kgs) |
6600.000<br>Bottles(Each<br>bottle<br>contains 60<br>tablets) |
|
|
|
|
|
RA concerned maytake further necessaryaction asper above decision of NC. |
|
|
|
|
|
| 124 |
Case No.:683/15/82-<br>ALC4/2018 |
Party Name:NEON<br>LABORATORIES LTD. |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019<br>Lic.No/Date:0310825329<br>30.11.2018 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02140/AM19/ |
RLA File<br>:03/95/040/00873/AM19/ |
|
Defer<br>Date:05.07.2019 |
|
**Decision:**RLA, Mumbai was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. However, the application is still awaited from RLA,<br>Mumbai. Hence, it was decided to issue a Reminder to RLA, Mumbai for furnishing a copy of<br>application expeditiously. |
|
|
|
Decision: RLA, Mumbai was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. However, the application is still awaited from RLA, Mumbai. Hence, it was decided to issue a Reminder to RLA, Mumbai for furnishing a copy of application expeditiously.
| 125 |
<br>Case No.:684/15/82-<br>ALC4/2018 |
Party Name:GLAND<br>PHARMA LIMITED<br>RLA File<br>:09/24/040/00419/AM19/ |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred<br> <br>Defer<br>Date:05.07.2019 |
|
<br>HQ File<br>:01/82/050/02141/AM19/ |
|
Lic.No/Date:0910066930<br>03.12.2018 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
40
|
|
Case No.:685/15/82- |
|
Party Name:GLAND |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
PHARMA LIMITED |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
| 126 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0910066931 |
|
Defer |
|
|
:01/82/050/02142/AM19/ |
|
:09/24/040/00420/AM19/ |
|
03.12.2018 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
|
Case No.:686/15/82- |
|
Party Name:GENESYS |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
BIOLOGICS PRIVATE |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
LIMITED |
|
05.07.2019 |
|
|
| 127 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0910066932 |
|
Defer |
|
|
:01/82/050/02143/AM19/ |
|
:09/24/040/00427/AM19/ |
|
03.12.2018 |
|
Date:05.07.2019 |
|
|
**Decision:**The Committee considered the case as per agenda in the presence of technical experts and it |
|
|
|
|
|
|
|
|
was decided to forward a copyof application to DBT for obtainingits comments. |
|
|
|
|
|
|
| Case No.:687/15/82- |
|
Party Name:EAGLE |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
CHEMICAL WORKS |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310825360 |
|
|
| :01/82/050/02144/AM19/ |
|
:03/94/040/00685/AM19/ |
|
03.12.2018 |
|
|
|
|
ALC4/2018<br>CHEMICAL WORKS<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02144/AM19/<br>RLA File<br>:03/94/040/00685/AM19/<br>Lic.No/Date:0310825360<br>03.12.2018 |
ALC4/2018<br>CHEMICAL WORKS<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02144/AM19/<br>RLA File<br>:03/94/040/00685/AM19/<br>Lic.No/Date:0310825360<br>03.12.2018 |
ALC4/2018<br>CHEMICAL WORKS<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02144/AM19/<br>RLA File<br>:03/94/040/00685/AM19/<br>Lic.No/Date:0310825360<br>03.12.2018 |
|
|
|
**Decision:**The Committee considered case as per agenda and as per earlier decision taken by NC in |
|
|
|
| 128 |
|
its 13/82-ALC4/2018 meeting dated 14.01.2019, it was decided to ratify the ad-hoc input<br>under para 4.7 of HBP as per details below or as applied by firm whichever is lower:- |
|
output norms |
|
|
|
Export product<br>Qty.<br>Sl. |
Import items |
Qty. |
|
|
|
No. |
|
|
|
|
|
CALCIUM OROTATE<br>1 kg<br>1 |
OROTIC ACID |
1.059 kg |
|
|
|
DIHYDRATE |
|
|
|
|
|
RA concerned maytake further necessaryaction asper above decision of NC |
|
|
|
|
|
Case No.:688/15/82- |
|
Party Name:JODAS EXPOIM |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
PVT.LTD |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
| 129 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0510408748 |
|
Defer |
|
|
:01/82/050/02145/AM19/ |
|
:05/23/040/00385/AM19/ |
|
04.12.2018 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
|
Case No.:691/15/82- |
|
Party Name:ORTIN |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
LABORATORIES LTD |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
| 130 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0910066937 |
|
Defer |
|
|
:01/82/050/02148/AM19/ |
|
:09/24/040/00423/AM19/ |
|
04.12.2018 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
41
| Case No.:754/15/82- |
|
Party Name:CLARIANT |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
INDIA LIMITED |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310825405 |
|
|
| :01/82/050/02211/AM19/ |
|
:03/94/040/00766/AM19/ |
|
04.12.2018 |
|
|
|
Case No.:754/15/82-<br>ALC4/2018 |
Case No.:754/15/82-<br>ALC4/2018 |
Party Name:CLARIANT<br>INDIA LIMITED |
Party Name:CLARIANT<br>INDIA LIMITED |
Party Name:CLARIANT<br>INDIA LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Approved |
Status:<br>Approved |
Status:<br>Approved |
|
HQ File<br>:01/82/050/02211/AM19/ |
|
RLA File<br>:03/94/040/00766/AM19/ |
|
|
Lic.No/Date:0310825405<br>04.12.2018 |
|
|
|
|
**Decision:**The Committee considered case as per agenda and as per earlier decision taken by NC in<br>its 6/82-ALC4/2014 meeting dated 29.08.2014, it was decided to ratify the ad-hoc input output norms<br>under para 4.7 of HBP as per details below or as applied by firm whichever is lower:- |
|
|
|
|
|
|
|
|
| 131 |
<br>Exportproduct<br>EHT (ETHYL<br> |
Qty. |
|
Sl. No. |
Import items |
|
|
Qty. |
|
|
|
1 kg |
|
1. |
PARA NITRO BENZOIC ACID(PNBA) |
|
|
1.034 kg |
|
|
HEXYL TRIAZONE)<br>/ ETONE |
|
|
2. |
PERCHLORO |
ETHYLENE(PCE) |
|
0.606 kg |
|
|
|
|
|
3. |
METHANOL |
|
|
2.940 kg |
|
|
|
|
|
4. |
2 ETHYL HE |
XANOL |
|
0.882 kg |
|
|
|
|
|
5. |
ACETO NITR |
ILE |
|
1.30 kg |
|
|
|
|
|
6. |
XYLENE(OR |
THO XYLENE) |
|
1.00 kg |
|
|
|
|
|
7. |
CYANURIC C |
HLORIDE |
|
0.640 kg |
|
|
|
|
|
|
|
|
|
|
|
|
RA concerned maytake further necessaryaction asper above decision of NC |
|
|
|
|
|
|
|
|
|
|
|
|
|
| 132 |
<br>Case No.:103/15/82-<br>ALC4/2018 |
Party Name:STERLING<br>AXILIARIES PVT LTD |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Dfd |
|
|
U |
|
eerre |
|
<br> |
|
|
|
|
HQ File<br>:01/82/050/01560/AM19/ |
RLA File<br>:03/95/040/00851/AM19/ |
Lic.No/Date:0310825462<br>05.12.2018 |
Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
|
|
|
Case No.:140/15/82- |
|
Party Name:YASHO |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
INDUSTRIES LIMITED |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
| 133 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0310825441 |
|
Defer |
|
|
:01/82/050/01597/AM19/ |
|
:03/95/040/00911/AM19/ |
|
05.12.2018 |
|
Date:05.07.2019 |
|
|
**Decision:**The Committee considered the case as per agenda and it was decided to call Appendix 4E |
|
|
|
|
|
|
|
|
havingcomplete technical details like chemistry,% ofyield at each stepand molecular weight. |
|
|
|
|
|
|
|
|
Case No.:692/15/82- |
|
Party Name:ORTIN |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
LABORATORIES LTD |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
| 134 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0910066938 |
|
Defer |
|
|
:01/82/050/02149/AM19/ |
|
:09/24/040/00424/AM19/ |
|
05.12.2018 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
42
| Case No.:694/15/82- |
|
Party Name:AUROBINDO |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
PHARMA LIMITED |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0910066942 |
|
|
| :01/82/050/02151/AM19/ |
|
:09/24/040/00430/AM19/ |
|
05.12.2018 |
|
|
|
Case No.:694/15/82-<br>ALC4/2018<br> <br> <br>HQ File<br>:01/82/050/02151/AM19/<br> <br> |
Case No.:694/15/82-<br>ALC4/2018<br> <br> <br>HQ File<br>:01/82/050/02151/AM19/<br> <br> |
Case No.:694/15/82-<br>ALC4/2018<br> <br> <br>HQ File<br>:01/82/050/02151/AM19/<br> <br> |
Party Name:AUROBINDO<br>PHARMA LIMITED |
Party Name:AUROBINDO<br>PHARMA LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Approved |
Status:<br>Approved |
|
|
|
|
RLA File<br>:09/24/040/00430/AM19/ |
|
Lic.No/Date:0910066942<br>05.12.2018 |
|
|
| 135 |
**Decision:**The Committee considered the case as per agenda in the presence of Technical Experts and<br>in<br>the<br>light<br>of<br>earlier<br>decision<br>taken<br>by<br>NC<br>in<br>its<br>Meeting<br>No.<br>15/82-ALC4/2018<br>, dated 22.03.2019, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as<br>per details below or as applied by firm whichever is lower:<br>Export Product<br>Qty.<br>Sl.<br>No.<br>Import Items<br>Qty.<br>FINASTERIDE<br>1 kg<br>1<br>Azaandrostane carboxamide (Androst-4-aza-3-<br>one-17Beta-N-Tert-Butyl Carboxamide)<br>1.7647 kg<br>2<br>Bis (Trimethylsilyl) trifluoroacetamide (BSTFA)<br>1.47 kg<br>3<br>2,3-Dichloro-5,6-dicyano-1,4-benzoquinone<br>(DDQ)<br>0.86 kg<br>4<br>Activated Carbon (Carbon Enoanticromos)<br>0.012 kg<br>5<br>Methanol (Methyl Alcohol)<br>4.66 kg<br>6<br>Methylene chloride (MDC)<br>7.50 kg<br>7<br>Tetrahydrofuran (THF)<br>3.00 kg<br>8<br>Toluene<br>4.84 kg<br>RA concerned maytake further necessaryaction asper above decision of NC. |
|
|
|
|
|
|
|
|
|
Export Product |
Qty. |
Sl.<br>No. |
Import Items |
|
|
Qty. |
|
|
FINASTERIDE |
1 kg |
1 |
Azaandrostane carboxamide (Androst-4-aza-3-<br>one-17Beta-N-Tert-Butyl Carboxamide) |
|
|
1.7647 kg |
|
|
|
|
2 |
Bis (Trimethylsilyl) trifluoroacetamide (BSTFA) |
|
|
1.47 kg |
|
|
|
|
3 |
2,3-Dichloro-5,6-dicyano-1,4-benzoquinone<br>(DDQ) |
|
|
0.86 kg |
|
|
|
|
4 |
Activated Carbon (Carbon Enoanticromos) |
|
|
0.012 kg |
|
|
|
|
5 |
Methanol (Methyl Alcohol) |
|
|
4.66 kg |
|
|
|
|
6 |
Methylene chloride (MDC) |
|
|
7.50 kg |
|
|
|
|
7 |
Tetrahydrofuran (THF) |
|
|
3.00 kg |
|
|
|
|
8 |
Toluene |
|
|
4.84 kg |
|
|
|
|
necessaryaction asper above decision of NC. |
|
|
|
|
| Case No.:695/15/82- |
|
Party Name:AUROBINDO |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
PHARMA LIMITED |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0910066943 |
|
|
| :01/82/050/02152/AM19/ |
|
:09/24/040/00435/AM19/ |
|
05.12.2018 |
|
|
|
Case No.:695/15/82-<br>ALC4/2018<br> <br> <br>HQ File<br>:01/82/050/02152/AM19/<br> <br> |
Case No.:695/15/82-<br>ALC4/2018<br> <br> <br>HQ File<br>:01/82/050/02152/AM19/<br> <br> |
Party Name:AUROBINDO<br>PHARMA LIMITED |
Party Name:AUROBINDO<br>PHARMA LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Approved |
Status:<br>Approved |
|
|
|
RLA File<br>:09/24/040/00435/AM19/ |
|
Lic.No/Date:0910066943<br>05.12.2018 |
|
|
| 136 |
**Decision:**The Committee considered the case as per agenda in the presence of Technical Experts and<br>in<br>the<br>light<br>of<br>earlier<br>decision<br>taken<br>by<br>NC<br>in<br>its<br>Meeting<br>No.<br>15/82-ALC4/2018<br>, dated 22.03.2019, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as<br>per details below or as applied by firm whichever is lower: |
|
|
|
|
|
|
|
Export product |
Qty. |
Sl.<br>No. |
Import items |
|
|
Qty. |
|
SILODOSIN |
1 kg |
1 |
(R)-Amine Tartrate<br>or [5-[(2R)-2-Aminopropyl]-1-[3-<br>(Benzoyloxy)Propyl)-2,3-Dihydro-1H-Indole-7-<br>Carbonitrile(2R,3R)-2,3-Dihydroxybutanedioate] |
|
|
2.50 kg |
|
|
|
2 |
Acetonitrile |
|
|
2.65 kg |
|
|
|
3 |
Dimethyl Sulfoxide |
|
|
2.65 kg |
|
|
|
4 |
Cyclohexane |
|
|
0.54 kg |
|
|
|
5 |
Isopropyl Acetate |
|
|
4.95 kg |
|
|
|
6 |
Methanol (Methyl Alcohol) |
|
|
6.58 kg |
|
|
|
7 |
Methylene Chloride (MDC) |
|
|
6.00 kg |
|
|
|
8 |
Potassium Carbonate (Anhydrous) |
|
|
0.67 kg |
|
|
|
9 |
TFEP Ethyl Mesylate<br>or [2-[2-(2,2,2-Trifluoroethoxy)Phenoxy]Ethyl<br>Methanesulfonate] |
|
|
1.53 kg |
|
RA concerned maytake further |
|
necessaryaction asper above decision of NC. |
|
|
|
|
43
| 137 |
<br>Case No.:696/15/82-<br>ALC4/2018 |
Party Name:AUROBINDO<br>PHARMA LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02153/AM19/ |
RLA File<br>:09/24/040/00436/AM19/ |
Lic.No/Date:0910066944<br>05.12.2018 |
Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 138 |
Case No.:744/15/82-<br>ALC4/2018 |
Party Name:LUPIN LIMITED<br>RLA File<br>:03/95/040/00876/AM19/ |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred<br> <br>Defer<br>Date:05.07.2019 |
|
<br>HQ File<br>:01/82/050/02201/AM19/ |
|
Lic.No/Date:0310825438<br>05.12.2018 |
|
|
**Decision:**RLA, Mumbai was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. However, the application is still awaited from RLA,<br>Mumbai. Hence, it was decided to issue a Reminder to RLA, Mumbai for furnishing a copy of<br>application expeditiously. |
|
|
|
| 139 |
Case No.:773/15/82-<br>ALC4/2018 |
Party Name:LUPIN<br>LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02230/AM19/ |
RLA File<br>:03/95/040/00902/AM19/ |
Lic.No/Date:0310825460<br>05.12.2018 |
Defer<br>Date:05.07.2019 |
|
**Decision:**RLA, Mumbai was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. However, the application is still awaited from RLA,<br>Mumbai. Hence, it was decided to issue a Reminder to RLA, Mumbai for furnishing a copy of<br>application expeditiously. |
|
|
|
Decision: RLA, Mumbai was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. However, the application is still awaited from RLA, Mumbai. Hence, it was decided to issue a Reminder to RLA, Mumbai for furnishing a copy of application expeditiously.
| 140 |
<br>Case No.:186/15/82-<br>ALC4/2018 |
Party Name:WOCKHARDT<br>LIMITED<br>RLA File<br>:03/95/040/00900/AM19/ |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred<br> <br>Defer<br>Date:05.07.2019 |
|
<br>HQ File<br>:01/82/050/01643/AM19/ |
|
Lic.No/Date:0310825487<br>06.12.2018 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 141 |
<br>Case No.:698/15/82-<br>ALC4/2018 |
Party Name:VISION DRUGS<br>PVT LTD |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02155/AM19/ |
RLA File<br>:09/24/040/00412/AM19/ |
Lic.No/Date:0910066949<br>06.12.2018 |
Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
44
| Case No.:699/15/82- |
|
Party Name:CRYSTAL |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
QUINONE PVT LTD |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0810144041 |
|
|
| :01/82/050/02156/AM19/ |
|
:08/24/040/00296/AM19/ |
|
06.12.2018 |
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower: 142
| Export product |
Qty. |
Sl. |
Import items |
Qty. |
|
|
No. |
|
|
| 2-CHLORO-1,4- |
1 kg |
1 |
PARADIMETHOXYBENZE |
0.88 kg |
| DIMETHOXYBENZENE |
|
|
NE [1,4 |
|
|
|
|
DIMETHOXYBENZENE |
|
|
|
|
(PDMB)] |
|
|
|
Case No.:700/15/82- |
|
Party Name:J.B. |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
CHEMICALS & |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
PHARMACEUTICALS |
|
05.07.2019 |
|
|
| 143 |
|
|
|
LIMITED |
|
|
|
|
|
|
HQ File |
|
RLA File |
|
Lic.No/Date:0310825472 |
|
Defer |
|
|
:01/82/050/02157/AM19/ |
|
:03/94/040/00748/AM19/ |
|
06.12.2018 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
| Case No.:702/15/82- |
|
Party Name:GLOBAL |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
CALCIUM PRIVATE |
|
ALC4/2019 |
|
Approved |
|
|
LIMITED |
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0710114247 |
|
|
| :01/82/050/02159/AM19/ |
|
:07/24/040/00212/AM19/ |
|
06.12.2018 |
|
|
|
|
**Decision:**The Committee considered the case as |
**Decision:**The Committee considered the case as |
**Decision:**The Committee considered the case as |
per agenda in the presence of Technical Experts and |
per agenda in the presence of Technical Experts and |
per agenda in the presence of Technical Experts and |
|
|
in<br>the<br>light<br>of<br>earlier<br>decision |
|
taken<br>by |
NC<br>in<br>its<br>Meeting<br>No. |
<br>15/82-ALC4/2018 |
|
|
|
, dated 22.03.2019, it was decided to ratify the ad-hoc |
|
|
input output norms under para |
4.7 of HBP Vol. I as |
|
|
|
per details below or as applied by firm whichever is lower: |
|
|
|
|
|
| 144 |
|
Export product |
Qty. |
<br>Sl. No. |
Import items |
|
Qty. |
|
|
CALCIUM GLUCONATE (EP |
1 kg |
1 |
CALCIUM GLUCONATE- |
|
1.09 kg |
|
|
FOR INJECTION/JP/USP) |
|
|
ORAL GRADE |
|
|
|
|
CALCIUM |
1 kg |
1 |
CALCIUM GLUCONATE- |
|
0.946 kg |
|
|
BOROGLUCONATE |
|
|
ORAL GRADE |
|
|
|
|
CALCIUM GLUBIONATE |
1 kg |
1 |
CALCIUM GLUCONATE- |
|
0.430 kg |
|
|
(FOR INJECTION) |
|
|
ORAL GRADE |
|
|
|
|
RA concerned maytake further necessary |
|
action asper |
above decision of NC. |
|
|
45
| Case No.:149/15/82- |
|
Party Name:POLYGEL |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
INDUSTRIES PVT.LTD |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310825534 |
|
|
| :01/82/050/01606/AM19/ |
|
:03/95/040/00906/AM19/ |
|
07.12.2018 |
|
|
|
Case No.:149/15/82-<br>ALC4/2018 |
Case No.:149/15/82-<br>ALC4/2018 |
Party Name:POLYGEL<br>INDUSTRIES PVT.LTD<br> <br> <br> |
Party Name:POLYGEL<br>INDUSTRIES PVT.LTD<br> <br> <br> |
Party Name:POLYGEL<br>INDUSTRIES PVT.LTD<br> <br> <br> |
Party Name:POLYGEL<br>INDUSTRIES PVT.LTD<br> <br> <br> |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Approved |
|
HQ File<br>:01/82/050/01606/AM19/ |
|
RLA File<br>:03/95/040/00906/AM19/<br> <br> |
|
|
|
Lic.No/Date:0310825534<br>07.12.2018 |
|
| 145 |
**Decision:**The Committee considered case as per agenda and deliberated on<br>presence of the technical experts and it was decided to ratify the ad-hoc input output<br>4.7 of HBP as per details below or as applied by firm whichever is lower:<br>Export product<br>Qty.<br>Sl.<br>No.<br>Import items<br>ISO PROPYL BUTYL TITANATE<br>(PURETI TPT 15B)<br>1 kg<br>1<br>TETRA ISO PROPYL<br>TITANATE<br>2<br>TETRA NORMAL<br>BUTYL TITANATE<br>RA concerned maytake further necessaryaction asper above decision of NC. |
|
|
|
|
|
|
the matter in the<br>norms under para<br>Qty.<br>0.8405 kg<br>0.1795 kg |
|
|
Export product |
|
Qty. |
Sl.<br>No. |
Import items |
|
Qty. |
|
|
ISO PROPYL BUTYL TITANATE<br>(PURETI TPT 15B) |
|
1 kg |
1 |
TETRA ISO PROPYL<br>TITANATE |
|
0.8405 kg |
|
|
|
|
|
2 |
TETRA NORMAL<br>BUTYL TITANATE |
|
0.1795 kg |
|
|
|
|
action a |
sper above decision of NC. |
|
|
|
| 146 |
<br>Case No.:185/15/82-<br>ALC4/2018 |
Party Name:YASHO<br>INDUSTRIES LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019<br>Lic.No/Date:0310825514<br>07.12.2018 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/01642/AM19/ |
RLA File<br>:03/95/040/00925/AM19/ |
|
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 147 |
<br>Case No.:88/15/82-<br>ALC4/2018 |
Party Name:J.B.<br>CHEMICALS &<br>PHARMACEUTICALS<br>LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019<br>Lic.No/Date:0310825559<br>10.12.2018 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/01545/AM19/ |
RLA File<br>:03/94/040/00774/AM19/ |
|
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 148 |
<br>Case No.:703/15/82-<br>ALC4/2018 |
Party Name:SRINI<br>PHARMACEUTICALS<br>PRIVATE LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019<br>Lic.No/Date:0910066958<br>10.12.2018 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02160/AM19/ |
RLA File<br>:09/24/040/00413/AM19/ |
|
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
46
Case No.:704/15/82- Party Name:CLEAN Meet No/Date:3/82- Status: ALC4/2018 SCIENCE AND ALC4/2019 Approved TECHNOLOGY PVT.LTD. 05.07.2019 HQ File RLA File Lic.No/Date:3110067248 :01/82/050/02161/AM19/ :31/83/040/00133/AM19/ 10.12.2018 Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 7/82-ALC4/2018 , dated 24.08.2018, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as 149 per details below or as applied by firm whichever is lower:
| Export product |
Qty. |
Sl.No. |
Import items |
Qty. |
| Guaiacol |
1 kg |
1 |
Anisole Purity 93% Max. |
1.17 kg |
|
|
2 |
Hydrogen Peroxide Purity 60% |
0.687 kg |
|
|
3 |
Acetone (Solvent) |
0.14 kg |
| 150 |
<br>Case No.:706/15/82-<br>ALC4/2018 |
Party Name:J.B.<br>CHEMICALS &<br>PHARMACEUTICALS<br>LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02163/AM19/ |
RLA File<br>:03/94/040/00773/AM19/ |
Lic.No/Date:0310825552<br>10.12.2018 |
Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 151 |
Case No.:715/15/82-<br>ALC4/2018 |
Party Name:MALLADI<br>DRUGS &<br>PHARMACEUTICALS<br>LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02172/AM19/ |
RLA File<br>:04/24/040/00143/AM19/ |
Lic.No/Date:0410164962<br>10.12.2018 |
Defer<br>Date:05.07.2019 |
|
**Decision:**RLA, Chennai was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. However, the application is still awaited from RLA,<br>Chennai. Hence, it was decided to issue a Reminder to RLA, Chennai for furnishing a copy of application<br>expeditiously. |
|
|
|
Decision: RLA, Chennai was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. However, the application is still awaited from RLA, Chennai. Hence, it was decided to issue a Reminder to RLA, Chennai for furnishing a copy of application expeditiously.
| 152 |
<br>Case No.:139/15/82-<br>ALC4/2018 |
Party Name:RUBICON<br>RESEARCH PRIVATE<br>LIMITED<br>RLA File<br>:03/95/040/00889/AM19/ |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred<br> <br>Defer<br>Date:05.07.2019 |
|
<br>HQ File<br>:01/82/050/01596/AM19/ |
|
Lic.No/Date:0310825587<br>11.12.2018 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
47
| 153<br> <br> <br> <br>:<br> |
Case No.:711/15/82-<br>ALC4/2018 |
Party Name:SUVEN LIFE<br>SCIENCES LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred<br> <br>Defer<br>Date:05.07.2019 |
|
HQ File<br>01/82/050/02168/AM19/ |
RLA File<br>:09/24/040/00441/AM19/ |
Lic.No/Date:0910066959<br>11.12.2018 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
| Case No.:712/15/82- |
|
Party Name:DELTA |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
FINOCHEM PVT.LTD. |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:031082561 |
|
|
| :01/82/050/02169/AM19/ |
|
:03/94/040/00740/AM19/ |
|
1 |
|
|
|
|
|
|
11.12.2018 |
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the 154 presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
| Export product |
Qty. |
Sl. |
Import items |
Qty. |
|
|
No. |
|
|
| N Octyl Bromide ( 1-Bromo Octane) |
1 kg |
1 |
N Octanol ( N Octyl Alcohol) |
0.744 kg |
|
|
2 |
Liquid Bromine |
0.460 kg |
| 155<br> <br> <br> <br>:<br> <br>t<br> <br> <br> |
Case No.:100/15/82-<br>ALC4/2018 |
Party Name:PANACEA<br>BIOTEC LTD., |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Approved<br> |
|
HQ File<br>01/82/050/01557/AM19/ |
RLA File<br>:05/24/040/00499/AM19/ |
Lic.No/Date:0510408880<br>12.12.2018 |
|
|
**Decision:**The Committee considered case as per agenda and deliberated on the matter in the presence of<br>he technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as<br>per details below or as applied by firm whichever is lower (on one time basis):<br>Export product<br>Qty.<br>Sl.<br>No.<br>Import items<br>Qty.<br>ALPHADOL CAPSULES (EACH<br>SOFT GELATIN CAPSULE<br>CONTAINS: ALFACALCIDOL<br>0.25 MCG.)<br>2700000 Capsules<br>1<br>ALFACALCIDOL<br>1.785<br>gram<br>ALPHADOL-CA CAPSULES<br>(EACH SOFT GELATIN<br>CAPSULE CONTAINS:<br>ALFACALCIDOL 0.25 mcg &<br>CALCIUM CARBONATE 500mg<br>EQUIVALENT TO<br>ELEMENTAL CALCIUM 200<br>mg)<br>2400000 Capsules<br>The Committee allowed the above norms on one time basis and no repeat norms is allowed.<br>RA concerned maytake further necessaryaction asper above decision of NC. |
|
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower (on one time basis):
48
| 156 |
<br>Case No.:106/15/82-<br>ALC4/2018<br> <br> <br> <br>HQ File<br>:01/82/050/01563/AM19/<br> <br> |
Party Name:SONGWON<br>SPECIALTY CHEMICALS<br>INDIA PVT. LTD. |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred<br> <br>Defer<br>Date:05.07.2019 |
|
|
RLA File<br>:34/24/040/00294/AM19/ |
Lic.No/Date:3410044750<br>12.12.2018 |
|
|
**Decision:**The Committee considered the case as per agenda in the presence of technical experts and it<br>was decided to call for complete technical details asper Appendix 4E from the firm. |
|
|
|
| 157 |
<br>Case No.:152/15/82-<br>ALC4/2018<br> <br> <br> <br>HQ File<br>:01/82/050/01609/AM19/<br> <br>: |
Party Name:PRASOL<br>CHEMICALS PRIVATE<br>LIMITED<br>RLA File<br>03/95/040/00948/AM19/ |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019<br>Lic.No/Date:0310825623<br>12.12.2018 |
Status:<br>Deferred |
|
|
|
|
Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| Case No.:189/15/82- |
|
Party Name:TATA |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
CHEMICALS LIMITED |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310825645 |
|
Defer |
| :01/82/050/01646/AM19/ |
|
:03/95/040/00901/AM19/ |
|
13.12.2018 |
|
Date:05.07.2019 |
158 Decision: The Committee considered the case as per agenda in the presence of technical experts and it was decided to call for following information:
(i) Use of item of export. (ii) Complete 4E with technical details. (iii) Calculation Sheet to arrive at the quantity of raw material asked. (iv) Past Production Consumption Data duly certified by CE.
| Case No.:716/15/82- |
|
Party Name:JUBILANT LIFE |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
SCIENCES LIMITED |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0510408887 |
|
|
| :01/82/050/02173/AM19/ |
|
:05/23/040/00243/AM19/ |
|
13.12.2018 |
|
|
|
Case No.:716/15/82-<br>ALC4/2018 |
Party Name:JUBILANT LIFE<br>SCIENCES LIMITED<br>RLA File<br>:05/23/040/00243/AM19/ |
Party Name:JUBILANT LIFE<br>SCIENCES LIMITED<br>RLA File<br>:05/23/040/00243/AM19/ |
Party Name:JUBILANT LIFE<br>SCIENCES LIMITED<br>RLA File<br>:05/23/040/00243/AM19/ |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Approved |
|
HQ File<br>:01/82/050/02173/AM19/ |
|
|
|
Lic.No/Date:0510408887<br>13.12.2018 |
|
|
| 159 |
**Decision:**The Committee considered the cases as per agenda and in the light of earlier decision taken in<br>meeting no. 15/82-ALC4/2018 dated 22.03.2019, it was decided to ratify norms under Para 4.7 of HBP v1<br>as per details given below or as applied by the firm, whichever is less: |
|
|
|
|
|
|
|
Export product |
Qty. |
Sl.No. |
Import items |
|
Qty. |
|
|
<br>Beta Picoline |
1 kg |
1 |
Denatured Ethyl Alcohol |
|
1.121 kg |
|
|
|
|
2 |
Propionaldehyde |
|
0.057 kg |
|
|
|
|
3 |
Methanol |
|
0.76 kg |
|
|
|
|
4 |
Ammonia |
|
0.82 kg |
|
|
|
|
5 |
Alumino Silicate Catalyst |
|
0.007 kg |
|
|
Piperidine (Min Purity 99%) |
1 kg |
1 |
Ruthenium Alumina Catalyst<br>(Ruthenium 5 %) |
|
0.00196 kg |
|
|
|
|
2 |
Alumina Silicate Catalyst |
|
0.01896 kg |
|
|
|
|
3 |
Denatured Ethyl Alcohol |
|
2.242 kg |
|
|
|
|
4 |
Propionaldehyde |
|
No details |
|
|
|
|
5 |
Methanol |
|
1.441 kg |
|
|
RA maytake appropriate action |
asper the |
decision of Norms Committee. |
|
|
|
|
49
| Case No.:720/15/82- |
|
Party Name:CADILA |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
HEALTHCARE LTD |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0810144085 |
|
|
| :01/82/050/02177/AM19/ |
|
:08/24/040/00276/AM19/ |
|
13.12.2018 |
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
Export product Qty. AZELASTINE HYDROCHLORIDE NASAL SPRAY 137 MCG (30 ML BOTTLE) 1103453.000 (EACH ML CONTAIN 1 MG OF AZELASTINE HYDROCHLORIDE) Number (ACTIVE INGREDIENT : AZELASTINE HYDROCHLORI DE - NET WT. 33.104 KGS) & (PACKING MATERIAL IN FINISHED FORM - NET NOS. 1103453) 160 AZELASTINE HYDROCHLORIDE NASAL SPRAY 205.5 MCG (30 ML 293767.000 BOTTLE) (EACH ML CONTAIN 1.5 MG OF AZELASTINE HYDROCHLORIDE) Number (ACTIVE INGREDIENT : AZELASTINE HYDROCHLORIDE - NET WT. 13.220 - KGS) & (PACKING MATERIAL IN FINISHED FORM NET NOS. 293767) Sl. Import items Qty. No. 1 AZELASTINE HYDROCHLORIDE 47.254 kg 2 30 CC HDPE 18 MM BOTTLE NS Relevant as per packing (AS PER GENERAL POLICY FOR PACKING MATERIAL policy WASTAGE ALLOWED @ 1%) 3 PUMP/ACTUATOR/CLIP Relevant as per packing (AS PER GENERAL POLICY FOR PACKING MATERIAL policy WASTAGE ALLOWED @ 1%)
| 161 |
Case No.:721/15/82-<br>ALC4/2018 |
Party Name:VERVE<br>HUMAN CARE<br>LABORATORIES |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02178/AM19/ |
RLA File<br>:61/24/040/00020/AM19/ |
Lic.No/Date:6110001570<br>13.12.2018 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**RLA, Dehradun was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. However, the application is still awaited from RLA,<br>Dehradun. Hence, it was decided to issue a Reminder to RLA, Dehradun for furnishing a copy of<br>application expeditiously. |
|
|
|
50
| Case No.:131/15/82- |
|
Party Name:STERLING |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
AUXILIARIES PVT LTD |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310825740 |
|
|
| :01/82/050/01588/AM19/ |
|
:03/95/040/00959/AM19/ |
|
18.12.2018 |
|
|
|
Case No.:131/15/82-<br>ALC4/2018 |
Party Name:STERLING<br>AUXILIARIES PVT LTD |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019<br>Lic.No/Date:0310825740<br>18.12.2018 |
Status:<br>Approved |
|
HQ File<br>:01/82/050/01588/AM19/ |
RLA File<br>:03/95/040/00959/AM19/ |
|
|
| 162 |
<br>**Decision:**The Committee considered case as per agenda and deliberated on the matter in the<br>presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7<br>of HBP as per details below or as applied by firm whichever is lower:<br>Export product<br>Qty.<br>Sl.<br>No.<br>Import items<br>Qty.<br>STERO DIPA 99<br>(Diisopropanolamine)<br>1 kg<br>1<br>DIISOPROPANOLAMINE 99<br>0.98 kg<br>STERO DIPA 85<br>(DIISOPROPANOLAMINE)<br>1 kg<br>1<br>DIISOPROPANOLAMINE 99<br>0.95 kg<br>STEROQUAT 80 (MG)<br>(Benzalkonium Chloride)<br>1 kg<br>1<br>FARMIN DM 2465 (Alkyl Dimethyl<br>Amine)<br>0.5886kg<br>STEROQUAT 50<br>(Benzalkonium Chloride<br>50%)<br>1 kg<br>1<br>FARMIN DM 2465 (Alkyl Dimethyl<br>Amine)<br>0.325 kg<br>BPR81242 (Imidazoline<br>based formulatedproduct)<br>1 kg<br>1<br>Tall Oil fatty Acid (TOFA)<br>0.696 kg<br>2<br>DiethyleneTriamine (DETA)<br>0.1285kg<br>RA concerned maytake further necessaryaction asper above decision of NC. |
|
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
| Case No.:724/15/82- |
|
Party Name:DHANUKA |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
LABORATORIES LTD |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0510408950 |
|
|
| :01/82/050/02181/AM19/ |
|
:05/23/040/00399/AM19/ |
|
18.12.2018 |
|
|
|
Case No.:724/15/82-<br>ALC4/2018 |
Party Name:DHANUKA<br>LABORATORIES LTD |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Approved |
|
HQ File<br>:01/82/050/02181/AM19/ |
RLA File<br>:05/23/040/00399/AM19/ |
Lic.No/Date:0510408950<br>18.12.2018 |
|
| 163 |
<br>**Decision:**The Committee considered the cases as per agenda and in the light of earlier decision taken in<br>meeting no. 1/82-ALC4/2019 dated 03.06.2019, it was decided to ratify norms under Para 4.7 of HBP v1 as<br>per details given below or as applied by the firm, whichever is less:<br>Export Product<br>Qty.<br>Sl.<br>No.<br>Import items<br>Qty.<br>CEFDINIR USP/BP/IP/JP/EP<br>POWDER<br>1 kg<br>1<br>7-Phenylacetamideo<br>-3-<br>Chloromethyl<br>Cephalosporanic<br>Acid Para Methoxy Benzyl Ester<br>(GCLE)<br>2.263 kg<br>2<br>TRIPHENYL PHOSPHINE<br>1.234 kg<br>3<br>SODIUM IODIDE<br>0.11 kg<br>4<br>PHENOL<br>2.42 kg<br>5<br>METHYLENE CHLORIDE<br>12.76 kg<br>6<br>TETRA HYDRO FURAN(THF)<br>2.55 kg<br>7<br>METHANOL<br>4.25 kg<br>8<br>FORMALDEHYDE<br>2.74 kg<br>9<br>CAEM<br>1.397 kg<br>10<br>TRIETHYLAMINE<br>0.155 kg<br>11<br>n-BUTYL ACETATE<br>1.49kg<br>RA maytake appropriate action asper the decision of Norms Committee. |
|
|
|
Decision: The Committee considered the cases as per agenda and in the light of earlier decision taken in meeting no. 1/82-ALC4/2019 dated 03.06.2019, it was decided to ratify norms under Para 4.7 of HBP v1 as per details given below or as applied by the firm, whichever is less:
51
| Case No.:725/15/82- |
|
Party Name:MELOG |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
SPECIALITY CHEMICALS |
|
ALC4/2019 |
|
Approved |
|
|
PVT. LTD. |
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310825718 |
|
|
| :01/82/050/02182/AM19/ |
|
:03/95/040/00947/AM19/ |
|
18.12.2018 |
|
|
|
Case No.:725/15/82-<br>ALC4/2018 |
Party Name:MELOG<br>SPECIALITY CHEMICALS<br>PVT. LTD. |
Party Name:MELOG<br>SPECIALITY CHEMICALS<br>PVT. LTD. |
Party Name:MELOG<br>SPECIALITY CHEMICALS<br>PVT. LTD. |
Party Name:MELOG<br>SPECIALITY CHEMICALS<br>PVT. LTD. |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Approved |
|
HQ File<br>:01/82/050/02182/AM19/ |
RLA File<br>:03/95/040/00947/AM19/ |
|
|
|
Lic.No/Date:0310825718<br>18.12.2018 |
|
|
| 164 |
<br>**Decision:**The Committee considered the cases as per agenda and in the light of earlier decision taken in<br>meeting no. 1/82-ALC4/2019 dated 03.06.2019, it was decided to ratify norms under Para 4.7 of HBP v1 as<br>per details given below or as applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl.<br>No.<br>Import items<br>Qty.<br>MR-3 (2,4,6-TRI[(2,4-<br>DIHYDROXY 3<br>METHYL)PHENYL]1,3,5-<br>TRIAZINE<br>1 kg<br>1<br>2 METHYL RESORCINOL<br>1.140 kg<br>2<br>CYANURIC CHLORIDE<br>0.479 kg<br>3<br>SULFOLENE<br>1.80 kg<br>RA maytake appropriate action asper the decision of Norms Committee. |
|
|
|
|
|
|
|
|
<br>Export product |
|
Qty. |
Sl.<br>No. |
Import items |
|
Qty. |
|
|
MR-3 (2,4,6-TRI[(2,4-<br>DIHYDROXY 3<br>METHYL)PHENYL]1,3,5-<br>TRIAZINE |
|
1 kg |
1 |
2 METHYL RESORCINOL |
|
1.140 kg |
|
|
|
|
|
2 |
CYANURIC CHLORIDE |
|
0.479 kg |
|
|
|
|
|
3 |
SULFOLENE |
|
1.80 kg |
|
|
RA maytake appropriate action asper the decision of Norms Committee. |
|
|
|
|
|
|
|
| 165 |
<br>Case No.:726/15/82-<br>ALC4/2018 |
Party Name:NATCO<br>PHARMA LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02183/AM19/ |
RLA File<br>:09/24/040/00417/AM19/ |
Lic.No/Date:0910066973<br>18.12.2018 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 166 |
<br>Case No.:727/15/82-<br>ALC4/2018 |
Party Name:AUROBINDO<br>PHARMA LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02184/AM19/ |
RLA File<br>:09/24/040/00443/AM19/ |
Lic.No/Date:0910066974<br>18.12.2018 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
52
| Case No.:728/15/82- |
|
Party Name:AUROBINDO |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
PHARMA LIMITED |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0910066975 |
|
|
| :01/82/050/02185/AM19/ |
|
:09/24/040/00442/AM19/ |
|
18.12.2018 |
|
|
|
Case No.:728/15/82-<br>ALC4/2018 |
Case No.:728/15/82-<br>ALC4/2018 |
Party Name:AUROBINDO<br>PHARMA LIMITED |
Party Name:AUROBINDO<br>PHARMA LIMITED |
Party Name:AUROBINDO<br>PHARMA LIMITED |
Party Name:AUROBINDO<br>PHARMA LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Approved |
Status:<br>Approved |
|
HQ File<br>:01/82/050/02185/AM19/ |
|
RLA File<br>:09/24/040/00442/AM19/ |
|
|
|
Lic.No/Date:0910066975<br>18.12.2018 |
|
|
| 167 |
<br>**Decision:**The Committee considered case as per agenda and deliberated on the matter in the presence of<br>the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as<br>per details below or as applied by firm whichever is lower:<br>Export Product<br>Qty.<br>Sl.<br>No.<br>Import items<br>Qty.<br>DOLUTEGRAVIR SODIUM<br>1 kg<br>1<br>(R)-3-Amino-1-butanol (or) (R)-3-<br>Amino-butan-1-ol<br>0.395 kg<br>2<br>2,4 -Difluoro benzylamine<br>0.47 kg<br>3<br>Acetonitrile<br>1.57 kg<br>4<br>Activated<br>Carbon<br>(Carbon<br>Enoanticromos)<br>0.100 kg<br>5<br>Dimethyl Oxalate<br>1.677 kg<br>6<br>Isopropyl Alcohol<br>1.71 kg<br>7<br>Lithiumhydroxide Monohydrate<br>0.355 kg<br>8<br>Methanesulfonic Acid<br>0.122 kg<br>9<br>Methanol(Methyl Alcohol)<br>2.63 kg<br>10<br>Methyl 4-Chloroacetoacetate (or)<br>Methyl 4-Chloro-3-Oxo-Butanoate<br>1.245 kg<br>11<br>Methylene Chloride<br>3.29kg<br>12<br>Pivaloyl Chloride<br>0.38 kg<br>13<br>Tetrahydrofuran<br>1.70 kg<br>14<br>Triethylamine<br>0.367 kg<br>RA concerned maytake further necessaryaction asper above decision of NC. |
|
|
|
|
|
|
|
|
|
|
Export Product |
|
Qty. |
Sl.<br>No. |
Import items |
|
|
Qty. |
|
|
DOLUTEGRAVIR SODIUM |
|
1 kg |
1 |
(R)-3-Amino-1-butanol (or) (R)-3-<br>Amino-butan-1-ol |
|
|
0.395 kg |
|
|
|
|
|
2 |
2,4 -Difluoro benzylamine |
|
|
0.47 kg |
|
|
|
|
|
3 |
Acetonitrile |
|
|
1.57 kg |
|
|
|
|
|
4 |
Activated<br>Carbon<br>(Carbon<br>Enoanticromos) |
|
|
0.100 kg |
|
|
|
|
|
5 |
Dimethyl Oxalate |
|
|
1.677 kg |
|
|
|
|
|
6 |
Isopropyl Alcohol |
|
|
1.71 kg |
|
|
|
|
|
7 |
Lithiumhydroxide Monohydrate |
|
|
0.355 kg |
|
|
|
|
|
8 |
Methanesulfonic Acid |
|
|
0.122 kg |
|
|
|
|
|
9 |
Methanol(Methyl Alcohol) |
|
|
2.63 kg |
|
|
|
|
|
10 |
Methyl 4-Chloroacetoacetate (or)<br>Methyl 4-Chloro-3-Oxo-Butanoate |
|
|
1.245 kg |
|
|
|
|
|
11 |
Methylene Chloride |
|
|
3.29kg |
|
|
|
|
|
12 |
Pivaloyl Chloride |
|
|
0.38 kg |
|
|
|
|
|
13 |
Tetrahydrofuran |
|
|
1.70 kg |
|
|
|
|
|
14 |
Triethylamine |
|
|
0.367 kg |
|
|
|
|
|
|
|
|
|
|
53
| Case No.:729/15/82- |
|
Party Name:AUROBINDO |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
PHARMA LIMITED |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0910066976 |
|
|
| :01/82/050/02186/AM19/ |
|
:09/24/040/00458/AM19/ |
|
18.12.2018 |
|
|
|
Case No.:729/15/82-<br>ALC4/2018 |
Case No.:729/15/82-<br>ALC4/2018 |
|
Party Name:AUROBINDO<br>PHARMA LIMITED |
Party Name:AUROBINDO<br>PHARMA LIMITED |
Party Name:AUROBINDO<br>PHARMA LIMITED |
|
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
|
|
Status:<br>Approved |
Status:<br>Approved |
|
HQ File<br>:01/82/050/02186/AM19/ |
|
|
RLA File<br>:09/24/040/00458/AM19/ |
|
|
|
Lic.No/Date:09100669<br>18.12.2018 |
76 |
|
|
|
|
**Decision:**The Committee considered the cases as per agenda and in the light of earlier decision taken in |
|
|
|
|
|
|
|
|
|
|
|
|
meeting no. 15/82-ALC4/2018 dated 22.03.02019, it was decided to ratify norms under Para 4.7 of HBP v1<br>as per details given below or as applied by the firm, whichever is less: |
|
|
|
|
|
|
|
|
|
|
|
| 168 |
<br> |
|
|
|
|
|
|
|
|
Qty. |
|
|
|
|
Export product |
|
Qty. |
Sl.<br>No. |
Import item |
s |
|
|
Qty. |
|
|
|
|
TENOFOVIR<br>DISOPROXIL FUMARAT |
E |
1 kg |
1. |
(R)-PMPA- |
Pure (PMPA) |
|
|
0.769 kg |
|
|
|
|
|
|
|
2. |
Chlorometh |
yl Isopropyl Carbonate |
|
|
1.3527 kg |
|
|
|
|
|
|
|
3. |
Triethylamine |
|
|
|
0.4477 kg |
|
|
|
|
|
|
|
4. |
N-Methyl-2-Pyrrolidone |
|
|
|
1.4878 kg |
|
|
|
|
|
|
|
5. |
Activated Carbon (Carbon<br>Enoanticromos) |
|
|
|
0.016 kg |
|
|
|
|
|
|
|
6. |
Isopropyl Acetate |
|
|
|
1.62 kg |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7. |
Isopropyl Alcohol |
|
|
|
2.85 kg |
|
|
|
|
|
|
|
8. |
Methylene Chloride (MDC) |
|
|
|
4.32 kg |
|
|
|
|
|
|
|
9 |
Tl |
|
|
|
026 k |
|
|
|
RA maytake appropriate action a |
|
|
|
. |
ouene |
|
|
|
. g |
|
|
|
|
|
|
sper the decision of Norms Committee. |
|
|
|
|
|
|
|
|
| Case No.:730/15/82- |
|
Party Name:PERKIN |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
LABORATORIES |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0910066977 |
|
|
| :01/82/050/02187/AM19/ |
|
:09/24/040/00444/AM19/ |
|
18.12.2018 |
|
|
|
Case No.:730/15/82-<br>ALC4/2018 |
Case No.:730/15/82-<br>ALC4/2018 |
Party Name:PERKIN<br>LABORATORIES |
Party Name:PERKIN<br>LABORATORIES |
Party Name:PERKIN<br>LABORATORIES |
Party Name:PERKIN<br>LABORATORIES |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Approved |
Status:<br>Approved |
|
HQ File<br>:01/82/050/02187/AM19/ |
|
RLA File<br>:09/24/040/00444/AM19/ |
|
|
|
Lic.No/Date:0910066977<br>18.12.2018 |
|
|
|
|
**Decision:**The Committee considered case as per agenda and deliberated on the matter in the presence of<br>the technical exerts and it was decided to ratif the ad-hoc inut outut norms under ara 47 of HBP as |
|
|
|
|
|
|
|
|
|
| 169 |
<br>p y<br>per details below or as applied by firm whichever is lower:<br> <br>Export product<br>Qty.<br>Sl.<br>No.<br>Bromo Ketorolac<br>1500.000 kg<br>1 |
|
|
|
|
p p<br> |
|
p .<br>Qty.<br>1185.000 kg |
|
|
|
|
Export product |
|
Qty. |
Sl. |
Import items |
|
Qty. |
|
|
|
|
|
|
|
No. |
|
|
|
|
|
|
|
Bromo Ketorolac |
|
1500.000 kg |
1 |
Pyrrole |
|
1185.000 kg |
|
|
|
|
(OR) 5-Benzoyl, 3bromo-2,3-<br>Dihydro,1-H pyrrolizine-1-<br>carboxylic acid |
|
|
2 |
Isopropenyl Acetate |
|
1350.000 kg |
|
|
|
|
|
|
|
3 |
Dimethyl sulphoxide |
|
2565.000 kg |
|
|
|
|
|
|
|
4 |
DMF |
|
2295.000 kg |
|
|
|
|
|
|
|
5 |
Potassium Carbonate |
|
6240.000 kg |
|
|
|
|
|
|
|
6 |
Di-ethyl malonate |
|
3435.000 kg |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RA maytake appropriate action asper the decision of Norms Committee. |
|
|
|
|
|
|
|
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
54
|
|
Case No.:732/15/82- |
|
Party Name:ASHISH LIFE |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
SCIENCE PVT.LTD. |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
| 170 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0310825741 |
|
Defer |
|
|
:01/82/050/02189/AM19/ |
|
:03/94/040/00719/AM19/ |
|
18.12.2018 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
| Case No.:733/15/82- |
|
Party Name:S V LABS PVT |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
LTD |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0910066978 |
|
|
| :01/82/050/02190/AM19/ |
|
:09/24/040/00469/AM19/ |
|
18.12.2018 |
|
|
|
|
**Decision:**The Committee considered case as per agenda and deliberated on the matter in the presence of |
**Decision:**The Committee considered case as per agenda and deliberated on the matter in the presence of |
**Decision:**The Committee considered case as per agenda and deliberated on the matter in the presence of |
**Decision:**The Committee considered case as per agenda and deliberated on the matter in the presence of |
**Decision:**The Committee considered case as per agenda and deliberated on the matter in the presence of |
**Decision:**The Committee considered case as per agenda and deliberated on the matter in the presence of |
**Decision:**The Committee considered case as per agenda and deliberated on the matter in the presence of |
|
|
the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as |
|
|
|
|
|
|
|
|
per details below or as applied by firm whichever is lower:<br> |
|
|
|
|
|
|
|
|
|
Export product |
Qty. |
Sl. |
Import items |
Qty. |
|
| 171 |
|
|
|
|
No. |
|
|
|
|
|
|
Cyclohexyl Ester (CEI) |
1500.000 kg |
1 |
Glyoxyalic acid (50%) |
0.743 kg |
|
|
|
|
|
|
2 |
2,5 Dihydroxy-1,4 Dithiane |
0.325 kg |
|
|
|
|
|
|
|
(Diol) |
|
|
|
|
|
|
|
3 |
Triphosgene |
0.40 kg |
|
|
|
|
|
|
4 |
Cytosine |
0.412 kg |
|
|
|
|
|
|
5 |
METHYLENE CHLORIDE |
2.63 kg |
|
|
|
|
|
|
|
STABILIZED WITH |
|
|
|
|
|
|
|
|
AMYLENE 50 PPM(MDC) |
|
|
|
|
|
|
|
6 |
L-Menthol |
0.751 kg |
|
|
|
RA maytake appropriate action asper the decision of Norms Committee. |
|
|
|
|
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
|
|
Case No.:735/15/82- |
|
Party Name:CIPLA |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
LIMITED. |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
| 172 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0310825758 |
|
Defer |
|
|
:01/82/050/02192/AM19/ |
|
:03/94/040/00753/AM19/ |
|
18.12.2018 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
|
Case No.:736/15/82- |
|
Party Name:AMI |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
ORGANICS LIMITED |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
| 173 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:5210042870 |
|
Defer |
|
|
:01/82/050/02193/AM19/ |
|
:52/24/040/00068/AM19/ |
|
18.12.2018 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
55
|
|
Case No.:99/15/82- |
|
Party Name:SUN |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
PHARMACEUTICAL |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
INDUSTRIES LTD. |
|
05.07.2019 |
|
|
| 174 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0510408988 |
|
Defer |
|
|
:01/82/050/01556/AM19/ |
|
:05/24/040/00503/AM19/ |
|
19.12.2018 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
|
Case No.:738/15/82- |
|
Party Name:VIVIMED LABS |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
LIMITED |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
| 175 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0910066983 |
|
Defer |
|
|
:01/82/050/02195/AM19/ |
|
:09/24/040/00460/AM19/ |
|
19.12.2018 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
| Case No.:739/15/82- |
|
Party Name:BALAJI AMINES |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
LIMITED |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:3110067257 |
|
|
| :01/82/050/02196/AM19/ |
|
:31/83/040/00131/AM19/ |
|
19.12.2018 |
|
|
Decision: The Committee considered the cases as per agenda and in the light of earlier decision taken in meeting no. 10/82-ALC4/2018 dated 16.10.2018, it was decided to ratify norms under Para 4.7 of HBP v1 as per details given below or as applied by the firm, whichever is less: 176
| Export product |
Qty. |
Sl. No. |
Import items |
Qty. |
| N-METHYL-2- |
1 kg |
1 |
METHANOL |
0.370 kg |
| PYRROLIDONE |
|
2 |
AMMONIA ANHYDROUS |
0.160 kg |
|
|
3 |
1,4 BUTANEDIOL |
1.044 kg |
|
|
4 |
METHYLAMINE CATALYST |
0.00080 kg |
|
|
5 |
GBL CATALYST |
0.00075 kg |
56
| Case No.:740/15/82- |
|
Party Name:AARTI DRUGS |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
LIMITED |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310825780 |
|
|
| :01/82/050/02197/AM19/ |
|
:03/94/040/00772/AM19/ |
|
19.12.2018 |
|
|
|
Case No.:740/15/82-<br>ALC4/2018 |
Party Name:AARTI DRUGS<br>LIMITED<br>RLA File<br>:03/94/040/00772/AM19/ |
Party Name:AARTI DRUGS<br>LIMITED<br>RLA File<br>:03/94/040/00772/AM19/ |
Party Name:AARTI DRUGS<br>LIMITED<br>RLA File<br>:03/94/040/00772/AM19/ |
Party Name:AARTI DRUGS<br>LIMITED<br>RLA File<br>:03/94/040/00772/AM19/ |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Approved |
|
HQ File<br>:01/82/050/02197/AM19/ |
|
|
|
|
Lic.No/Date:0310825780<br>19.12.2018 |
|
|
| 177 |
**Decision:**The Committee considered the cases as per agenda and in the light of earlier decision taken in<br>meeting no. 13/82-ALC4/2018 dated 14.01.2019, it was decided to ratify norms under Para 4.7 of HBP v1<br>as per details given below or as applied by the firm, whichever is less: |
|
|
|
|
|
|
|
|
<br>Export product |
|
Qty. |
Sl.<br>No. |
Import items |
|
Qty. |
|
|
Ciprofloxacin Hydrochloride |
|
1 kg |
1 |
Ethyl 3 Cyclopropylamino-2(2,4<br>Dichloro-5 Fluorobenzoyl)<br>Acrylate |
|
1.294 kg |
|
|
|
|
|
2 |
Caustic Soda Flakes |
|
0.35 kg |
|
|
|
|
|
3 |
Sulpuric Acid (98%) |
|
Not importable |
|
|
|
|
|
4 |
Toluene |
|
0.123 kg |
|
|
|
|
|
5 |
Anhydrous Piperazine |
|
0.39 kg |
|
|
RA maytake appropriate action as |
|
per the decision of Norms Committee. |
|
|
|
|
|
| 178 |
<br>Case No.:1025/15/82-<br>ALC4/2018<br> <br> <br> <br>HQ File<br>:01/82/050/02482/AM19/<br> <br> |
Party Name:ANLON<br>HEALTHCARE<br>PRIVATELIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
|
RLA File<br>:24/24/040/00044/AM19/ |
Lic.No/Date:2410042604<br>19.12.2018 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| Case No.:209/15/82- |
|
Party Name:NECTAR |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
LIFESCIENCES LIMITED |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:2210016040 |
|
|
| :01/82/050/01666/AM19/ |
|
:22/24/040/00041/AM19/ |
|
20.12.2018 |
|
|
Decision: The Committee considered the cases as per agenda and in the light of earlier decision taken in meeting no. 14/82-ALC4/2018 dated 14.02.2019, it was decided to ratify norms under Para 4.7 of HBP v1 as per details given below or as applied by the firm, whichever is less:
179
| Export product |
Qty. |
Sl.<br>No. |
Import items |
Qty. |
| Cefuroxime<br>Axetil<br>Amorphous |
1 kg |
1 |
Desacetyl-7-Amino Cephalosporanic Acid (D-<br>7-ACA) |
0.752 kg |
|
|
2 |
Ethyl acetate |
3.56 kg |
|
|
3 |
Methanol |
0.59 kg |
|
|
4 |
Syn-Methoxyimino Furanyl Acetic Acid<br>Ammonium Salt (SMIA) |
0.70 kg |
|
|
5 |
Activated Carbon |
0.100 kg |
|
|
6 |
Methylene Chloride |
2.18 kg |
|
|
7 |
Acetonitrile |
0.93 kg |
|
|
8 |
Chlorosulphonyl Isocyanate |
0.53 kg |
|
|
9 |
Acetone |
1.67 kg |
|
|
10 |
N,N-Dimethyl Acetamide |
1.06 kg |
|
|
11 |
Cyclohexane |
0.87kg |
57
|
|
Case No.:742/15/82-<br>Party Name:BEST VALUE |
|
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018<br>CHEM PVT. LTD. |
|
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
05.07.2019 |
|
|
|
|
HQ File<br>RLA File |
|
|
Lic.No/Date:3410044774 |
|
Defer |
| 180 |
|
:01/82/050/02199/AM19/<br>:34/24/040/00295/AM19/ |
|
|
20.12.2018 |
|
Date:05.07.2019 |
|
|
Decision:<br>RLA, Vadodara was requested vide e-mail |
dated 05.04.2019 to furnish the hard copy of |
|
|
|
|
|
|
4.07 application of subject Advance Authorization. Application awaited from RLA, Vadodara. However, |
|
|
|
|
|
|
|
the application is still awaited. Hence, it was decided to issue |
a Reminder to RLA, Vadodara for furnishing |
|
|
|
|
|
|
a copyof application expeditiously. |
|
|
|
|
|
Decision: RLA, Vadodara was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Vadodara. However, the application is still awaited. Hence, it was decided to issue a Reminder to RLA, Vadodara for furnishing a copy of application expeditiously.
|
|
Case No.:743/15/82- |
|
Party Name:SHUBHLAXMI |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
INDUSTRIES |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
|
|
HQ File |
|
RLA File |
|
Lic.No/Date:0810144119 |
|
Defer |
| 181 |
|
:01/82/050/02200/AM19/ |
|
:08/24/040/00267/AM19/ |
|
20.12.2018 |
|
Date:05.07.2019 |
|
|
Decision:<br>RLA, Ahmedabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy |
|
|
|
|
|
|
|
|
of 4.07 application of subject Advance Authorization. Application awaited from RLA, Ahmedabad. |
|
|
|
|
|
|
|
|
However, the application is still awaited. Hence, it was decided to issue a Reminder to RLA, Ahmedabad |
|
|
|
|
|
|
|
|
for furnishinga copyof application expeditiously. |
|
|
|
|
|
|
Decision: RLA, Ahmedabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Ahmedabad. However, the application is still awaited. Hence, it was decided to issue a Reminder to RLA, Ahmedabad for furnishing a copy of application expeditiously.
|
|
Case No.:745/15/82- |
|
Party Name:CIPLA |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
LIMITED. |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
| 182 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0310825817 |
|
Defer |
|
|
:01/82/050/02202/AM19/ |
|
:03/94/040/00782/AM19/ |
|
20.12.2018 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
| Case No.:747/15/82- |
|
Party Name:BLISS GVS |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
PHARMA LTD. |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310825821 |
|
|
| :01/82/050/02204/AM19/ |
|
:03/94/040/00765/AM19/ |
|
20.12.2018 |
|
|
|
|
ALC4/2018<br>PHARMA LTD.<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02204/AM19/<br>RLA File<br>:03/94/040/00765/AM19/<br>Lic.No/Date:0310825821<br>20.12.2018 |
ALC4/2018<br>PHARMA LTD.<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02204/AM19/<br>RLA File<br>:03/94/040/00765/AM19/<br>Lic.No/Date:0310825821<br>20.12.2018 |
ALC4/2018<br>PHARMA LTD.<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02204/AM19/<br>RLA File<br>:03/94/040/00765/AM19/<br>Lic.No/Date:0310825821<br>20.12.2018 |
ALC4/2018<br>PHARMA LTD.<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02204/AM19/<br>RLA File<br>:03/94/040/00765/AM19/<br>Lic.No/Date:0310825821<br>20.12.2018 |
ALC4/2018<br>PHARMA LTD.<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02204/AM19/<br>RLA File<br>:03/94/040/00765/AM19/<br>Lic.No/Date:0310825821<br>20.12.2018 |
ALC4/2018<br>PHARMA LTD.<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02204/AM19/<br>RLA File<br>:03/94/040/00765/AM19/<br>Lic.No/Date:0310825821<br>20.12.2018 |
ALC4/2018<br>PHARMA LTD.<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02204/AM19/<br>RLA File<br>:03/94/040/00765/AM19/<br>Lic.No/Date:0310825821<br>20.12.2018 |
ALC4/2018<br>PHARMA LTD.<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02204/AM19/<br>RLA File<br>:03/94/040/00765/AM19/<br>Lic.No/Date:0310825821<br>20.12.2018 |
|
|
**Decision:**The Committee considered case as per agenda and deliberated on the matter in the presence of |
|
|
|
|
|
|
|
|
|
the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as |
|
|
|
|
|
|
|
|
|
per details below or as applied<br> |
|
by firm whichever is lower: |
|
|
|
|
|
|
|
|
Export product |
|
Qty. |
Sl. |
Import items |
Qty. |
|
|
|
|
|
|
|
No. |
|
|
|
| 183 |
|
|
Gsunate-50/<br>Artesunatesuppositories |
Malavan-50<br>50<br>mg |
117660.000<br>Number |
1 |
Artesunate |
6.000 kg |
|
|
|
|
( Net Contain clindamycin phosphate |
|
|
|
|
|
|
|
|
|
5.883 Kgs.) |
|
|
|
|
|
|
|
|
|
Gsunate-100/Malavan-100 |
|
117650.000 |
2 |
Artesunate |
12.000 kg |
|
|
|
|
Artesunatesuppositories |
100<br>mg |
Number |
|
|
|
|
|
|
|
( Net Contain clindamycin phosphate |
|
|
|
|
|
|
|
|
|
11.765 Kgs.) |
|
|
|
|
|
|
|
|
|
Gsunate-200/ |
Malavan200 |
34315.000 |
3 |
Artesunate |
7.000 kg |
|
|
|
|
Artesunatesuppositories |
200<br>mg |
Number |
|
|
|
|
|
|
|
( Net Contain clindamycin phosphate |
|
|
|
|
|
|
|
|
|
6.863 Kgs.) |
|
|
|
|
|
|
|
|
RA maytake appropriate action asper the decision of Norms Committee. |
|
|
|
|
|
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
58
| 184 |
Case No.:748/15/82-<br>ALC4/2018<br>Party Name:SPANSULES<br>FORMULATIONS<br>Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019<br>Status:<br>Deferred<br>HQ File<br>:01/82/050/02205/AM19/<br>RLA File<br>:09/24/040/00418/AM19/<br>Lic.No/Date:0910066987<br>20.12.2018<br>Defer<br>Date:05.07.2019<br>**Decision:**The Committee considered the case as per agenda in the presence of technical experts and it<br>was decided to call for DML from the firm. |
| Case No.:749/15/82- |
|
Party Name:SRINI |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
PHARMACEUTICALS |
|
ALC4/2019 |
|
Approved |
|
|
PRIVATE LIMITED |
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:091006698 |
|
|
| :01/82/050/02206/AM19/ |
|
:09/24/040/00464/AM19/ |
|
9 |
|
|
|
|
|
|
20.12.2018 |
|
|
|
Case No.:749/15/82-<br>ALC4/2018<br>HQ File<br>:01/82/050/02206/AM19/ |
Party Name:SRINI<br>PHARMACEUTICALS<br>PRIVATE LIMITED<br>RLA File<br>:09/24/040/00464/AM19/ |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019<br>Lic.No/Date:091006698<br>9<br>20.12.2018 |
Status:<br>Approved |
| 185 |
**Decision:**The Committee considered case as per agenda and deliberated on the matter in the presence<br>of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP<br>as per details below or as applied by firm whichever is lower:<br>Export product<br>Qty.<br>Sl. No.<br>Import items<br>Qty.<br>FLUVOXAMINE<br>MALEATE<br>1 kg<br>1<br>1-CHLORO-4-METHOXY BUTANE<br>1.01 kg<br>2<br>4-(TRIFLUORO<br>METHYL)<br>BENZONITRILE<br>0.93 kg<br>3<br>TETRA HYDROFURAN<br>1.9845 kg<br>4<br>2-CHLOROETHYLAMINE HCL<br>0.48 kg<br>5<br>SODIUM HYDROXIDE MICRO<br>PEARLS<br>1.313 kg<br>RA concerned maytake further necessaryaction asper above decision of NC. |
|
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
| 186 |
Case No.:752/15/82-<br>ALC4/2018<br>HQ File<br>:01/82/050/02209/AM19/ |
Party Name:ATUL<br>LIMITED,<br>RLA File<br>:08/24/040/00303/AM19/ |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019<br>Lic.No/Date:0810144142<br>21.12.2018 |
Status: Deferred<br> <br>Defer<br>Date:05.07.2019 |
|
Decision:<br>RLA, Ahmedabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy<br>of 4.07 application of subject Advance Authorization. Application awaited from RLA, Ahmedabad.<br>However, the application is still awaited. Hence, it was decided to issue a Reminder to RLA, Ahmedabad<br>for furnishinga copyof application expeditiously. |
|
|
|
59
| Case No.:753/15/82- |
|
Party Name:AARTI DRUGS |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
LIMITED |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310825880 |
|
|
| :01/82/050/02210/AM19/ |
|
:03/94/040/00800/AM19/ |
|
21.12.2018 |
|
|
|
Case No.:753/15/82-<br>ALC4/2018 |
Party Name:AARTI DRUGS<br>LIMITED<br>RLA File<br>:03/94/040/00800/AM19/ |
Party Name:AARTI DRUGS<br>LIMITED<br>RLA File<br>:03/94/040/00800/AM19/ |
Party Name:AARTI DRUGS<br>LIMITED<br>RLA File<br>:03/94/040/00800/AM19/ |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Approved |
|
HQ File<br>:01/82/050/02210/AM19/ |
|
|
|
Lic.No/Date:0310825880<br>21.12.2018 |
|
| 187 |
**Decision:**The Committee considered the cases as per agenda and in the light of earlier decision taken in<br>meeting no. 13/82-ALC4/2018 dated 14.01.2019, it was decided to ratify norms under Para 4.7 of HBP v1<br>as per details given below or as applied by the firm, whichever is less: |
|
|
|
|
|
|
<br>Export product |
Qty. |
Sl.<br>No. |
Import items |
|
Qty. |
|
Ciprofloxacin Hydrochloride |
1 kg |
1 |
Ethyl 3 Cyclopropylamino-2(2,4<br>Dichloro-5 Fluorobenzoyl) Acrylate |
|
1.294 kg |
|
|
|
2 |
Caustic Soda Flakes |
|
0.35 kg |
|
|
|
3 |
Sulpuric Acid (98%) |
|
Not<br>importable |
|
|
|
4 |
Toluene |
|
0.123 kg |
|
|
|
5 |
Anhydrous Piperazine |
|
0.39 kg |
|
RA maytake appropriate action |
asper the decision of Norms Committee. |
|
|
|
|
|
Case No.:126/15/82- |
|
Party Name:POLYGEL |
|
Meet No/Date:3/82- |
|
Status: |
|
ALC4/2018 |
|
INDUSTRIES PVT.LTD |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
05.07.2019 |
|
|
|
HQ File |
|
RLA File |
|
Lic.No/Date:0310825887 |
|
Defer |
|
:01/82/050/01583/AM19/ |
|
:03/95/040/00969/AM19/ |
|
24.12.2018 |
|
Date:05.07.2019 |
188 Decision: The Committee considered the case as per agenda in the presence of technical experts, it was decided to call for following information:
(i) Exact chemical name of import item No. 2 (ii) Catalogue of import item No. 2.
60
| Case No.:758/15/82- |
|
Party Name:OPTRIX |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
LABORATORIES PRIVATE |
|
ALC4/2019 |
|
Approved |
|
|
LIMITED |
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0910066997 |
|
|
| :01/82/050/02215/AM19/ |
|
:09/24/040/00472/AM19/ |
|
24.12.2018 |
|
|
|
|
**Decision:**The Committee considered case as per agenda and deliberated on the matter in |
**Decision:**The Committee considered case as per agenda and deliberated on the matter in |
**Decision:**The Committee considered case as per agenda and deliberated on the matter in |
**Decision:**The Committee considered case as per agenda and deliberated on the matter in |
**Decision:**The Committee considered case as per agenda and deliberated on the matter in |
the presence of |
|
|
|
the technical experts and it was decided to |
|
|
ratify |
the ad-hoc input output norms under para 4.7 of HBP as |
|
|
|
|
per details below or as applied by firm whichever is lower: |
|
|
|
|
|
|
|
|
|
Export product |
Qty. |
Sl. |
Import items |
Qty. |
|
|
|
|
|
|
No. |
|
|
|
| 189 |
|
|
TEDIZOLID PHOSPHATE |
1 kg |
1 |
5-Bromo-2-(2-Methyl-2H-Tetrazol-5- |
0.746 kg |
|
|
|
|
|
|
|
Yl)-Pyridine |
|
|
|
|
|
|
|
2 |
(R)-3-(4-Bromo-3-fluorophenyl)-5- |
0.90 kg |
|
|
|
|
|
|
|
(hydroxymethyl)oxazolidin-2-one |
|
|
|
|
|
|
|
3 |
Dichlorobis(di-tert- |
0.025 kg |
|
|
|
|
|
|
|
butylphenylphosphine)palladium(II) |
|
|
|
|
|
|
|
4 |
Bis(pinacolato)diboron |
0.706 kg |
|
|
|
|
|
|
5 |
1,1-Bis (diphenylphosphino) |
Not shown |
|
|
|
|
|
|
|
ferrocene]dichloropalladium(II) |
in the |
|
|
|
|
|
|
|
|
process |
|
|
|
RA maytake appropriate action as |
|
per the decision of Norms Committee. |
|
|
|
|
|
|
Case No.:925/15/82- |
|
Party Name:OPTRIX |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
LABORATORIES PRIVATE |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
LIMITED |
|
05.07.2019 |
|
|
| 190 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0910066998 |
|
Defer |
|
|
:01/82/050/02382/AM19/ |
|
:09/24/040/00470/AM19/ |
|
24.12.2018 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
| Case No.:761/15/82- |
|
Party Name:CADILA |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
HEALTHCARE LTD |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0810144172 |
|
|
| :01/82/050/02218/AM19/ |
|
:08/24/040/00310/AM19/ |
|
26.12.2018 |
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as 191 per details below or as applied by firm whichever is lower:
| Export product |
Qty. |
Sl. |
Import items |
Qty. |
|
|
No. |
|
|
| 2-chloromethyl-4-Methyl |
1 kg |
1 |
2-amino Acetophenone |
0.99 kg |
| Quinazoline(CD 605 BS) |
|
2 |
Methyl Cyclohexane |
1.954 kg |
192 Case No.:762/15/82-
Status:
Meet No/Date:3/82-
Party Name:HPL
61
|
ALC4/2018<br>HQ File<br>:01/82/050/02219/AM19/ |
ADDITIVES<br>LIMITED(FORMERLY<br>KNOWN HIGH POLYMER |
ADDITIVES<br>LIMITED(FORMERLY<br>KNOWN HIGH POLYMER |
ADDITIVES<br>LIMITED(FORMERLY<br>KNOWN HIGH POLYMER |
ADDITIVES<br>LIMITED(FORMERLY<br>KNOWN HIGH POLYMER |
ALC4/2019<br>05.07.2019 |
ALC4/2019<br>05.07.2019 |
Deferred<br> <br>Defer<br>Date:05.07.2019 |
Deferred<br> <br>Defer<br>Date:05.07.2019 |
Deferred<br> <br>Defer<br>Date:05.07.2019 |
|
|
RLA File<br>:05/23/040/00403/AM19/ |
|
|
|
Lic.No/Date:0510409068<br>26.12.2018 |
|
|
|
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 193 |
Case No.:766/15/82-<br>ALC4/2018 |
Party Name:OPTRIX<br>LABORATORIES PRIVATE<br>LIMITED<br>RLA File<br>:09/24/040/00471/AM19/ |
|
|
|
|
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
|
|
Status:<br>Approved |
|
HQ File<br>:01/82/050/02223/AM19/ |
|
|
|
|
|
Lic.No/Date:0910067002<br>27.12.2018 |
|
|
|
|
<br>**Decision:**The Committee considered case as per agenda and deliberated on the matter in the presence of<br>the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as<br>per details below or as applied by firm whichever is lower: |
|
|
|
|
|
|
|
|
|
|
Export product |
|
Qty. |
Sl.<br>No. |
Import items |
|
|
|
Qty. |
|
|
Eplerenone |
|
1 kg |
1 |
(7A,17A)-17-Hydroxy-3-oxo-pregna-<br>4,9(11)-diene-7,21-dicarboxylic acid g-<br>lactonemethylester |
|
|
|
1.42 kg |
|
|
RA maytake appropriate action as |
|
per the decision of Norms Committee. |
|
|
|
|
|
|
|
| 194 |
<br>Case No.:767/15/82-<br>ALC4/2018<br> <br> <br>HQ File<br>:01/82/050/02224/AM19/<br> <br> |
Party Name:CIPLA<br>LIMITED. |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019<br>Lic.No/Date:0310825972<br>27.12.2018 |
Status:<br>Deferred |
|
|
RLA File<br>:03/94/040/00826/AM19/ |
|
Defer<br>Date:05.07.2019 |
|
Decision:<br>Deferred for c |
omments of TE. |
|
|
| Case No.:116/15/82- |
|
Party Name:O C |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
SPECIALITIES PVT.LTD. |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310826001 |
|
|
| :01/82/050/01573/AM19/ |
|
:03/95/040/01022/AM19/ |
|
28.12.2018 |
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as 195 per details below or as applied by firm whichever is lower:
| Export product |
Qty. |
Sl. |
Import items |
Qty. |
|
|
No. |
|
|
| 2,6 DICHLORO BENZOYL |
1 kg |
1 |
2,6 DICHLORO BENZALDEHYDE |
0.927 kg |
| CHLORIDE |
|
|
|
|
62
| Case No.:770/15/82- |
|
Party Name:J.B. CHEMICALS |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
& PHARMACEUTICALS |
|
ALC4/2019 |
|
Approved |
|
|
LIMITED |
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310826011 |
|
|
| :01/82/050/02227/AM19/ |
|
:03/94/040/00818/AM19/ |
|
28.12.2018 |
|
|
|
Case No.:770/15/82-<br>ALC4/2018 |
Case No.:770/15/82-<br>ALC4/2018 |
Party Name:J.B. CHEMICALS<br>& PHARMACEUTICALS<br>LIMITED |
Party Name:J.B. CHEMICALS<br>& PHARMACEUTICALS<br>LIMITED |
Party Name:J.B. CHEMICALS<br>& PHARMACEUTICALS<br>LIMITED |
Party Name:J.B. CHEMICALS<br>& PHARMACEUTICALS<br>LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Approved |
|
HQ File<br>:01/82/050/02227/AM19/ |
|
RLA File<br>:03/94/040/00818/AM19/ |
|
|
|
Lic.No/Date:0310826<br>28.12.2018 |
011 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
**Decision:**The Committee c<br>the technical experts and it wa<br>per details below or as applied |
onsidered case as per agenda a<br>s decided to ratify the ad-hoc<br>by firm whichever is lower: |
|
|
|
nd deliberated on the matte<br>input output norms under |
|
r in the presence of<br>para 4.7 of HBP as |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Export product |
Qty. |
|
Sl.<br>No. |
Import items |
|
|
|
Qty. |
|
|
Rinza sip with Vitamin C<br>(Flavours Orange/ Lemon/<br>Black Currant/ Other<br>flavours)<br>& Rinza Sip (Flavours<br>Orange/ Lemon/ Black<br>currant/ Cranberry/ Honey<br>Lemon/ Other flavours). |
30303050.000<br>Number<br>Sachet |
|
1 |
Caffeine Anhydrous Powder |
|
|
|
918.18 kg |
|
| 196 |
<br>Each sachet of 5gm contains<br>Caffeine Anhydrous Powder<br> |
|
|
|
|
|
|
|
|
|
|
30mg. Net content of<br>Caffeine Anhydrous Powder<br>909.09 Kgs. |
|
|
|
|
|
|
|
|
|
|
Rinza Tablet Each tablet |
35772360000 |
|
2 |
Caff |
ine Anhydrous Powder |
|
|
109463 kg |
|
|
.<br>Contains Caffeine<br>Anhydrous Powder 30 mg, |
.<br>Number<br>Tablet |
|
|
|
|
|
|
. |
|
|
|
|
|
3 |
Para |
cetamol IP/BP |
|
|
18243.90 kg |
|
|
and Paracetamol BP 500 mg.<br>Net Content of Caffeine<br>Anhydrous Powder -<br>1073.17 Kgs and<br>Paracetamol IP/ BP-<br>17886.18 Kgs |
|
|
|
|
|
|
|
|
|
|
Rinza Sip for Children<br>(Flavours Rasp berry/ other<br>flavours). Each sachet of<br>3gm contains Paracetamol<br>IP/BP - 280mg.<br> |
46932250.000<br>Number<br>Tablet |
|
4 |
Paracetamol IP/BP |
|
|
|
13272.44 kg |
|
|
Net content-13141.03 Kgs. |
|
|
|
|
|
|
|
|
|
|
RA matake aroriate action aser the decision of Norms Committee |
|
|
|
|
|
|
|
|
|
|
y ppp |
p |
|
|
|
. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 197 |
Case No.:771/15/82- |
|
PartyName:AUROBINDO |
|
|
|
Meet No/Date:3/82- |
|
|
Status: |
Status:
197 Case No.:771/15/82-
Party Name:AUROBINDO
Meet No/Date:3/82-
63
| ALC4/2018 |
|
PHARMA LIMITED |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0910067005 |
|
|
| :01/82/050/02228/AM19/ |
|
:09/24/040/00448/AM19/ |
|
31.12.2018 |
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
| Export product |
Qty. |
Sl. |
Import items |
Qty. |
|
|
No. |
|
|
| AMOXICILLIN TRIHYDRATE |
1 kg |
1 |
6-APA (6-Amino Penicillanic |
0.55 kg |
| Condition: The firm shall have to |
|
|
Acid) |
|
| complete the EO within 12 |
|
|
(Pre-import Condition imposed) |
|
| months from the date of clearance |
|
2 |
Methyl D-(-)-4-Hydroxy- |
0.477 kg |
| of each import consignment of |
|
|
Phenylglycinate (OR) D-(-)-4- |
|
| Sl.No.1 of the Import List as per |
|
|
hydroxyphenylglycine Methyl |
|
| Appendix 4J read with PN |
|
|
Ester [PHPG Ester] |
|
| No.62/24.03.2017 |
|
3 |
Penicillin G Amidase (Particle size |
0.0017 kg |
|
|
|
250 - 500 micron, Creamish to |
|
|
|
|
Brown regularly shaped beads) |
|
| 198 |
<br>Case No.:772/15/82-<br>ALC4/2018 |
Party Name:AUROBINDO<br>PHARMA LIMITED<br>RLA File<br>:09/24/040/00445/AM19/ |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred<br> <br>Defer<br>Date:05.07.2019 |
|
<br>HQ File<br>:01/82/050/02229/AM19/ |
|
Lic.No/Date:0910067006<br>31.12.2018 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 199 |
<br>Case No.:775/15/82-<br>ALC4/2018 |
Party Name:SUVEN LIFE<br>SCIENCES LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019<br>Lic.No/Date:0910067014<br>31.12.2018 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02232/AM19/ |
RLA File<br>:09/24/040/00482/AM19/ |
|
Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
Status:
200 Case No.:779/15/82-
Party Name:BALAJI AMINES Meet No/Date:3/82-
64
| ALC4/2018 |
|
LIMITED |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:3110067272 |
|
|
| :01/82/050/02236/AM19/ |
|
:31/83/040/00129/AM19/ |
|
31.12.2018 |
|
|
Decision: The Committee considered the cases as per agenda and in the light of earlier decision taken in meeting no. 10/82-ALC4/2018 dated 16.10.2018, it was decided to ratify norms under Para 4.7 of HBP v1 as per details given below or as applied by the firm, whichever is less:
| Export product |
Qty. |
Sl. No. |
Import items |
Qty. |
| N-METHYL-2- |
1 kg |
1 |
METHANOL |
0.370 kg |
| PYRROLIDONE |
|
2 |
AMMONIA ANHYDROUS |
0.160 kg |
|
|
3 |
1,4 BUTANEDIOL |
1.044 kg |
|
|
4 |
METHYLAMINE CATALYST |
0.00080 kg |
|
|
5 |
GBL CATALYST |
0.00075 kg |
| Case No.:780/15/82- |
|
Party Name:BALAJI AMINES |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
LIMITED |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:3110067273 |
|
|
| :01/82/050/02237/AM19/ |
|
:31/83/040/00148/AM19/ |
|
31.12.2018 |
|
|
Decision: The Committee considered the cases as per agenda and in the light of earlier decision taken in meeting no. 12/82-ALC4/2018 dated 12.12.2018, it was decided to ratify norms under Para 4.7 of HBP v1 201 as per details given below or as applied by the firm, whichever is less:
| Export product |
Qty. |
Sl. No. |
Import items |
Qty. |
| GAMMA BUTYROLACONE |
1 kg |
1 |
1,4 BUTANEDIOL |
1.16 kg |
|
|
2 |
GBL CATAYLYST |
0.001 kg |
| Case No.:781/15/82- |
|
Party Name:BALAJI AMINES |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
LIMITED |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:3110067274 |
|
|
| :01/82/050/02238/AM19/ |
|
:31/83/040/00149/AM19/ |
|
31.12.2018 |
|
|
Decision: The Committee considered the cases as per agenda and in the light of earlier decision taken in meeting no. 1/82-ALC4/2019 dated 03.06.2019, it was decided to ratify norms under Para 4.7 of HBP v1 as 202 per details given below or as applied by the firm, whichever is less:
| Export product |
Qty. |
Sl. No. |
Import items |
Qty. |
| N-ETHYL-2- |
1 kg |
1 |
GAMMA BUTYROLACTONE |
0.72 kg |
| PYRROLIDONE |
|
2 |
MONOETHYLAMINE 70% |
0.533 kg |
|
|
|
SOLUTION |
|
65
| Case No.:119/15/82-<br>Party Name:THINQ PHARMA<br>Meet No/Date:3/82- |
Case No.:119/15/82-<br>Party Name:THINQ PHARMA<br>Meet No/Date:3/82- |
|
|
Status: |
| ALC4/2018<br>CRO LIMITED<br>ALC4/2019 |
|
|
|
Approved |
|
05.07.2019 |
|
|
|
| HQ File<br>RLA File |
Lic.No/Date:0310826050 |
|
|
|
| :01/82/050/01576/AM19/<br>:03/95/040/00872/AM19/<br>01.01.2019 |
|
|
|
|
| **Decision:**The Committee considered case as per agenda and deliberated on the matter in the presence of |
|
|
|
|
| the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as |
|
|
|
|
| per details below or as applied by firm whichever is lower: |
|
|
|
|
| Export product<br>Qty. |
Sl.<br>Import items |
|
Qty. |
|
|
No. |
|
|
|
| G-101 (All Trans Retinoic Acid,1-<br>1 kg |
1<br>Tretinoin (All Trans Retinoic |
|
1.00 kg |
|
| Hydroxy-3,3-dimethyl-2-Butanone |
Acid) |
|
|
|
| Ester) |
2<br>1-Chloropinacolone |
|
0.469 kg |
|
|
3<br>Cesium Carbonate |
|
1.135 kg |
|
| RA maytake appropriate action asper the decision of Norms Committee. |
|
|
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower: 203
|
|
Case No.:784/15/82- |
|
Party Name:SMS |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
LIFESCIENCES INDIA |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
LIMITED |
|
05.07.2019 |
|
|
|
|
HQ File |
|
RLA File |
|
Lic.No/Date:0910067021 |
|
Defer |
| 204 |
|
:01/82/050/02241/AM19/ |
|
:09/24/040/00490/AM19/ |
|
01.01.2019 |
|
Date:05.07.2019 |
|
|
Decision:<br>RLA, Hyderabad was requested vide e-mail |
|
|
dated 05.04.2019 to furnish the hard copy of |
|
|
|
|
|
4.07 application of subject Advance Authorization. Application awaited from RLA, Hyderabad. However, |
|
|
|
|
|
|
|
|
the application is still awaited. Hence, it was decided to |
|
|
issue a Reminder to RLA, Hyderabad for |
|
|
|
|
|
furnishinga copyof application expeditiously. |
|
|
|
|
|
|
Decision: RLA, Hyderabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Hyderabad. However, the application is still awaited. Hence, it was decided to issue a Reminder to RLA, Hyderabad for furnishing a copy of application expeditiously.
| Case No.:785/15/82- |
|
Party Name:LUPIN LIMITED |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
|
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310826058 |
|
|
| :01/82/050/02242/AM19/ |
|
:03/95/040/01003/AM19/ |
|
01.01.2019 |
|
|
|
|
ALC4/2018<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02242/AM19/<br>RLA File<br>:03/95/040/01003/AM19/<br>Lic.No/Date:0310826058<br>01.01.2019 |
ALC4/2018<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02242/AM19/<br>RLA File<br>:03/95/040/01003/AM19/<br>Lic.No/Date:0310826058<br>01.01.2019 |
ALC4/2018<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02242/AM19/<br>RLA File<br>:03/95/040/01003/AM19/<br>Lic.No/Date:0310826058<br>01.01.2019 |
ALC4/2018<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02242/AM19/<br>RLA File<br>:03/95/040/01003/AM19/<br>Lic.No/Date:0310826058<br>01.01.2019 |
ALC4/2018<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02242/AM19/<br>RLA File<br>:03/95/040/01003/AM19/<br>Lic.No/Date:0310826058<br>01.01.2019 |
ALC4/2018<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02242/AM19/<br>RLA File<br>:03/95/040/01003/AM19/<br>Lic.No/Date:0310826058<br>01.01.2019 |
|
|
|
**Decision:**The Committee considered case as per agenda and deliberated on the matter in the presence of |
|
|
|
|
|
|
|
|
the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as |
|
|
|
|
|
|
|
|
per details below or as applied by firm whichever is lower: |
|
|
|
|
|
|
| 205 |
|
|
Export product |
Qty. |
Sl. |
Import items |
Qty. |
|
|
|
|
|
|
No. |
|
|
|
|
|
|
BIPERIDEN |
1 Number |
1 |
BIPERIDEN |
1.02 mg/tablet |
|
|
|
|
HYDROCHLORIDE 1MG |
|
|
HYDROCHLORIDE |
|
|
|
|
|
TABLETS |
|
|
|
|
|
|
|
|
(NET WT. 50.40 KGS, |
|
|
|
|
|
|
|
|
WEIGHT OF DRUG : 52.42 |
|
|
|
|
|
|
|
|
KGS) |
|
|
|
|
|
|
|
RA maytake appropriate action asper the decision of Norms Committee. |
|
|
|
|
|
|
66
| Case No.:843/15/82- |
|
Party Name:IPCA |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
LABORATORIES LIMITED |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310826061 |
|
|
| :01/82/050/02300/AM19/ |
|
:03/94/040/00825/AM19/ |
|
01.01.2019 |
|
|
|
|
ALC4/2018<br>LABORATORIES LIMITED<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02300/AM19/<br>RLA File<br>:03/94/040/00825/AM19/<br>Lic.No/Date:0310826061<br>01.01.2019 |
ALC4/2018<br>LABORATORIES LIMITED<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02300/AM19/<br>RLA File<br>:03/94/040/00825/AM19/<br>Lic.No/Date:0310826061<br>01.01.2019 |
ALC4/2018<br>LABORATORIES LIMITED<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02300/AM19/<br>RLA File<br>:03/94/040/00825/AM19/<br>Lic.No/Date:0310826061<br>01.01.2019 |
ALC4/2018<br>LABORATORIES LIMITED<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02300/AM19/<br>RLA File<br>:03/94/040/00825/AM19/<br>Lic.No/Date:0310826061<br>01.01.2019 |
ALC4/2018<br>LABORATORIES LIMITED<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02300/AM19/<br>RLA File<br>:03/94/040/00825/AM19/<br>Lic.No/Date:0310826061<br>01.01.2019 |
ALC4/2018<br>LABORATORIES LIMITED<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02300/AM19/<br>RLA File<br>:03/94/040/00825/AM19/<br>Lic.No/Date:0310826061<br>01.01.2019 |
ALC4/2018<br>LABORATORIES LIMITED<br>ALC4/2019<br>05.07.2019<br>Approved<br>HQ File<br>:01/82/050/02300/AM19/<br>RLA File<br>:03/94/040/00825/AM19/<br>Lic.No/Date:0310826061<br>01.01.2019 |
|
|
**Decision:**The Committee considered the cases as per agenda and in the light of earlier decision taken in |
|
|
|
|
|
|
|
|
meeting no. 14/82-ALC4/2018 dated 14.02.2019, it was decided to ratify norms under Para |
|
|
|
|
4.7 of HBP v1 |
|
|
|
as per details given below or |
|
|
as applied by the firm, whichever is less: |
|
|
|
| 206 |
|
|
Export product |
Qty. |
Sl. |
Import Items |
Qty. |
|
|
|
|
|
|
No. |
|
|
|
|
|
|
Lumefantrine |
1 kg |
1. |
a(Dibutylamine Methyl) 2,7-Dichloro-4-Fluoren |
0.8693 kg |
|
|
|
|
|
|
|
Methanol[DBA]/2,7-Dichloro-A- |
|
|
|
|
|
|
|
|
(Dibutylamino)Methyl-9H-Fluorene-4-Methanol |
|
|
|
|
|
|
|
2. |
P-Chlorobenzyldehyde |
0.3477 kg |
|
|
|
|
|
|
3. |
Acetone |
0.604 kg |
|
|
|
|
|
|
4. |
Methanol |
0.600 kg |
|
|
|
RA maytake appropriate action asper the decision of Norms Committee. |
|
|
|
|
|
|
Decision: The Committee considered the cases as per agenda and in the light of earlier decision taken in meeting no. 14/82-ALC4/2018 dated 14.02.2019, it was decided to ratify norms under Para 4.7 of HBP v1 as per details given below or as applied by the firm, whichever is less:
|
|
Case No.:788/15/82- |
|
Party Name:MANKIND |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
PHARMA LTD |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
| 207 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0510409149 |
|
Defer |
|
|
:01/82/050/02245/AM19/ |
|
:05/24/040/00552/AM19/ |
|
02.01.2019 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
| Case No.:789/15/82- |
|
Party Name:POSY |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
PHARMACHEM PVT. LTD. |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0810144202 |
|
|
| :01/82/050/02246/AM19/ |
|
:08/24/040/00253/AM19/ |
|
02.01.2019 |
|
|
208
Decision: The Committee considered the cases as per agenda and in the light of earlier decision taken in meeting no. 15/82-ALC4/2018 dated 22.03.2019, it was decided to ratify norms under Para 4.7 of HBP v1 as per details given below or as applied by the firm, whichever is less:
| Export product |
Qty. |
Sl. |
Import Items |
Qty. |
|
|
No. |
|
|
| SODIUM |
1 kg |
1. |
CITRIC ACID MONOHYDRATE |
0.421 kg |
| CITRATE BP /<br>USP |
|
2. |
CAUSTIC SODA FLAKES / PEARLS |
0.736 kg |
67
|
Case No.:792/15/82-<br>ALC4/2018 |
Party Name:BIOLOGICAL E<br>LTD |
Meet No/Date:3/82-<br>ALC4/2019 |
Status:<br>Deferred |
| 209 |
|
<br>RLA File<br>:09/24/040/00479/AM19/ |
<br>05.07.2019 |
<br>Defer<br>Date:05.07.2019 |
|
<br>HQ File<br>:01/82/050/02249/AM19/ |
|
Lic.No/Date:0910067026<br>03.01.2019 |
|
|
**Decision:**A copy of applicat<br>DBT. |
ion has been forwarded to DBT |
on 17.07.2019. Deferred |
for comments of |
|
|
|
|
|
|
|
Case No.:794/15/82- |
|
Party Name:BDR |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
PHARMACEUTICALS |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
INTERNATIONAL PVT. |
|
05.07.2019 |
|
|
| 210 |
|
|
|
LTD. |
|
|
|
|
|
|
HQ File |
|
RLA File |
|
Lic.No/Date:0310826132 |
|
Defer |
|
|
:01/82/050/02251/AM19/ |
|
:03/94/040/00836/AM19/ |
|
03.01.2019 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
|
Case No.:796/15/82- |
|
Party |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
Name:D.K.BIOPHARMA |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
PRIVATE LIMITED |
|
05.07.2019 |
|
|
| 211 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0310826158 |
|
Defer |
|
|
:01/82/050/02253/AM19/ |
|
:03/94/040/00842/AM19/ |
|
04.01.2019 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
|
Case No.:798/15/82- |
|
Party Name:NEULAND |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
LABORATORIES LTD |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
| 212 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0910067032 |
|
Defer |
|
|
:01/82/050/02255/AM19/ |
|
:09/24/040/00488/AM19/ |
|
04.01.2019 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
|
Case No.:1072/15/82- |
|
Party Name:MALLADI |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
DRUGS & |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
PHARMACEUTICALS |
|
05.07.2019 |
|
|
| 213 |
|
|
|
LIMITED |
|
|
|
|
|
|
HQ File |
|
RLA File |
|
Lic.No/Date:0410165065 |
|
Defer |
|
|
:01/82/050/02529/AM19/ |
|
:04/24/040/00218/AM19/ |
|
04.01.2019 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
|
Case No.:109/15/82- |
|
Party Name:U SQUARE |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
LIFESCIENCE PRIVATE |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
LIMITED |
|
05.07.2019 |
|
|
| 214 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0810144243 |
|
Defer |
|
|
:01/82/050/01566/AM19/ |
|
:08/24/040/00329/AM19/ |
|
07.01.2019 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
68
|
|
Case No.:202/15/82- |
|
Party Name:SUN |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
PHARMACEUTICAL |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
INDUSTRIES LTD. |
|
05.07.2019 |
|
|
| 215 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0510409204 |
|
Defer |
|
|
:01/82/050/01659/AM19/ |
|
:05/24/040/00554/AM19/ |
|
07.01.2019 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
| Case No.:800/15/82- |
|
Party Name:LUPIN LIMITED |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
|
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310826190 |
|
|
| :01/82/050/02257/AM19/ |
|
:03/95/040/01047/AM19/ |
|
07.01.2019 |
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower: 216
| Export product |
Qty. |
Sl. |
Import items |
Qty. |
|
|
No. |
|
|
| BIPERIDEN HYDROCHLORIDE |
1 Number |
1 |
BIPERIDEN |
1.02 mg/tablet |
| 1MG TABLETS |
|
|
HYDROCHLORIDE |
|
| (NET WT. 35.00 KGS, WEIGHT OF |
|
|
|
|
| DRUG : 36.40 KGS) |
|
|
|
|
|
|
Case No.:201/15/82- |
|
Party Name:RECKITT |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
BENCKISER (INDIA) |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
PRIVATE LIMITED |
|
05.07.2019 |
|
|
| 217 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0510409279 |
|
Defer |
|
|
:01/82/050/01658/AM19/ |
|
:05/24/040/00572/AM19/ |
|
09.01.2019 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
|
Case No.:805/15/82- |
|
Party Name:DEEPAK |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
NOVOCHEM |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
TECHNOLOGIES LTD |
|
05.07.2019 |
|
|
| 218 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:3110067278 |
|
Defer |
|
|
:01/82/050/02262/AM19/ |
|
:31/83/040/00157/AM19/ |
|
09.01.2019 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
|
Case No.:123/15/82- |
|
Party Name:REYAANSH |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
HEALTHCARE |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
| 219 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0310826282 |
|
Defer |
|
|
:01/82/050/01580/AM19/ |
|
:03/95/040/01019/AM19/ |
|
10.01.2019 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
69
| Case No.:807/15/82- |
|
Party Name:PAB |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
ORGANICS PVT.LTD, |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:341004481 |
|
|
| :01/82/050/02264/AM19/ |
|
:34/24/040/00234/AM19/ |
|
1 |
|
|
|
|
|
|
10.01.2019 |
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 220 4.7 of HBP as per details below or as applied by firm whichever is lower:
| Export product |
Qty. |
Sl.<br>No. |
Import items |
Qty. |
| (+) -3- (CARBAMOYLMETHYL) -<br>5- METHYLHEXANOIC ACID |
1 kg |
1 |
2-CYANOACETAMIDE |
1.40 kg |
|
|
2 |
ISOVALERALDEHYDE<br>(ISOVALERAL) |
0.72 kg |
| Case No.:808/15/82- |
|
Party Name:ADISHANK |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
CHEMICALS PVT.LTD. |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310826300 |
|
|
| :01/82/050/02265/AM19/ |
|
:03/94/040/00659/AM19/ |
|
10.01.2019 |
|
|
Decision: The Committee considered the cases as per agenda and in the light of earlier decision taken in meeting no. 12/82-ALC4/2018 dated 12.12.2018, it was decided to ratify norms under Para 4.7 of HBP v1 221 as per details given below or as applied by the firm, whichever is less:
| Export product<br>DI<br>PHENYL<br>ISO<br>DECYL<br>PHOSPHITE(DPDP) |
Qty. |
Sl.<br>No. |
Import Items |
Qty. |
|
1 kg |
1. |
Phenol |
0.557 kg |
|
|
2. |
2 -Propyl Heptanol |
0.386 kg |
| 222 |
<br>Case No.:809/15/82-<br>ALC4/2018 |
Party Name:ATUL<br>LIMITED, |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019<br>Lic.No/Date:0810144289<br>10.01.2019 |
Status:<br>Deferred<br> <br>Defer<br>Date:05.07.2019 |
|
<br>HQ File<br>:01/82/050/02266/AM19/ |
RLA File<br>:08/24/040/00327/AM19/ |
|
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 223 |
<br>Case No.:811/15/82-<br>ALC4/2018 |
Party Name:ATUL<br>LIMITED, |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019<br>Lic.No/Date:0810144290<br>10.01.2019 |
Status:<br>Deferred<br> <br>Defer<br>Date:05.07.2019 |
|
<br>HQ File<br>:01/82/050/02268/AM19/ |
RLA File<br>:08/24/040/00328/AM19/ |
|
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
70
|
|
Case No.:812/15/82- |
|
Party Name:BALAJI |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
AMINES LIMITED |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
| 224 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:3110067279 |
|
Defer |
|
|
:01/82/050/02269/AM19/ |
|
:31/83/040/00158/AM19/ |
|
10.01.2019 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
|
Case No.:815/15/82- |
|
Party Name:ELPPE |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
CHEMICALS PRIVATE |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
LIMITED |
|
05.07.2019 |
|
|
| 225 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0310826358 |
|
Defer |
|
|
:01/82/050/02272/AM19/ |
|
:03/94/040/00889/AM19/ |
|
14.01.2019 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
| Case No.:817/15/82- |
|
Party Name:HEMA DYE |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
CHEM PVT. LTD. |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310826383 |
|
|
| :01/82/050/02274/AM19/ |
|
:03/94/040/00830/AM19/ |
|
15.01.2019 |
|
|
Decision: The Committee considered the cases as per agenda and in the light of earlier decision taken in meeting no. 5/82-ALC4/2018 dated 25.07..2018 and 14/AM19 dated 14.02.2019, it was decided to ratify norms under Para 4.7 of HBP v1 as per details given below or as applied by the firm, whichever is less: 226
| Export product |
Qty. |
Sl. |
Import items |
Qty. |
|
|
No. |
|
|
| C- HYDROCHINONDIMETHETH |
1 kg |
1 |
PARADIMETHOXYBENZENE |
0.875 kg |
| ER D (CEA) (2 CHLORO,1,4 |
|
|
(PDMB) |
|
| DIMETHOXY BENZENE) |
|
|
(HYDROQUINONEDIMETHYL |
|
|
|
|
ETHER ) (HQDME) (DMB- |
|
|
|
|
1,4DIMETHOXYBENZENE) |
|
71
|
|
Case No.:820/15/82- |
|
Party Name:AURORE LIFE |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
SCIENCES PRIVATE |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
LIMITED |
|
05.07.2019 |
|
|
| 227 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0910067061 |
|
Defer |
|
|
:01/82/050/02277/AM19/ |
|
:09/24/040/00508/AM19/ |
|
16.01.2019 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
|
Case No.:823/15/82- |
|
Party Name:BRAWN |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
LABORATORIES LTD |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
| 228 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0510409352 |
|
Defer |
|
|
:01/82/050/02280/AM19/ |
|
:05/23/040/00441/AM19/ |
|
16.01.2019 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
|
Case No.:1026/15/82- |
|
Party Name:ANLON |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
HEALTHCARE |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
PRIVATELIMITED |
|
05.07.2019 |
|
|
| 229 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:2410042628 |
|
Defer |
|
|
:01/82/050/02483/AM19/ |
|
:24/24/040/00049/AM19/ |
|
16.01.2019 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
| Case No.:825/15/82- |
|
Party Name:BRAWN |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
LABORATORIES LTD |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0510409373 |
|
|
| :01/82/050/02282/AM19/ |
|
:05/23/040/00467/AM19/ |
|
17.01.2019 |
|
|
|
|
**Decision:**The Committee |
**Decision:**The Committee |
considered the cases |
considered the cases |
as per agenda and in the light of earlier decision taken in |
as per agenda and in the light of earlier decision taken in |
as per agenda and in the light of earlier decision taken in |
|
|
meeting no. 15/82-ALC4/2018 dated 22.03.2019, it was decided to ratify norms under Para 4.7 of HBP v1 |
|
|
|
|
|
|
|
|
as per details given below or as applied by |
|
|
the firm, whichever is less: |
|
|
|
| 230 |
|
|
Export product |
Qty. |
Sl. |
Import items |
Qty. |
|
|
|
|
|
|
No. |
|
|
|
|
|
|
CIPROFLOXACIN |
One 500 |
1. |
CIPROFLOXACIN |
555.0 mg/500 |
|
|
|
|
TABLETS 500MG |
mg tablet |
|
HYDROCHLORIDE USP |
mg Tablets |
|
|
|
|
(OFF WHITE |
|
|
(FAINTLY YELLOWISH TO |
|
|
|
|
|
ELONGATED, |
|
|
LIGHT YELLOW |
|
|
|
|
|
BICONVEX, FLIM |
|
|
CRYSTALS) |
|
|
|
|
|
COATED TABLET, |
|
|
|
|
|
|
|
|
SCORED ON ONE SIDE) |
|
|
|
|
|
|
|
RA maytake appropriate action asper the decision of Norms Committee. |
|
|
|
|
|
|
Decision: The Committee considered the cases as per agenda and in the light of earlier decision taken in meeting no. 15/82-ALC4/2018 dated 22.03.2019, it was decided to ratify norms under Para 4.7 of HBP v1 as per details given below or as applied by the firm, whichever is less:
72
| Case No.:828/15/82- |
|
Party Name:ADISHANK |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
CHEMICALS PVT.LTD. |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310826440 |
|
|
| :01/82/050/02285/AM19/ |
|
:03/94/040/00865/AM19/ |
|
17.01.2019 |
|
|
Decision: The Committee considered the cases as per agenda and in the light of earlier decision taken in meeting no. 12/82-ALC4/2018 dated 12.12.2018, it was decided to ratify norms under Para 4.7 of HBP v1 231 as per details given below or as applied by the firm, whichever is less:
| Export product |
|
|
|
Qty. |
Sl. |
Import Items |
Qty. |
|
|
|
|
|
No. |
|
|
| DI<br>PHENYL |
ISO |
DECYL |
PHOSPHITE |
1 kg |
1. |
Phenol |
0.557 kg |
| (DPDP) |
|
|
|
|
2. |
2 -Propyl Heptanol |
0.386 kg |
| 232 |
<br>Case No.:829/15/82-<br>ALC4/2018<br>HQ File<br>:01/82/050/02286/AM19/ |
Party Name:AUROBINDO<br>PHARMA LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
|
RLA File<br>:09/24/040/00499/AM19/ |
Lic.No/Date:0910067071<br>18.01.2019 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 233 |
<br>Case No.:830/15/82-<br>ALC4/2018<br>HQ File<br>:01/82/050/02287/AM19/ |
Party Name:R CHEM<br>(SOMANAHALLI)<br>PVT.LTD, |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
|
RLA File<br>:09/24/040/00516/AM19/ |
Lic.No/Date:0910067074<br>18.01.2019 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| Case No.:831/15/82- |
|
Party Name:BENZO CHEM |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
INDUSTRIES PRIVATE |
|
ALC4/2019 |
|
Approved |
|
|
LIMITED, |
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310826458 |
|
|
| :01/82/050/02288/AM19/ |
|
:03/94/040/00853/AM19/ |
|
18.01.2019 |
|
|
Decision: The Committee considered the cases as per agenda and in the light of earlier decision taken in meeting no. 1/82-ALC4/2019 dated 03.06.2019, it was decided to ratify norms under Para 4.7 of HBP v1 as per details given below or as applied by the firm, whichever is less:
234
| Export Product |
Qty. |
Sl.<br>No. |
Import items |
Qty. |
| 2-DIMETHYLAMINO-2-<br>PHENYLBUTAN-1-OL<br>(DAFOL) |
1 kg |
1 |
PROPIOPHENONE |
1.408 kg |
|
|
2 |
SODIUM CYANIDE |
0.599kg |
|
|
3 |
PARA FORMALDEHYDE |
0.528 kg |
|
|
4 |
SODIUM BOROHYDRIDE |
0.528 kg |
|
|
5 |
TETRA HYDRO FURAN(THF) |
1.00 kg |
73
| Case No.:832/15/82- |
|
Party Name:BENZO CHEM |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
INDUSTRIES PRIVATE |
|
ALC4/2019 |
|
Approved |
|
|
LIMITED, |
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310826462 |
|
|
| :01/82/050/02289/AM19/ |
|
:03/94/040/00837/AM19/ |
|
18.01.2019 |
|
|
Decision: The Committee considered the cases as per agenda and in the light of earlier decision taken in meeting no. 1/82-ALC4/2019 dated 03.06.2019, it was decided to ratify norms under Para 4.7 of HBP v1 as per details given below or as applied by the firm, whichever is less:
235
| Export Product |
Qty. |
Sl.<br>No. |
Import items |
Qty. |
| 2-DIMETHYLAMINO-2-<br>PHENYLBUTAN-1-OL<br>(DAFOL) |
1 kg |
1 |
PROPIOPHENONE |
1.408 kg |
|
|
2 |
SODIUM CYANIDE |
0.599kg |
|
|
3 |
PARA FORMALDEHYDE |
0.528 kg |
|
|
4 |
SODIUM BOROHYDRIDE |
0.528 kg |
|
|
5 |
TETRA HYDRO FURAN(THF) |
1.00 kg |
| Case No.:835/15/82- |
|
Party Name:CADILA |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
HEALTHCARE LTD |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0810144365 |
|
|
| :01/82/050/02292/AM19/ |
|
:08/24/040/00315/AM19/ |
|
22.01.2019 |
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower: 236
| Export product |
Qty. |
Sl.<br>No. |
Import items |
Qty. |
| DIOSMIN TABLETS 600 MG<br>(ACTIVE INGREDIENT :<br>DIOSMIN PH EUR - NET WT.<br>500.220KGS) |
833700<br>Number |
1 |
DIOSMIN PH EUR |
510.224 kg |
| 237 |
Case No.:837/15/82-<br>ALC4/2018 |
Party Name:DANOPHARM<br>CHEMICALS PRIVATE<br>LTD. |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
HQ File<br>:01/82/050/02294/AM19/ |
RLA File<br>:03/94/040/00886/AM19/ |
Lic.No/Date:0310826539<br>22.01.2019 |
Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
74
| 238 |
<br>Case No.:869/15/82-<br>ALC4/2018 |
Party Name:ALKALI<br>METALS LTD., |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02326/AM19/ |
RLA File<br>:09/24/040/00495/AM19/ |
Lic.No/Date:0910067104<br>23.01.2019 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 239 |
<br>Case No.:842/15/82-<br>ALC4/2018 |
Party Name:S.M. HERBALS<br>PVT.LTD. |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02299/AM19/ |
RLA File<br>:05/24/040/00602/AM19/ |
Lic.No/Date:0510409465<br>24.01.2019 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 240 |
<br>Case No.:212/15/82-<br>ALC4/2018 |
Party Name:VENUS<br>REMEDIES LTD., |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/01669/AM19/ |
RLA File<br>:22/24/040/00079/AM19/ |
Lic.No/Date:2210016070<br>25.01.2019 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 241 |
<br>Case No.:844/15/82-<br>ALC4/2018 |
Party Name:KLJ<br>PLASTICIZERS LIMITED. |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02301/AM19/ |
RLA File<br>:05/23/040/00475/AM19/ |
Lic.No/Date:0510409477<br>25.01.2019 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 242 |
<br>Case No.:845/15/82-<br>ALC4/2018 |
Party Name:J.B.<br>CHEMICALS &<br>PHARMACEUTICALS<br>LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
HQ File<br>:01/82/050/02302/AM19/ |
RLA File<br>:03/94/040/00925/AM19/ |
Lic.No/Date:0310826640<br>25.01.2019 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 243 |
Case No.:847/15/82-<br>ALC4/2018 |
Party Name:LIRICON<br>TRADING |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02304/AM19/ |
RLA File<br>:03/95/040/01055/AM19/ |
Lic.No/Date:0310826653<br>25.01.2019 |
<br>Defer<br>Date:05.07.2019 |
|
Decision:<br>RLA, Mumbai was requested vide e-mail dated 05.04.2019 to furnish the hard copy of<br>4.07 application of subject Advance Authorization. Application awaited from RLA, Mumbai. However,<br>the application is still awaited. Hence, it was decided to issue a Reminder to RLA, Mumbai for furnishing<br>a copyof application expeditiously. |
|
|
|
75
| 244 |
Case No.:848/15/82-<br>ALC4/2018 |
Party Name:VIVIMED LIFE<br>SCIENCES PRIVATE<br>LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02305/AM19/ |
RLA File<br>:09/24/040/00505/AM19/ |
Lic.No/Date:0910067112<br>28.01.2019 |
Defer<br>Date:05.07.2019 |
|
Decision:<br>RLA, Hyderabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of<br>4.07 application of subject Advance Authorization. Application awaited from RLA, Hyderabad. However,<br>the application is still awaited. Hence, it was decided to issue a Reminder to RLA, Hyderabad for<br>furnishinga copyof application expeditiously. |
|
|
|
| 245 |
Case No.:851/15/82-<br>ALC4/2018 |
Party Name:SI GROUP -<br>INDIA PRIVATE LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02308/AM19/ |
RLA File<br>:03/95/040/01108/AM19/ |
Lic.No/Date:0310826724<br>30.01.2019 |
Defer<br>Date:05.07.2019 |
|
Decision:<br>RLA, Bangalore was requested vide e-mail dated 05.04.2019 to furnish the hard copy of<br>4.07 application of subject Advance Authorization. Application awaited from RLA, Bangalore. However,<br>the application is still awaited. Hence, it was decided to issue a Reminder to RLA, Bangalore for<br>furnishinga copyof application expeditiously. |
|
|
|
| 246 |
<br>Case No.:853/15/82-<br>ALC4/2018 |
Party Name:ALPHAMED<br>FORMULATIONS P LTD.<br>RLA File<br>:09/24/040/00511/AM19/ |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred<br> <br>Defer<br>Date:05.07.2019 |
|
<br>HQ File<br>:01/82/050/02310/AM19/ |
|
Lic.No/Date:0910067120<br>31.01.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
| Case No.:854/15/82- |
|
Party Name:SAI RAM |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
CHEMICALS |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:2610012873 |
|
|
| :01/82/050/02311/AM19/ |
|
:26/24/040/00016/AM19/ |
|
31.01.2019 |
|
|
Decision: The Committee considered the cases as per agenda and in the light of earlier decision taken in meeting no. 13/82-ALC4/2018 dated 14.01.2019, it was decided to ratify norms under Para 4.7 of HBP v1 as per details given below or as applied by the firm, whichever is less:
247
| Export product |
Qty. |
Sl. |
Import items |
Qty. |
|
|
No. |
|
|
| (4R-CIS)-1,1-DIMETHYLETHYL-6- |
1 kg |
1 |
(4R-CIS)-1,1-DIMETHYLETHYL- |
1.01 kg |
| (2-AMINOMETHYL-2,2- |
|
|
6-CYANOMETHYL-2,2- |
|
| DIMETHYL-1,3-DIOXANE-4- |
|
|
DIMETHYL-1,3-DIOXANE-4- |
|
| ACETATE (AMINO KETAL) |
|
|
ACETATE |
|
76
| 248 |
<br>Case No.:855/15/82-<br>ALC4/2018<br> <br> <br> <br>HQ File<br>:01/82/050/02312/AM19/<br> <br> |
Party Name:SMS<br>LIFESCIENCES INDIA<br>LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
|
RLA File<br>:09/24/040/00542/AM19/ |
Lic.No/Date:0910067122<br>31.01.2019 |
<br>Defer<br>Date:05.07.2019 |
|
Decision:<br>RLA, Hyderabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of<br>4.07 application of subject Advance Authorization. Application awaited from RLA, Hyderabad. However,<br>the application is still awaited. Hence, it was decided to issue a Reminder to RLA, Hyderabad for<br>furnishinga copyof application expeditiously. |
|
|
|
Decision: RLA, Hyderabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Hyderabad. However, the application is still awaited. Hence, it was decided to issue a Reminder to RLA, Hyderabad for furnishing a copy of application expeditiously.
| Case No.:856/15/82- |
|
Party Name:TATVA |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
CHINTAN PHARMA CHEM |
|
ALC4/2019 |
|
Approved |
|
|
PVT LTD |
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:3410044856 |
|
|
| :01/82/050/02313/AM19/ |
|
:34/24/040/00308/AM19/ |
|
31.01.2019 |
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower: 249
| Export product |
Qty. |
Sl.<br>No. |
Import items |
Qty. |
| METHYL TRIPHENYL<br>PHOSPHONIUM BROMIDE<br>CAS No. 1779-49-3, ASSAY NLT<br>98% |
1 kg |
1 |
TRIPHENYL PHOSPHINE<br>CAS NO: 603-35-0 ASSAY<br>NLT 98% |
0.78 kg |
| Case No.:858/15/82- |
|
Party Name:MANGALAM |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
DRUGS & ORGANICS |
|
ALC4/2019 |
|
Approved |
|
|
LIMITED |
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310826762 |
|
|
| :01/82/050/02315/AM19/ |
|
:03/95/040/01138/AM19/ |
|
01.02.2019 |
|
|
Decision: The Committee considered the cases as per agenda and in the light of earlier decision taken in meeting no. 1/82-ALC4/2019 dated 03.06.2019, it was decided to ratify norms under Para 4.7 of HBP v1 as 250 per details given below or as applied by the firm, whichever is less:
| Export product |
Qty. |
Sl. |
Import items |
Qty. |
|
|
No. |
|
|
| DIHYDROARTEMISININ |
1 kg |
1 |
ARTEMISININ |
1.00 kg |
|
|
2 |
SODIUM BOROHYDRIDE |
0.20kg |
77
| Case No.:860/15/82- |
|
Party Name:DORF-KETAL |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
CHEMICALS INDIA |
|
ALC4/2019 |
|
Approved |
|
|
PVT.LTD. |
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310826778 |
|
|
| :01/82/050/02317/AM19/ |
|
:03/94/040/00894/AM19/ |
|
01.02.2019 |
|
|
|
Case No.:860/15/82-<br>ALC4/2018 |
Party Name:DORF-KETAL<br>CHEMICALS INDIA<br>PVT.LTD.<br>RLA File<br>:03/94/040/00894/AM19/ |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019<br>Lic.No/Date:0310826778<br>01.02.2019 |
Status:<br>Approved<br> |
|
HQ File<br>:01/82/050/02317/AM19/ |
|
|
|
| 251 |
<br>**Decision:**The Committee considered case as per agenda and deliberated on the matter in the presence of<br>the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as<br>per details below or as applied by firm whichever is lower:<br>Export product<br>Qty.<br>Sl.<br>No.<br>Import items<br>Qty.<br>3,5 Xylenol (3-5-Dimethylphenol)<br>1 kg<br>1<br>ISOPHORONE<br>1.49 kg<br>RA concerned maytake further necessaryaction asper above decision of NC. |
|
|
|
| 252 |
<br>Case No.:861/15/82-<br>ALC4/2018 |
Party Name:INNOVARE<br>LABS PRIVATE LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02318/AM19/ |
RLA File<br>:09/24/040/00535/AM19/ |
Lic.No/Date:0910067125<br>01.02.2019 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
|
| 253 |
<br>Case No.:863/15/82-<br>ALC4/2018 |
Party Name:JAYANT AGRO<br>ORGANICS LTD.,<br> <br> <br> <br>RLA File<br>:03/94/040/00948/AM19/<br> <br> |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019<br> <br><br>Lic.No/Date:0310826798<br>04.02.2019<br> <br> |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02320/AM19/ |
|
|
Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 254 |
<br>Case No.:864/15/82-<br>ALC4/2018 |
Party Name:J.B.<br>CHEMICALS &<br>PHARMACEUTICALS<br>LIMITED<br> <br> <br> <br>RLA File<br>:03/94/040/00944/AM19/<br> <br> |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019<br> <br><br>Lic.No/Date:0310826799<br>04.02.2019<br> <br> |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02321/AM19/ |
|
|
Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
78
| Case No.:865/15/82- |
|
Party Name:FDC LTD |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
|
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310826803 |
|
|
| :01/82/050/02322/AM19/ |
|
:03/94/040/00950/AM19/ |
|
04.02.2019 |
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as 255 per details below or as applied by firm whichever is lower:
| Export product |
Qty. |
Sl.<br>No. |
Import items |
Qty. |
| OFLOXACIN OPTHALMIC<br>SOL 0.3% 5ML |
1800000.000 Vial |
1 |
OFLOXACIN |
27.54 kg |
|
|
Case No.:870/15/82- |
|
Party Name:SHREE |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
BANKEY BEHARI LAL |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
FLAVORS |
|
05.07.2019 |
|
|
| 256 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0510409585 |
|
Defer |
|
|
:01/82/050/02327/AM19/ |
|
:05/24/040/00623/AM19/ |
|
05.02.2019 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
|
Case No.:873/15/82- |
|
Party Name:CADILA |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
HEALTHCARE LTD |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
| 257 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0810144496 |
|
Defer |
|
|
:01/82/050/02330/AM19/ |
|
:08/24/040/00379/AM19/ |
|
05.02.2019 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
|
Case No.:874/15/82- |
|
Party Name:CADILA |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
HEALTHCARE LTD |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
| 258 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0810144497 |
|
Defer |
|
|
:01/82/050/02331/AM19/ |
|
:08/24/040/00372/AM19/ |
|
05.02.2019 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
|
Case No.:875/15/82- |
|
Party Name:CADILA |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
HEALTHCARE LTD |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
| 259 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0810144498 |
|
Defer |
|
|
:01/82/050/02332/AM19/ |
|
:08/24/040/00381/AM19/ |
|
05.02.2019 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
79
|
|
Case No.:876/15/82- |
|
Party Name:MOREPEN |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
LABORATORIES LTD., |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
| 260 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0510409596 |
|
Defer |
|
|
:01/82/050/02333/AM19/ |
|
:05/24/040/00634/AM19/ |
|
05.02.2019 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
|
Case No.:1027/15/82- |
|
Party Name:ANLON |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
HEALTHCARE |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
PRIVATELIMITED |
|
05.07.2019 |
|
|
| 261 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:2410042653 |
|
Defer |
|
|
:01/82/050/02484/AM19/ |
|
:24/24/040/00053/AM19/ |
|
05.02.2019 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
| Case No.:877/15/82- |
|
Party Name:PANACEA |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
BIOTEC LTD., |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0510409606 |
|
|
| :01/82/050/02334/AM19/ |
|
:05/24/040/00642/AM19/ |
|
06.02.2019 |
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower: 262
| Export product |
Qty. |
Sl. |
Import items |
Qty. |
|
|
No. |
|
|
| ALPHADOL CAPSULES (EACH |
4500000 Capsules |
1 |
ALFACALCIDOL |
1.575 |
| SOFT GELATIN CAPSULE |
|
|
|
gram |
| CONTAINS: ALFACALCIDOL |
|
|
|
|
| 0.25 MCG) |
|
|
|
|
The Committee allowed the above norms on one time basis and no repeat norms is allowed. RA concerned may take further necessary action as per above decision of NC.
| Case No.:879/15/82- |
|
Party Name:SAGA |
|
Meet No/Date:3/82- |
|
Status: Approved |
| ALC4/2018 |
|
LABORATORIES |
|
ALC4/2019 |
|
|
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:081014452 |
|
|
| :01/82/050/02336/AM19/ |
|
:08/24/040/00368/AM19/ |
|
1 |
|
|
|
|
|
|
06.02.2019 |
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of 263 the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:
| Export product |
Qty. |
Sl. |
Import items |
Qty. |
|
|
No. |
|
|
| DIFLAH 500 (Diosmin and |
3100000 |
1 |
DIOSMIN + HESPERIDIN |
1581.00 kg |
| Hesperidin Tablets 500mg) |
Number |
|
9:1 |
|
80
| 264 |
<br>Case No.:880/15/82-<br>ALC4/2018 |
Party Name:DEEPAK<br>NOVOCHEM<br>TECHNOLOGIES LTD |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02337/AM19/ |
RLA File<br>:31/83/040/00162/AM19/ |
Lic.No/Date:3110067309<br>06.02.2019 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 265 |
Case No.:881/15/82-<br>ALC4/2018 |
Party Name:SHILPA<br>MEDICARE LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02338/AM19/ |
RLA File<br>:07/24/040/00263/AM19/ |
Lic.No/Date:0710114519<br>07.02.2019 |
<br>Defer<br>Date:05.07.2019 |
|
Decision:<br>RLA, Bangalore was requested vide e-mail dated 05.04.2019 to furnish the hard copy of<br>4.07 application of subject Advance Authorization. Application awaited from RLA, Bangalore. However,<br>the application is still awaited. Hence, it was decided to issue a Reminder to RLA, Bangalore for<br>furnishinga copyof application expeditiously. |
|
|
|
| Case No.:882/15/82- |
|
Party Name:SURVIVAL |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
TECHNOLOGIES PVT.LTD. |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310826900 |
|
|
| :01/82/050/02339/AM19/ |
|
:03/95/040/01150/AM19/ |
|
07.02.2019 |
|
|
Decision: The Committee considered the cases as per agenda and in the light of earlier decision taken in 266 meeting no. 2/82-ALC4/2018 dated 16.05.2018, it was decided to ratify norms under Para 4.7 of HBP v1 as per details given below or as applied by the firm, whichever is less:
| Export product |
Qty. |
Import items |
Qty. |
| 4-HYDROXY BENZYL ALCOHOL |
1 kg |
4-HYDROXY BENZALDEHYDE |
1.35 kg |
|
|
SODIUM BOROHYDRIDE |
0.207 kg |
| 267 |
Case No.:883/15/82-<br>ALC4/2018 |
Party Name:MAHESHRAJ<br>CHEMICALS PVT.LTD |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02340/AM19/ |
RLA File<br>:08/24/040/00374/AM19/ |
Lic.No/Date:0810144562<br>08.02.2019 |
<br>Defer<br>Date:05.07.2019 |
|
Decision:<br>RLA, Ahmedabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy<br>of 4.07 application of subject Advance Authorization. Application awaited from RLA, Ahmedabad.<br>However, the application is still awaited. Hence, it was decided to issue a Reminder to RLA, Ahmedabad<br>for furnishinga copyof application expeditiously. |
|
|
|
Decision: RLA, Ahmedabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07 application of subject Advance Authorization. Application awaited from RLA, Ahmedabad. However, the application is still awaited. Hence, it was decided to issue a Reminder to RLA, Ahmedabad for furnishing a copy of application expeditiously.
81
|
|
Case No.:885/15/82- |
|
Party Name:ORTIN |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
LABORATORIES LTD |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
| 268 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0910067148 |
|
Defer |
|
|
:01/82/050/02342/AM19/ |
|
:09/24/040/00538/AM19/ |
|
08.02.2019 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
|
Case No.:887/15/82- |
|
Party Name:ENAL DRUGS |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
PVT LTD., |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
| 269 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0910067153 |
|
Defer |
|
|
:01/82/050/02344/AM19/ |
|
:09/24/040/00543/AM19/ |
|
08.02.2019 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
|
Case No.:888/15/82- |
|
Party Name:ASTRAL |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
STERITECH PVT. LTD. |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
|
|
05.07.2019 |
|
|
| 270 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:3410044867 |
|
Defer |
|
|
:01/82/050/02345/AM19/ |
|
:34/24/040/00333/AM19/ |
|
08.02.2019 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
|
Case No.:891/15/82- |
|
Party Name:GELTEC |
|
Meet No/Date:3/82- |
|
Status: Deferred |
|
|
ALC4/2018 |
|
PRIVATE LIMITED |
|
ALC4/2019 |
|
|
|
|
|
|
|
|
05.07.2019 |
|
|
| 271 |
|
HQ File |
|
RLA File |
|
Lic.No/Date:0310826970 |
|
Defer |
|
|
:01/82/050/02348/AM19/ |
|
:03/94/040/00970/AM19/ |
|
11.02.2019 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
|
Case No.:892/15/82- |
|
Party Name:J.B. |
|
Meet No/Date:3/82- |
|
Status: |
|
|
ALC4/2018 |
|
CHEMICALS & |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
PHARMACEUTICALS |
|
05.07.2019 |
|
|
| 272 |
|
|
|
LIMITED |
|
|
|
|
|
|
HQ File |
|
RLA File |
|
Lic.No/Date:0310826971 |
|
Defer |
|
|
:01/82/050/02349/AM19/ |
|
:03/94/040/00978/AM19/ |
|
11.02.2019 |
|
Date:05.07.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
|
|
|
|
|
|
|
|
| 273 |
Case No.:894/15/82-<br>ALC4/2018 |
Party Name:DEEPAK<br>PHENOLICS LIMITED |
Meet No/Date:3/82-<br>ALC4/2019 |
Status:<br>Deferred |
|
<br> |
|
<br>05.07.2019 |
|
|
<br>HQ File |
RLA File |
LicNo/Date:3410044883 |
<br>Defer |
|
<br>:01/82/050/02351/AM19/ |
<br>:34/24/040/00328/AM19/ |
.<br>12.02.2019 |
<br> <br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
82
| 274 |
<br>Case No.:899/15/82-<br>ALC4/2018<br>HQ File<br>:01/82/050/02356/AM19/ |
Party Name:ATUL<br>LIMITED,<br> <br> <br> |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019<br> <br>Lic.No/Date:0810144581<br>12.02.2019<br> <br> |
Status: Deferred |
|
|
RLA File<br>:08/24/040/00371/AM19/<br> <br> |
|
Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 275 |
<br>Case No.:896/15/82-<br>ALC4/2018 |
Party Name:AUROBINDO<br>PHARMA LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02353/AM19/ |
RLA File<br>:09/24/040/00555/AM19/ |
Lic.No/Date:0910067168<br>13.02.2019 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 276 |
<br>Case No.:897/15/82-<br>ALC4/2018 |
Party Name:SATYADEVA<br>PHARMACEUTICALS PVT<br>LTD |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02354/AM19/ |
RLA File<br>:09/24/040/00551/AM19/ |
Lic.No/Date:0910067170<br>13.02.2019 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 277 |
Case No.:898/15/82-<br>ALC4/2018 |
Party Name:DR. REDDYS<br>LABORATORIES LIMITED<br>RLA File<br>:09/24/040/00558/AM19/ |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred<br> <br>Defer<br>Date:05.07.2019 |
|
<br>HQ File<br>:01/82/050/02355/AM19/ |
|
Lic.No/Date:0910067171<br>13.02.2019 |
|
|
**Decision:**RLA, Hyderabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of 4.07<br>application of subject Advance Authorization. Application awaited from RLA, Hyderabad. However, the<br>application is still awaited. Hence, it was decided to issue a Reminder to RLA, Hyderabad for furnishing a<br>copyof application expeditiously. |
|
|
|
| Case No.:900/15/82- |
|
Party Name:ENCEE |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
AROMATICS PVT. LIMITED |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:3210078858 |
|
|
| :01/82/050/02357/AM19/ |
|
:32/24/040/00056/AM19/ |
|
13.02.2019 |
|
|
Decision: The Committee considered case as per agenda and deliberated on the matter in the presence of 278 the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower: Export product Qty. Sl. No. Import items Qty. Enamber / Kephalis / Tetrambrone 1 kg 1 Triethyl Orthoformate 2.400 kg
83
| 279 |
Case No.:901/15/82-<br>ALC4/2018 |
Party Name:KUMAR<br>ORGANIC PRODUCTS<br>LIMITED,<br>RLA File<br>:07/24/040/00244/AM19/ |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred<br> <br>Defer<br>Date:05.07.2019 |
|
<br>HQ File<br>:01/82/050/02358/AM19/ |
|
Lic.No/Date:0710114543<br>13.02.2019 |
|
|
**Decision:**RLA, Ahmedabad was requested vide e-mail dated 05.04.2019 to furnish the hard copy of<br>4.07 application of subject Advance Authorization. Application awaited from RLA, Ahmedabad.<br>However, the application is still awaited. Hence, it was decided to issue a Reminder to RLA, Ahmedabad<br>for furnishinga copyof application expeditiously. |
|
|
|
| 280 |
<br>Case No.:902/15/82-<br>ALC4/2018 |
Party Name:INNOVARE<br>LABS PRIVATE LIMITED<br>RLA File<br>:09/24/040/00549/AM19/ |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred<br> <br>Defer<br>Date:05.07.2019 |
|
<br>HQ File<br>:01/82/050/02359/AM19/ |
|
Lic.No/Date:0910067173<br>14.02.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 281 |
<br>Case No.:903/15/82-<br>ALC4/2018 |
Party Name:MATRIX FINE<br>SCIENCES PVT.LTD.,<br>RLA File<br>:03/95/040/01113/AM19/ |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred<br> <br>Defer<br>Date:05.07.2019 |
|
<br>HQ File<br>:01/82/050/02360/AM19/ |
|
Lic.No/Date:0310827030<br>14.02.2019 |
|
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 282 |
<br>Case No.:905/15/82-<br>ALC4/2018<br>HQ File<br>:01/82/050/02362/AM19/ |
Party Name:JODAS<br>EXPOIM PVT.LTD<br> <br> <br> |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019<br> <br>Lic.No/Date:0510409675<br>15.02.2019<br> <br> |
Status: Deferred |
|
|
RLA File<br>:05/23/040/00508/AM19/<br> <br> |
|
Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 283 |
<br>Case No.:906/15/82-<br>ALC4/2018 |
Party Name:JODAS EXPOIM<br>PVT.LTD |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02363/AM19/ |
RLA File<br>:05/23/040/00507/AM19/ |
Lic.No/Date:0510409676<br>15.02.2019 |
Defer<br>Date:22.03.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 284 |
<br>Case No.:907/15/82-<br>ALC4/2018 |
Party Name:AURORE LIFE<br>SCIENCES PRIVATE<br>LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02364/AM19/ |
RLA File<br>:09/24/040/00515/AM19/ |
Lic.No/Date:0910067181<br>15.02.2019 |
Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
84
| 285 |
<br>Case No.:911/15/82-<br>ALC4/2018 |
Party Name:YASHO<br>INDUSTRIES LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02368/AM19/ |
RLA File<br>:03/95/040/01195/AM19/ |
Lic.No/Date:0310827118<br>19.02.2019 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 286 |
<br>Case No.:916/15/82-<br>ALC4/2018 |
Party Name:OPTIMUS<br>DRUGS PRIVATE LIMITED |
<br>Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02373/AM19/ |
RLA File<br>:09/24/040/00569/AM19/ |
Lic.No/Date:0910067192<br>20.02.2019 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 287 |
<br>Case No.:919/15/82-<br>ALC4/2018 |
Party Name:ORTIN<br>LABORATORIES LTD |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02376/AM19/ |
RLA File<br>:09/24/040/00573/AM19/ |
Lic.No/Date:0910067198<br>21.02.2019 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| Case No.:921/15/82- |
|
Party Name:SHREE JAYA |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
LABORATORIES PVT LTD. |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0910067202 |
|
|
| :01/82/050/02378/AM19/ |
|
:09/24/040/00411/AM19/ |
|
21.02.2019 |
|
|
|
Case No.:921/15/82-<br>ALC4/2018 |
Case No.:921/15/82-<br>ALC4/2018 |
Party Name:SHREE JAYA<br>LABORATORIES PVT LTD. |
Party Name:SHREE JAYA<br>LABORATORIES PVT LTD. |
Party Name:SHREE JAYA<br>LABORATORIES PVT LTD. |
Party Name:SHREE JAYA<br>LABORATORIES PVT LTD. |
<br>Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Approved |
Status:<br>Approved |
|
HQ File<br>:01/82/050/02378/AM19/ |
|
RLA File<br>:09/24/040/00411/AM19/ |
|
|
|
Lic.No/Date:0910067202<br>21.02.2019 |
|
|
| 288 |
<br>**Decision:**The Committee considered the cases as per agenda and in the light of earlier decision taken in<br>meeting no. 5/82-ALC4/2015 dated 25.06.2015, it w as decided to ratify norms under Para 4.7 of HBP v1<br>as per details given below or as applied by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl.<br>No.<br>Import items<br>Qty.<br>2-CHLOROMETHYL-4-<br>METHOXY-3,5-<br>DIMETHYL<br>PYRIDINE<br>HCL<br>1 kg<br>1<br>3,5 LUTIDINE<br>1.04 kg<br>2<br>HYDROGEN PEROXIDE<br>1.13 kg<br>3<br>CHLOROFORM<br>5.20 kg<br>4<br>AMMONIUM PER SULPHATE<br>1.80 kg<br>5<br>THIONYL CHLORIDE<br>0.80 kg<br>RA maytake appropriate action asper the decision of Norms Committee. |
|
|
|
|
|
|
|
|
|
|
Export product |
|
Qty. |
Sl.<br>No. |
Import items |
|
|
Qty. |
|
|
2-CHLOROMETHYL-4-<br>METHOXY-3,5-<br>DIMETHYL<br>PYRIDINE<br>HCL |
|
1 kg |
1 |
3,5 LUTIDINE |
|
|
1.04 kg |
|
|
|
|
|
2 |
HYDROGEN PEROXIDE |
|
|
1.13 kg |
|
|
|
|
|
3 |
CHLOROFORM |
|
|
5.20 kg |
|
|
|
|
|
4 |
AMMONIUM PER SULPHATE |
|
|
1.80 kg |
|
|
|
|
|
5 |
THIONYL CHLORIDE |
|
|
0.80 kg |
|
|
|
|
per the decision of Norms Committee. |
|
|
|
|
|
| 289 |
<br>Case No.:922/15/82-<br>ALC4/2018 |
Party Name:GLOBE<br>TROTTERS PVT LTD |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02379/AM19/ |
RLA File<br>:03/94/040/01015/AM19/ |
Lic.No/Date:0310827201<br>21.02.2019 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
85
| Case No.:923/15/82- |
|
Party Name:ETERNIS FINE |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
CHEMICALS LIMITED, |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310827203 |
|
|
| :01/82/050/02380/AM19/ |
|
:03/94/040/01000/AM19/ |
|
21.02.2019 |
|
|
Decision: The Committee considered the cases as per agenda and in the light of earlier decision taken in meeting no. 13/82-ALC4/2018 dated 14.01.2019, it was decided to ratify norms under Para 4.7 of HBP v1 as per details given below or as applied by the firm, whichever is less: 290
| Export product |
Qty. |
Sl. |
Import items |
Qty. |
|
|
No. |
|
|
| COUMARIN |
1 kg |
1 |
SALICYLALDEHYDE |
1.09 kg |
|
|
2 |
ACETIC ANHYDRIDE |
Not Allowed |
|
|
3 |
METHANOL |
NotAllowed |
RA may take appropriate action as per the decision of Norms Committee
| 291 |
<br>Case No.:924/15/82-<br>ALC4/2018 |
Party Name:INDO AMINES<br>LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02381/AM19/ |
RLA File<br>:03/94/040/00984/AM19/ |
Lic.No/Date:0310827206<br>21.02.2019 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 292 |
<br>Case No.:927/15/82-<br>ALC4/2018 |
Party Name:SUVEN LIFE<br>SCIENCES LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02384/AM19/ |
RLA File<br>:09/24/040/00580/AM19/ |
Lic.No/Date:0910067211<br>22.02.2019 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 293 |
<br>Case No.:929/15/82-<br>ALC4/2018 |
Party Name:THINQ<br>PHARMA-CRO LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02386/AM19/ |
RLA File<br>:03/95/040/01186/AM19/ |
Lic.No/Date:0310827227<br>22.02.2019 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 294 |
<br>Case No.:931/15/82-<br>ALC4/2018 |
Party Name:MEHK<br>CHEMICALS PVT. LTD. |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02388/AM19/ |
RLA File<br>:03/95/040/01227/AM19/ |
Lic.No/Date:0310827242<br>22.02.2019 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
86
| 295 |
<br>Case No.:932/15/82-<br>ALC4/2018 |
Party Name:MEHK<br>CHEMICALS PVT. LTD. |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02389/AM19/ |
RLA File<br>:03/95/040/01209/AM19/ |
Lic.No/Date:0310827243<br>22.02.2019 |
Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| Case No.:934/15/82- |
|
Party Name:ASTRAL |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
STERITECH PVT. LTD. |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:3410044929 |
|
Defer |
| :01/82/050/02391/AM19/ |
|
:34/24/040/00356/AM19/ |
|
22.02.2019 |
|
Date:05.07.2019 |
296 Decision: The Committee considered the case as per agenda in the presence of technical experts and it was decided to call for following information:
(i) Dose of injection (ii) DML. (iii) Size of vial.
| Case No.:935/15/82- |
|
Party Name:ASTRAL |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
STERITECH PVT. LTD. |
|
ALC4/2019 |
|
Deferred |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:3410044930 |
|
Defer |
| :01/82/050/02392/AM19/ |
|
:34/24/040/00355/AM19/ |
|
22.02.2019 |
|
Date:05.07.2019 |
297 Decision: The Committee considered the case as per agenda in the presence of technical experts and it was decided to call for following information:
(i) Dose of injection (ii) DML. (iii) Size of vial.
| 298 |
<br>Case No.:936/15/82-<br>ALC4/2018 |
Party Name:VISION DRUGS<br>PVT LTD |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02393/AM19/ |
RLA File<br>:09/24/040/00575/AM19/ |
Lic.No/Date:0910067217<br>25.02.2019 |
Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 299 |
<br>Case No.:941/15/82-<br>ALC4/2018 |
Party Name:AMANTA<br>HEALTHCARE LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02398/AM19/ |
RLA File<br>:08/24/040/00405/AM19/ |
Lic.No/Date:0810144674<br>25.02.2019 |
Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
87
| 300 |
<br>Case No.:1033/15/82-<br>ALC4/2018 |
Party Name:SRIAM LABS<br>PRIVATE LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02490/AM19/ |
RLA File<br>:09/24/040/00591/AM19/ |
Lic.No/Date:0910067219<br>26.02.2019 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 301 |
<br>Case No.:1051/15/82-<br>ALC4/2018 |
Party Name:YASHO<br>INDUSTRIES LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02508/AM19/ |
RLA File<br>:03/95/040/01264/AM19/ |
Lic.No/Date:0310827302<br>26.02.2019 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| Case No.:1037/15/82- |
|
Party Name:GLAND |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
PHARMA LIMITED |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0910067223 |
|
|
| :01/82/050/02494/AM19/ |
|
:09/24/040/00497/AM19/ |
|
27.02.2019 |
|
|
Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 2/82-ALC4/2019 , dated 21.06.2019, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:
Export Product : 1. Adenosine Injection Prefilled Syringe 3mg/ml, 2ml in a PFS 302 2. Adenosine Injection Prefilled Syringe 3mg/ml, 4ml in a PFS
|
Sl. |
|
|
Quantity |
Quantity |
|
No. |
Import Item Name. |
|
3mg/ml, 2ml in a |
3mg/ml, 4ml in a |
|
|
|
|
PFS |
PFS |
|
1 |
Adenosine USP |
|
0.0066 gm/ vial |
0.0132 gm/ vial |
|
2 |
Barrel Syringes Glass |
|
Relevant, as per |
Relevant, as per |
|
3 |
V-OVS 10.6 Tip Caps |
|
packing policy |
packing policy |
|
4 |
Plunger Stoppers |
|
|
|
|
5 |
Plunger Rods |
|
|
|
| A concerned maytake further necessaryaction asper above decision of NC. |
|
|
|
|
|
| 303 |
<br>Case No.:1038/15/82-<br>ALC4/2018 |
Party Name:GLAND<br>PHARMA LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019<br>Lic.No/Date:0910067224<br>27.02.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02495/AM19/ |
RLA File<br>:09/24/040/00530/AM19/ |
|
Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
88
| 304 |
<br>Case No.:1039/15/82-<br>ALC4/2018 |
Party Name:GLAND<br>PHARMA LIMITED |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02496/AM19/ |
RLA File<br>:09/24/040/00491/AM19/ |
Lic.No/Date:0910067225<br>27.02.2019 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 305 |
<br>Case No.:1041/15/82-<br>ALC4/2018 |
Party Name:WEXFORD<br>LABORATORIES P LTD |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02498/AM19/ |
RLA File<br>:07/24/040/00276/AM19/ |
Lic.No/Date:0710114597<br>27.02.2019 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| Case No.:1048/15/82- |
|
Party Name:SPC LIFE |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
SCIENCES PVT. LTD. |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:3410044936 |
|
|
| :01/82/050/02505/AM19/ |
|
:34/24/040/00347/AM19/ |
|
27.02.2019 |
|
|
|
Case No.:1048/15/82-<br>ALC4/2018 |
Party Name:SPC LIFE<br>SCIENCES PVT. LTD. |
Party Name:SPC LIFE<br>SCIENCES PVT. LTD. |
Party Name:SPC LIFE<br>SCIENCES PVT. LTD. |
Party Name:SPC LIFE<br>SCIENCES PVT. LTD. |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Approved |
|
HQ File<br>:01/82/050/02505/AM19/ |
RLA File<br>:34/24/040/00347/AM19/ |
|
|
|
Lic.No/Date:3410044936<br>27.02.2019 |
|
| 306 |
<br>**Decision:**The Committee considered the case as per agenda in the presence of Technical Experts and in<br>the<br>light<br>of<br>earlier<br>decision<br>taken<br>by<br>NC<br>in<br>its<br>Meeting<br>No.<br>13/82-ALC4/2018<br>, dated 14.01.2019, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as<br>per details below or as applied by firm whichever is lower: |
|
|
|
|
|
|
|
<br>Export product |
|
Qty. |
Sl. No. |
Import items |
|
Qty. |
|
CHLOROHEXAN-2-ONE |
|
1 kg |
1 |
1-BROMO 3-CHLORO PROPANE.<br>CLEAR LIQUID. |
|
<br>2.05 kg |
|
|
|
|
2 |
METHYL<br>ACETO<br>ACETATE.<br>CLEAR COLOURLESS TO LIGHT<br>YELLOW LIQUID |
|
<br> <br>1.65 kg |
|
|
|
|
3 |
SODIUM<br>METHOXIDE.<br>WHITE POWDER |
|
<br>1.25 kg |
|
RA concerned maytake further necessaryaction asper above decision of NC. |
|
|
|
|
|
|
89
| Case No.:1052/15/82- |
|
Party Name:AVA |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
CHEMICALS PVT.LTD., |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310827339 |
|
|
| :01/82/050/02509/AM19/ |
|
:03/94/040/00933/AM19/ |
|
27.02.2019 |
|
|
Decision: The Committee considered the case as per agenda in the presence of Technical Experts and in the light of earlier decision taken by NC in its Meeting No. 1/82-ALC4/2019 307 , dated 03.06.2019, it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP Vol. I as per details below or as applied by firm whichever is lower:
| Export product |
Qty. |
Sl. |
Import items |
|
|
Qty. |
|
|
No. |
|
|
|
|
| EDTA Tetrasodium |
1 kg |
1 |
ETHYLENE |
DIAMINE |
TETRA |
0.75 kg |
|
|
|
ACETIC ACID |
|
|
|
| Case No.:1042/15/82- |
|
Party Name:BALAJI AMINES |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
LIMITED |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:3110067338 |
|
|
| :01/82/050/02499/AM19/ |
|
:31/83/040/00184/AM19/ |
|
28.02.2019 |
|
|
Decision: The Committee considered the cases as per agenda and in the light of earlier decision taken in meeting no. 12/82-ALC4/2018 dated 12.12.2018, it was decided to ratify norms under Para 4.7 of HBP v1 308 as per details given below or as applied by the firm, whichever is less:
| Export product |
Qty. |
Sl. No. |
Import items |
Qty. |
| GAMMA BUTYROLACONE |
1 kg |
1 |
1,4 BUTANEDIOL |
1.016 kg |
|
|
2 |
GBL CATAYLYST |
0.001 kg |
| 309 |
<br>Case No.:1044/15/82-<br>ALC4/2018 |
Party Name:CADILA<br>HEALTHCARE LTD |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02501/AM19/ |
RLA File<br>:08/24/040/00412/AM19/ |
Lic.No/Date:0810144716<br>28.02.2019 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| 310 |
<br>Case No.:1045/15/82-<br>ALC4/2018 |
Party Name:SAVA<br>HEALTHCARE LTD. |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02502/AM19/ |
RLA File<br>:31/83/040/00183/AM19/ |
Lic.No/Date:3110067341<br>01.03.2019 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
90
|
|
|
|
|
| 311 |
Case No.:1046/15/82-<br>ALC4/2018 |
Party Name:BIOLOGICAL E<br>LTD |
Meet No/Date:3/82-<br>ALC4/2019 |
Status:<br>Deferred |
|
|
|
05.07.2019 |
|
|
<br>HQ File |
RLA File |
Lic.No/Date:0910067234 |
<br>Defer |
|
:01/82/050/02503/AM19/ |
:09/24/040/00536/AM19/ |
01.03.2019 |
Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| Case No.:1055/15/82- |
|
Party Name:NEOGEN |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
CHEMICALS LIMITED |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310827406 |
|
|
| :01/82/050/02512/AM19/ |
|
:03/95/040/01248/AM19/ |
|
01.03.2019 |
|
|
Decision: The Committee considered the cases as per agenda and in the light of earlier decision taken in meeting no. 15/82-ALC4/2018 dated 22.03.2019, it was decided to ratify norms under Para 4.7 of HBP v1 as per details given below or as applied by the firm, whichever is less: 312
| Export product |
Qty. |
Sl. No. |
Import items |
Qty. |
| ETHYL-2- |
1 kg |
1 |
N-BUTYRIC ACID |
0.743 kg |
| BROMOBUTYRATE |
|
2 |
HYDROBROMIC ACID 48% |
1.425 kg |
|
|
3 |
HYDROGEN PEROXIDE 50% |
0.3618 kg |
|
|
4 |
ETHANOL |
0.2948 kg |
| Case No.:1056/15/82- |
|
Party Name:NEOGEN |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
CHEMICALS LIMITED |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310827408 |
|
|
| :01/82/050/02513/AM19/ |
|
:03/95/040/01249/AM19/ |
|
01.03.2019 |
|
|
Decision: The Committee considered the cases as per agenda and in the light of earlier decision taken in meeting no. 15/82-ALC4/2018 dated 22.03.2019, it was decided to ratify norms under Para 4.7 of HBP v1 as per details given below or as applied by the firm, whichever is less: 313
| Export product |
Qty. |
Sl. No. |
Import items |
Qty. |
| ETHYL-2- |
1 kg |
1 |
N-BUTYRIC ACID |
0.743 kg |
| BROMOBUTYRATE |
|
2 |
HYDROBROMIC ACID 48% |
1.425 kg |
|
|
3 |
HYDROGEN PEROXIDE 50% |
0.3618 kg |
|
|
4 |
ETHANOL |
0.2948 kg |
91
| 314 |
<br>Case No.:1057/15/82-<br>ALC4/2018 |
Party Name:CIPLA<br>LIMITED. |
Meet No/Date:3/82-<br>ALC4/2019<br>05.07.2019 |
Status:<br>Deferred |
|
<br>HQ File<br>:01/82/050/02514/AM19/ |
RLA File<br>:03/94/040/01019/AM19/ |
Lic.No/Date:0310827414<br>01.03.2019 |
<br>Defer<br>Date:05.07.2019 |
|
**Decision:**Deferred for comments of TE. |
|
|
|
| Case No.:1058/15/82- |
|
Party Name:ZYTEX |
|
Meet No/Date:3/82- |
|
Status: |
| ALC4/2018 |
|
BIOTECH PVT. LTD. |
|
ALC4/2019 |
|
Approved |
|
|
|
|
05.07.2019 |
|
|
| HQ File |
|
RLA File |
|
Lic.No/Date:0310827415 |
|
|
| :01/82/050/02515/AM19/ |
|
:03/95/040/01267/AM19/ |
|
01.03.2019 |
|
|
Decision: The Committee considered the cases as per agenda and in the light of earlier decision taken in meeting no. 1/82-ALC4/2019 dated 03.06.2019, it was decided to ratify norms under Para 4.7 of HBP v1 as 315 per details given below or as applied by the firm, whichever is less:
|
Export Product |
Qty. |
Sl. |
Import Items |
Qty. |
|
|
|
No. |
|
|
|
BACILLUS CEREUS |
1 kg |
1 |
PEPTONES(FNI 103) |
2.1 kg |
| RA maytake appropriate action asper the decision of Norms Committee. |
|
|
|
|
|
92
MANUAL CASES
| Case No. |
B-1 |
| Meeting No. |
3/AM20 |
| Date |
05.07.2019 |
| Firm’s Name |
M/s Glenmark Pharmaceuticals Limited, Mumbai |
| HQ F. No. |
01/82/050/01239/AM19/DES-III<br>01/82/050/01232/AM19/DES-III |
| RLA F. No. |
03/94/040/00275/AM19<br>03/94/040/00310/AM19 |
| Advance Authorization No. and Date |
0310822074 dated 02.07.2018<br>0310822310 dated 16.07.2018 |
| Subject |
Request of M/s Glenmark Pharmaceuticals Limited, Mumbai<br>for correction in the quantity of import item fixed against<br>Export Product No. 4 for Advance Authorization Nos.<br>0310822074 dated 02.07.2018 and 0310822310 dated 16.07.2018 |
| **Decision:**The Committee considered the case as per agenda in the presence of technical experts and it<br>was decided to revise the norms of Export Product No. 4 as under:<br>Sl.<br>No.<br>Export product<br>Qty.<br>Sl.<br>No.<br>Import items<br>Qty.<br>4<br>Supiroban 50gm Ointment (Pack<br>Size 50gms) ( Net Wt. of Mupirocin<br>USP is 55.000 Kgs.)<br>1 pack<br>1<br>Mupirocin USP<br>1.02 gm/50<br>gm pack<br>Rest of the earlier Minutes would remain the same.<br>RA may take appropriate action as per the decision of Norms Committee. |
|
93
|
Case No. |
B-2 |
|
Meeting No. |
3/AM20 |
|
Date |
05.07.2019 |
|
Firm’s Name |
M/s Glenmark Pharmaceuticals Limited, Mumbai |
|
HQ F. No. |
01/82/050/01282/AM19/DES-III<br>01/82/050/01350/AM19/DES-III |
|
RLA F. No. |
03/94/040/00303/AM19<br>03/94/040/00449/AM19 |
|
Advance Authorization No. and<br>Date |
0310822335 dated 17.07.2018<br>0310823141 dated 20.08.2018 |
|
Subject |
Request of M/s Glenmark Pharmaceuticals Limited, Mumbai for<br>correction in the quantity of import item fixed against Export<br>Product No. 1 for Advance Authorization Nos. 0310822335 dated<br>17.07.2018 and 0310823141 dated 20.08.2018 |
|
Decision:The Committee considered the case as per agenda in the presence of technical experts and it<br>was decided to revise the norms of Export Product No. 1 as under:<br>Sl.<br>No.<br>Export Product<br>Export<br>Qty.<br>Import Product<br>Quantity Allowed in kg<br>1<br>Lamotrigine Tablets CD 25mg<br>(Pack size 100 Tabs.) Net Wt.<br>of Lamotrigine is 54.250 Kgs.)<br>packs<br>Lamotrigine<br>25.50 mg/ 25 mg tablet<br>Rest of the earlier Minutes would remain the same.<br>RA may take appropriate action as per the decision of Norms Committee. |
|
94
|
Case No. |
Case No. |
B-3 |
B-3 |
B-3 |
B-3 |
B-3 |
|
Meeting No. |
|
3/AM20 |
|
|
|
|
|
Date |
|
05.07.2019 |
|
|
|
|
|
Firm’s Name |
|
M/s Glenmark Pharmaceuticals Ltd., Mumbai |
|
|
|
|
|
HQ F. No. |
|
01/82/050/01222/AM19/DES-III |
|
|
|
|
|
RLA F. No. |
|
03/94/040/00360/AM19 |
|
|
|
|
|
Advance Authorization No. and Date |
|
0310822541 dated 24.07.2018 |
|
|
|
|
|
Subject |
|
Request of M/s Glenmark Pharmaceuticals Limited, Mumbai for<br>correction in the norms fixed for Export Product No. 5 against<br>Advance<br>Authorization<br>No.<br>0310822541<br>Date: 24.07.2018 |
|
|
|
|
|
**Decision:**The Committee considered the case as per agenda in the presence of technical experts and it was<br>decided to revise the norms of Export Product No. 5 as under:<br>Sl.<br>No.<br>Export product<br>Qty.<br>Sl.<br>No.<br>Import items<br>Qty.<br>5<br>Estradiol Vaginal Cream 0.01%<br>42.5 gm (Net Wt. of Estradiol<br>Hemihydrate USP is 42.500 gm.)<br>1 No.<br>pack<br>1<br>Estradiol<br>Hemihydrate<br>USP<br>4.335 mg / pack<br>Rest of the earlier Minutes would remain the same.<br>RA may take appropriate action as per the decision of Norms Committee. |
|
|
|
|
|
|
|
Sl.<br>No. |
Export product |
|
Qty. |
Sl.<br>No. |
Import items |
Qty. |
|
5 |
Estradiol Vaginal Cream 0.01%<br>42.5 gm (Net Wt. of Estradiol<br>Hemihydrate USP is 42.500 gm.) |
|
1 No.<br>pack |
1 |
Estradiol<br>Hemihydrate<br>USP |
4.335 mg / pack |
|
Rest of the earlier Minutes would remain the same.<br>RA may take appropriate action as per the decision of Norms Committee. |
|
|
|
|
|
|
|
Case No. |
Case No. |
B-4 |
B-4 |
B-4 |
|
Meeting No. |
|
3/AM20 |
|
|
|
Date |
|
05.07.2019 |
|
|
|
Firm’s Name |
|
M/s Glenmark Pharmaceuticals Ltd., Mumbai |
|
|
|
HQ F. No. |
|
01/82/050/01270/AM19/DES-III |
|
|
|
RLA F. No. |
|
03/94/040/00411/AM19 |
|
|
|
Advance Authorization No. and Date |
|
0310822872 dated 07.08.2018 |
|
|
|
Subject |
|
Request of M/s Glenmark Pharmaceuticals Limited, Mumbai for<br>correction in the norms fixed for Export Product No. 3 and 8<br>against Advance Authorization No. 0310822872 dated 07.08.2018 |
|
|
|
Decision:The Committee considered the case as per agenda in the presence of technical experts and it was<br>decided to revise the norms as under:<br>Sl.<br>No.<br>Export Item<br>Norms for 1 No. Tablet of<br>import item<br>Norethindrone<br>Acetate<br>Ethinyl<br>Estradiol<br>1.<br>Norethindrone Acetate & Ethinyl Estradiol Tabs. 0.5 & 0.0025 mg<br>(Fem HRT) (Pack Size 84 Tabs.) ( Net Wt. of Norethindrone<br>Acetate is 7.350 Kgs.)<br>0.51 mg<br>0.00255 mg<br>2.<br>Norethindrone Acetate & Ethinyl Estradiol Tabs. 1mg & 0.005mg<br>(Fem<br>HRT)<br>(Pack<br>Size<br>84<br>Tabs.)<br>(Net Wt. of Norethindrone Acetate is 12.600 Kgs.)<br>1.02 mg<br>0.0051 mg<br>3.<br>Norethindrone Acetate & Ethinyl Estradiol Tabs. 1 & 0.02 mg<br>(Loestrin<br>21<br>1/20)<br>(Pack<br>Size<br>63<br>Tabs.)<br>( Net Wt. ofNorethindrone Acetate is 9.450 Kgs.)<br>1.02 mg<br>0.0204 mg<br>4.<br>Norethindrone Acetate Tab. USP 5mg (NETA) (Pack Size 30<br>Tabs.)<br>(Net Wt. of Norethindrone Acetate is 0.375 Kgs.)<br>5.10 mg<br>Nil |
|
|
|
|
|
Sl.<br>No. |
Export Item |
|
Norms for 1 No. Tablet of<br>import item |
|
|
|
|
|
Norethindrone<br>Acetate |
Ethinyl<br>Estradiol |
|
1. |
Norethindrone Acetate & Ethinyl Estradiol Tabs. 0.5 & 0.0025 mg<br>(Fem HRT) (Pack Size 84 Tabs.) ( Net Wt. of Norethindrone<br>Acetate is 7.350 Kgs.) |
|
0.51 mg |
0.00255 mg |
|
2. |
Norethindrone Acetate & Ethinyl Estradiol Tabs. 1mg & 0.005mg<br>(Fem<br>HRT)<br>(Pack<br>Size<br>84<br>Tabs.)<br>(Net Wt. of Norethindrone Acetate is 12.600 Kgs.) |
|
1.02 mg |
0.0051 mg |
|
3. |
Norethindrone Acetate & Ethinyl Estradiol Tabs. 1 & 0.02 mg<br>(Loestrin<br>21<br>1/20)<br>(Pack<br>Size<br>63<br>Tabs.)<br>( Net Wt. ofNorethindrone Acetate is 9.450 Kgs.) |
|
1.02 mg |
0.0204 mg |
|
4. |
Norethindrone Acetate Tab. USP 5mg (NETA) (Pack Size 30<br>Tabs.)<br>(Net Wt. of Norethindrone Acetate is 0.375 Kgs.) |
|
5.10 mg |
Nil |
95
|
5. |
Norethindrone Acetate Tab. USP 5mg (NETA) (Pack Size 90<br>Tabs.)<br>(Net Wt. of Norethindrone Acetate is 1.125 Kgs.) |
5.10 mg |
Nil |
|
6. |
Norethindrone Acetate Tab. USP 5mg (Pack Size 50 Tabs.)<br>(Net Wt. of Norethindrone Acetate is 0.625 Kgs.) |
5.10 mg |
Nil |
|
7. |
Norethindrone Acetate & Ethinyl Estradiol Tabs. 1mg & 0.005mg<br>US<br>(Fem<br>HRT)<br>(Pack<br>Size<br>90<br>Tabs.)<br>(Net Wt. of Norethindrone Acetate is 0.225 Kgs.) |
1.02 mg |
0.0051 mg |
|
8 |
Norethindrone<br>Acetate&EE<br>Tab<br>1.0/0.02mg<br>( Net Wt. ofNorethindrone Acetate is 1.575 Kgs.) |
1.02 mg |
0.0204 mg |
|
9. |
Norethindrone<br>Acetate&EE<br>Tab<br>1.0/0.02mg<br>Nor ACE& EE Tabs & Fe Fumarate (21/7 Regimen) / Hailey FE<br>1/20(Net Wt. of Norethindrone Acetate is 0.945 Kgs.) |
1.02 mg |
0.0204 mg |
|
10. |
Minastrin24Fe<br>(Norethindrone Acetate and Ethinyl Estradiol Chewable Tablets, 1<br>mg/0.02 mg and Ferrous Fumarate Tablets USP, 75 mg) ( Net Wt.<br>of Norethindrone Acetate is 3.600 Kgs.) |
1.02 mg |
0.0204 mg |
|
11. |
Norethindrone/EE<br>Tablets<br>[21]<br>(Loestrin<br>(r)<br>1.5/30)<br>(Microgestin 21 1.5/30) (Pack Size 63 Tabs.) ( Net Wt. of<br>Norethindrone Acetate is 4.725 Kgs.) |
1.53 mg |
0.0306 mg |
|
12 |
Norethindrone/EE/Fe Tablets [21/7] (Loestrin (r) Fe 1.5/30)<br>(Microgestin Fe) (Pack Size 84 Tabs.) ( Net Wt. of Norethindrone<br>Acetate is 4.725 Kgs.) |
1.53 mg |
0.0306 mg |
|
13 |
Norethindrone Acetate EE & FE Fumarate (Loestrin 24FE) 28x3<br>(Pack Size 84 Tabs.) ( Net Wt. of Norethindrone Acetate is 3.600<br>Kgs.) |
1.02 mg |
0.0204 mg |
|
RA may take appropriate action as per the decision of Norms Committee. |
|
|
|
Meeting ended with thanks to Chair.
No analysis has been generated for this document yet.